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Summary 
This thesis applies catFISH, a variant of the standard fluorescence in situ hybridisation 
technique, to study the neuronal ensembles activated by heroin and cocaine across 
brain structures involved in motivated behaviour, in the Sprague-Dawley rat. 
The first chapter reviews the pharmacology of heroin and cocaine, rodent models of 
drug-related behaviours, and heroin and cocaine’s ability to trigger immediate-early 
gene expression when administered acutely or chronically. It is suggested that the 
empirical evidence points towards a significant separation between the neuronal 
systems engaged by the two drugs. The main goal of this thesis was to test whether this 
separation can be seen within brain areas playing a key role in motivation and reward 
(e.g. the nucleus accumbens). Since immediate-early genes serve as markers of neuronal 
activity, and catFISH is a technique which can detect the expression of such genes in 
response to two separate stimuli, the technique was chosen as the best method to test 
if heroin and cocaine activate the same neuronal ensembles when administered acutely. 
The second chapter summarises the methods used across experiments described in 
following chapters. 
The third chapter presents an experiment addressing the methodological issues 
associated with using catFISH to study pharmacological stimuli. The technique was 
originally used to study the hippocampus and brain activity triggered by stimuli with 
well-controlled on- and offset (e.g. exposure to a novel environment or discrete cues). 
Arguably, acute drug injections comprise a stimulus with an on- and offset which can 
only be controlled indirectly – they depend on the drug dose and route of administration, 
among other factors. It was shown that acute intravenous injections of heroin and 
cocaine at doses usually self-administered by animals are suitable stimuli to use with 
catFISH. 
Chapter four describes an experiment showing that, across the striatum, the neuronal 
ensembles activated by an injection of cocaine followed by an injection of heroin overlap 
significantly less than the neuronal ensembles activated by two consecutive injections 
of cocaine. This is interpreted as direct evidence for a significant separation between 
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the neuronal pathways activated by heroin vs. cocaine, even in brain areas often 
considered a common neurobiological substrate for the effects of the two drugs. It must 
be noted that the magnitude and the nature of this separation depends on the particular 
part of the striatum and the order in which drugs are administered. 
Chapter five describes a pilot experiment attempting to incorporate the logic of the 
catFISH technique into a rodent drug self-administration paradigm. It was found that the 
rats preferred self-administering heroin over cocaine, and that there was no detectable 
expression of the homer 1a gene across the striatum in response to acute heroin and 
cocaine after extended experience with the two drugs. There was also no change from 
baseline expression of the homer 1a and arc genes in areas of the prefrontal cortex. 
Finally, chapter six summarises the main findings and the key methodological 
considerations from all three experiments. As a whole, it is suggested that the 
experiments in this thesis provide a proof of concept that heroin and cocaine are 
processed differently by the brain, even within brain areas considered to be common 
substrates for the reinforcing and addictive properties of the two drugs. Future studies 
should take this separation into account, as it may have important implications for 
understanding drug addiction as a whole. 
The appendices contain representative fluorescence microscopy images of brain tissue 
analysed for catFISH. 
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Chapter 1 – Introduction 
 
1. Why study heroin and cocaine?  
Recreational drug use and addiction 
For the year 2015, estimates of drug use and abuse across the world are proportionally 
low, but numerically high – an estimated 5% of people have used illicit drugs at least 
once in that year, and 29.5 million of those people have a diagnosed drug use disorder. 
The highest level of harm in health terms is caused by opioids, including heroin, and 
psychostimulants (methamphetamine and cocaine) follow after. Overall, 70% of total 
drug-induced health problems is attributable to opioids. This is in great part the result 
of rising misuse of pharmaceutical opioids and the risks associated with injectable drugs 
(United Nations Office on Drugs and Crime, 2017). Overall, heroin and cocaine still 
deserve their place at the top of the harm scale (D. Nutt, King, Saulsbury, & Blakemore, 
2007).  
Heroin and cocaine produce feelings of intense pleasure as well as other desirable 
effects (e.g. overcoming tiredness or alleviation of negative emotions) making the two 
drugs very attractive for recreational users. From a certain perspective, heroin, cocaine 
and other psychoactive substances can be used for self-medication: many recurrent 
drug users are struggling with some kind of a psychological issue such as aggression, 
depression or social anxiety, and drugs of abuse can ameliorate such problems 
(Khantzian, 1985). Alternatively, recreational drug use can be understood in terms of 
“drug instrumentalisation” where psychoactive substances are used as a means to 
control mental states at the will of the user. In the modern-day social environment 
humans often have to quickly switch between micro-environments demanding very 
different mental states (e.g. work vs. leisure). Drugs can provide such rapid changes in 
mental states in different ways such as enhancing social interaction, combating fatigue 
or enhancing cognitive performance (Muller & Schumann, 2011).  
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However, prolonged use of some drugs under certain circumstances and by certain 
individuals may transition to pathological use; i.e. addiction. Addiction is characterised, 
above all, by loss of control over drug intake, drug-taking despite negative consequences 
and at the expense of other pleasurable activities. Drug addiction can be very costly to 
both individuals and society. 
Prevention and treatment of addiction could benefit from the study of the neural 
circuitry engaged by both acute and chronic administration of drugs, as well as the study 
of the changes in this circuitry which are believed to mark the transition from 
recreational use to pathological use. Such has been the aim of both psychiatric and 
psychological research over the past few decades, but only recently scientists and 
medical practitioners have begun to acknowledge the complexity and diversity of drug 
abuse disorders.  
Diagnosis and theory of substance use disorders (drug addictions) 
As discussed above, addiction can be broadly defined as compulsive drug-seeking and -
taking despite negative consequences, and at the expense of other recreational 
activities. Within the mental health practice, this phenomenon has been termed 
substance use disorder, and the problematic use of different classes of drugs has been 
classified into a number of substance use disorders. The latest edition of the DSM-V 
classifies substance use disorders into 10 separate categories encompassing alcohol, 
cannabis, some hallucinogens, inhalants, opioids, sedatives, stimulants, tobacco and 
other/unknown (APA, 2013). There are 11 diagnostic criteria to describe these 
substance use disorders, which generally cover three aspects of problematic behaviour 
surrounding the use of the substance in question: loss of control, social impairment, and 
problematic use, plus two pharmacological criteria. The first grouping of criteria, loss of 
control, refers to the inability to stop or reduce use of the substance despite wanting to 
do so, using in higher quantities than intended, and craving – the intense desire to take 
the drug. Social impairment criteria cover aspects of substance use which interfere with 
the ability of the user to fulfil social roles or invest time in activities other than drug 
taking. Problematic use includes criteria describing the use of the substance in 
hazardous situations (e.g. while driving), or despite known physiological or psychological 
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problems caused by the substance. Finally, pharmacological criteria include tolerance 
and withdrawal. 
Although most diagnostic criteria can apply to all problematic use of substances, the 
separation of substance use disorders in the latest edition of the DSM-V comes from the 
recognition of important differences between the brain mechanisms underlying the 
abuse potential of different substances (Badiani, Belin, Epstein, Calu, & Shaham, 2011). 
This separation is also a step away from the commonly used term “addiction” which can 
refer to behavioural addictions such as pathological gambling. Regardless of the 
separation of drug abuse diagnoses, currently prominent psychobiological theories 
explaining the mechanisms behind substance abuse still revolve around the idea of a 
common mechanism for substance abuse (Piazza & Deroche-Gamonet, 2013). 
For example, Homeostatic Dysregulation Theory (Koob & Le Moal, 1997) suggests that 
pathological substance use arises from a persistent change in the set point of the reward 
circuitry of the brain – the dopamine system. That is, with prolonged use of substances 
that directly activate the brain’s reward system, the system becomes less sensitive 
(manifesting as tolerance to the acute effects of the drug and reduced sensitivity to 
other rewards). That, in turn, leads to a negative affective state in the absence of the 
drug (i.e. withdrawal) rendering drug-taking necessary to maintain a functional level of 
motivation. Central notions for this theory are the withdrawal syndrome (both 
physiological and psychological) and reduction in the sensitivity of the reward system. 
Another theoretical framework is set out by Incentive-Sensitization Theory (Berridge & 
Robinson, 2016; Robinson & Berridge, 1993) which emphasizes the difference between 
liking and “wanting” of abused substances, and sensitization of the mechanisms 
underlying the latter (the dopamine system). “Wanting” within this framework refers to 
the motivational drive elicited by substance-associated stimuli through classical 
conditioning, while liking refers to the hedonic responses elicited by the consumption of 
the substance (the “high”). According to the theory, prolonged drug use and individual 
genetic predisposition renders the dopaminergic system hyper-reactive to drug-
associated stimuli in such a way that exposure to these stimuli precipitates further drug 
use at the expense of other activities, and promotes relapse following abstinence. 
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Finally, substance abuse has also been viewed from the perspective of compromised 
executive control (Jentsch & Taylor, 1999) and aberrant learning (Everitt, Dickinson, & 
Robbins, 2001). Theory focusing on executive dysfunction emphasises the role of the 
prefrontal cortex (PFC) in the inhibition of impulsive responses, and the role of the 
amygdala in the influence of conditioned stimuli on behaviour. For example, impaired 
function of the PFC humans leads to impairments in tasks that tap into decision making 
and inhibitory control (Goldstein & Volkow, 2011). On the other hand, the amygdala is 
responsible for the suppression of behaviour by fear-conditioned stimuli and 
invigoration of behaviour in the presence of reward-associated stimuli (Everitt et al., 
1999). Thus, from this point of view, addiction arises in part because the individual is 
highly responsive to drug-associated cues because of amygdala hyperfunction, and less 
able to withhold engaging with these stimuli due to PFC hypofunction. On the other 
hand, aberrant learning theory emphasises the difference between outcome-sensitive 
behaviour (i.e. goal-directed behaviour) and stimulus-response (i.e. habitual behaviour), 
which are mediated by separate brain mechanisms involving the ventral vs. dorsal 
striatum dopamine, respectively (Everitt & Robbins, 2005). The mechanism underlying 
substance abuse proposed by such theories is that adaptive learning mechanisms are 
altered in substance abusers so that behaviour becomes less dependent on its outcome 
and more dependent on impulses and conditioned responses. 
There is no definite consensus yet as to which of the hitherto mentioned theories 
focuses on the key mechanisms by which substance abuse disorders are developed and 
maintained. However, aberrant learning theory has recently been challenged by one 
study clearly showing that addictive behaviour can arise even when drug-seeking is not 
habitual, and when it is controlled by dopamine in the ventral striatum (Singer, Fadanelli, 
Kawa, & Robinson, 2018). Nevertheless, it is safe to say that there are separate brain 
circuits engaged and altered by different classes of drugs. More importantly, in some 
cases, even when circuits overlap between drugs, drug effects go in opposite directions. 
This is particularly true for opiates and psychostimulants, and therefore – heroin and 
cocaine. If any psychobiological theory was to explain drug abuse, it would have to 
account for the mechanisms involved in each of the stages of development of the 
disorder. First, the acute rewarding effects of the drug, which drive initial recreational 
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use. Second, the physiological and psychological changes which accompany the 
transition to compulsive (pathological use), taking into account that such changes occur 
only in some individuals. Third, the mechanisms underlying the propensity to relapse 
after long periods of abstinence. Understanding these mechanisms requires 
manipulation of brain function which is currently possible only in the field of animal 
research. Rodent models have been especially useful in that endeavour, and have served 
as the basis for all currently available psychobiological theories of drug addiction. In 
many cases, however, such theories have overlooked some important differences 
between the mechanisms of heroin and cocaine which can have implications for the 
prevention and treatment of substance abuse disorders. 
Modelling drug reward and relapse into drug-seeking 
Before reviewing any animal models of drug reward and other aspects of substance 
abuse, it must be noted that the concept of reward in psychology is multifaceted. First, 
rewards serve as reinforcers. Second, rewards can include a hedonic/pleasure aspect; 
i.e. they produce positive affect when obtained. The definition of rewards as reinforcers 
is grounded in classical and operant conditioning: it refers to stimuli that elicit approach 
and consummatory behaviours, or to outcomes of actions that increase the probability 
of those actions occurring again. Reward, therefore, can take the form of “natural” 
reinforcers such as food and sex, or can be more abstract – as an extreme example, 
recently, it was shown that social interaction and aggression can be reinforcing in the 
mouse (Golden et al., 2017). Rewarding effects can also be implicit or explicit, in the 
sense that learning, positive affect and motivation can occur outside of conscious 
awareness. A good example of such a case is self-administration of morphine by humans 
at doses which do not differ from placebo in their subjective effects (Lamb et al., 1991). 
Thus, reward has motivational, cognitive and hedonic components, which are separable 
not only conceptually, but also in terms of the neurobiological mechanisms underlying 
them (Berridge & Robinson, 2003). 
There are numerous animal models capturing different aspects of drug reward, and 
some are specifically designed to measure these aspects separately. However, by and 
large, animal models of drug reward are variations of the operant self-administration 
and conditioned place preference (CPP) procedures. 
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The self-administration model is based on operant conditioning where an animal 
(usually a rat) is given the opportunity to interact with a manipulandum in order to 
receive an intravenous infusion of a drug. This is achieved through the implantation of 
an intrajugular catheter connected to an in infusion pump that is activated by pressing 
a lever or by a nose-poke. In this case drugs such as heroin and cocaine act as positive 
reinforcers, because the frequency of lever-presses or nose-pokes increases as the 
animal learns the contingency between the action and the outcome (Gardner, 2000). 
Often there is a control lever or a control hole present to show that the action is 
specifically oriented to the drug-paired manipulandum and is not just the result of 
general activity of the animal.  
In the CPP procedure, a compartment within a chamber is paired with the administration 
of a drug by the experimenter, while a different compartment is paired with the 
administration of a vehicle (e.g. saline). In this case, following repeated parings, the 
animal develops a preference for the drug-paired compartment when given the option 
to choose in drug-free conditions. The logic behind this paradigm is that if a drug such 
as cocaine or heroin induces a pleasant experience (i.e. acts as an unconditioned 
reward/reinforcer), this pleasantness will be associated with the environment through 
classical conditioning. Then, the environment will act as a conditioned stimulus which 
elicits approach (Tzschentke, 1998). Indeed, it is well-established that pairing of both 
heroin and cocaine effects with an environment make it preferable over a vehicle-paired 
environment (Brenhouse & Andersen, 2008; Schlussman et al., 2008). 
The self-administration paradigm has the advantage of modelling self-initiated drug-
taking, which arguably makes it a more ecologically valid model. However, the CPP 
procedure is also relevant since it suggests that even experimenter-administered drugs 
can have rewarding properties.  
The associative processes seen in CPP are also relevant in the sense that they relate to 
a key aspect of the relapse mechanism. Not only the environment, but also discrete cues 
can be associated with drug administration so that they themselves acquire rewarding 
properties. For example, laboratory animals that have learned to associate a light cue 
with the delivery of a drug infusion will later lever press for the presentation of the light 
(Di Ciano & Everitt, 2004a). This conditioned reinforcement is at the basis of modelling 
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drug seeking in general and plays a key role in models of relapse. In such models, rats 
learn to lever press for a drug after which the behaviour is extinguished through 
presentation of the lever, but no contingent drug delivery. With time, the animal 
decreases responding on the lever in the absence of the reinforcer. However, if a light is 
presented contingently on pressing of the lever during training, when the drug was 
available, and then this light was presented contingently again in a test session (in the 
absence of the drug), animals would reinstate lever pressing for the presentation of the 
light, even though the drug is not present (Grimm, Shaham, & Hope, 2002). Thus, 
presentation of a drug-associated stimulus can provoke a behaviour oriented towards 
drug-taking through a motivational process engaged thanks to classical conditioning. In 
addition, lever pressing can be reinstated through exposure to stress or administration 
of a small dose of the drug (de Wit & Stewart, 1981; Shaham & Stewart, 1995). The logic 
behind this model is that a similar process occurs in human substance abusers whereby 
drug-associated stimuli such as drug-taking paraphernalia, or seeing other people take 
the drug, can promote craving – a desire to take the drug (Epstein, Preston, Stewart, & 
Shaham, 2006).  
Similarly, CPP can be used to model reactivation of the memory of rewarding drug 
effects. In this paradigm, CPP is first established and then extinguished by pairing the 
drug-context with the delivery of a vehicle or simply exposing the animal to the drug-
paired context repeatedly without the drug. Then, once preference for the drug-paired 
environment has disappeared, this preference can be reinstated by exposing the animal 
to a small dose of the drug (Mueller, Perdikaris, & Stewart, 2002; Mueller & Stewart, 
2000). 
To summarise, both the rewarding properties of drugs and the propensity to relapse can 
be understood at least in part in terms of classical and operant conditioning. Therefore, 
any understanding of the mechanisms underlying drug reward driving recreational use, 
transition to pathological use, and relapse would require an understanding of the 
neurochemistry and neuroanatomy of brain circuits involved in these forms of learning. 
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Neuroanatomical substrates of reward and motivation 
Previous sections introduced major current theories of drug abuse and mentioned some 
key brain areas and neurotransmitter systems involved in the development of the 
disorder. This section will describe the connectivity and neurochemistry of brain areas 
mentioned throughout this thesis as targets of heroin and cocaine action in the brain, 
and as areas of interest in experimental chapters. These brain areas include the striatum 
and several of its input structures (PFC, amygdala, hippocampus, thalamus, ventral 
tegmental area (VTA) and substantia nigra), as well as some output structures. 
The striatum receives glutamatergic inputs from the thalamus, basolateral amygdala, 
hippocampus and prefrontal/sensorimotor cortices (Voorn, Vanderschuren, 
Groenewegen, Robbins, & Pennartz, 2004). These inputs can be divided in a dorsolateral 
to ventromedial direction, such that the ventromedial striatum receives input 
predominantly from limbic structures, while the dorsolateral striatum receives input 
mostly from the thalamus and sensorimotor cortices (fig. 1.1, p.10). Note, however, that 
only cortical inputs to the ventral striatum (Nacc) distinguish between core and shell – 
basolateral amygdalar and thalamic inputs have a complex organisation and project to 
both core and shell (Wright, Beijer, & Groenewegen, 1996).  More specifically, the Nacc 
shell receives input from the infralimbic cortex, ventral portions of prelimbic area, and 
ventral agranular insular cortex (lateral shell). The Nacc core receives some input from 
the ventral prelimbic area as well, but is mostly targeted by the dorsal PL, and (the lateral 
core) from dorsal agranular insula (Groenewegen, Wright, Beijer, & Voorn, 1999). The 
dorsomedial striatum receives input from the dorsal prelimbic and ventral orbital 
cortices, while the dorsolateral striatum receives input mostly from the anterior 
cingulate dorsal cortex and sensorimotor cortices (Berendse, Galis-de Graaf, & 
Groenewegen, 1992; Voorn et al., 2004). The striatum also receives dense dopaminergic 
innervation from the VTA and substantia nigra pars compacta (SNc). The former targets 
primarily the ventral striatum, while the latter provides dopaminergic input mostly to 
the dorsal striatum. However, there are some sparse reciprocal projections between SNc 
and core (Beckstead, Domesick, & Nauta, 1979). Finally, there are some GABAergic 
inputs to the ventral striatum, for example from the ventral pallidum (VP) forming 
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reciprocal connections with the Nacc. The ventromedial VP projects to the shell, while 
the dorsolateral VP – to the Nacc core (Brog, Salyapongse, Deutch, & Zahm, 1993). 
The main targets of striatal efferent projections are other regions of the basal ganglia: 
ventral pallidum, globus pallidus, substantia nigra pars compacta/reticulata, and the 
VTA. As already mentioned, the Nacc core projects to the dorsolateral VP, and the shell 
– to the ventromedial VP (Zahm & Heimer, 1990).  From the VP, projections continue to 
the thalamus, either directly (for the circuit passing through the Nacc shell) or via the 
substantia nigra pars reticulata, SNr (for the circuit passing through the Nacc core). The 
thalamus then sends projections back to the cortex to form the so-called cortico-basal 
ganglia-thalamocortical loops (Groenewegen, Galis-de Graaf, & Smeets, 1999). The 
dorsal striatum projects to the dorsal rather than ventral pallidum, and either directly to 
the GP internal/SNr, or indirectly through the GP external and STN. The direct and 
indirect pathways are characterised by predominantly dopamine D1 or D2-receptor-
expressing MSNs, respectively (Groenewegen, 2003; Maurin, Banrezes, Menetrey, 
Mailly, & Deniau, 1999; Nagy, Carter, & Fibiger, 1978). 
To summarise, the striatum receives glutamatergic input from several brain areas 
including the amygdala and PFC, and dopaminergic input from the SNc and VTA. The 
afferent projections to the striatum are not uniformly distributed, but are organised in 
a ventromedial to dorsolateral fashion: ventral and medial striatal regions receive dense 
innervation from limbic structures and the VTA, while dorsolateral regions receive 
somatosensory inputs and projections from the SNc. The striatum itself sends mainly 
GABAergic projections to its output targets. 
The striatum is comprised predominantly (95%) of GABAergic medium spiny neurons 
(MSNs), plus some GABAergic and cholinergic interneurons (Lobo, 2009). The GABAergic 
interneurons can be further subdivided in calbindin-, parvalbumin-, or neuropeptide-Y-
expressing ones (Tepper & Bolam, 2004). Contrary to the segregated topography of 
striatal glutamatergic inputs, these cell type distributions are generally uniform across 
the striatum. The MSNs can be further subdivided in dopamine D1- or D2-receptor 
expressing neurons (direct/indirect pathway MSNs), co-expressing either substance P or 
preproenkephalin A, respectively (Le Moine & Bloch, 1995). The dorsal striatum exhibits 
a prominent separation between D1-expressing and D2-expressing MSNs, while the 
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ventral striatum (especially Nacc shell) contains a relatively greater proportion of MSNs 
expressing both types of receptor (Bertran-Gonzalez et al., 2008). 
 
Fig. 1.1. Schematic representation of the major afferent glutamatergic projections of the 
striatum originating from the prefrontal cortex, thalamus, amygdala and hippocampus. 
Subdivisions of these four areas and their corresponding projections areas in the 
striatum are coloured the same. This is a simplified schematic representing the densest 
projections. Adapted from Voorn et al. (2004). Note the dorsolateral-ventromedial 
distribution of somatosensory vs. limbic inputs, with the prefrontal cortex inputs being 
the leading organisational principle. Cortical subdivisions as follows - SMC: 
somatosensory; ACd: anterior cingulate dorsal; PLd and PLv: prelimbic dorsal and ventral, 
respectively; IL: infralimbic; AId and AIv: agranular insular dorsal and ventral, 
respectively. Thalamic subdivisions – PV: paravetricular; IMD: intermediodorsal; CeM: 
central medial; MD: mediodorsal; PC: paracentral; CL: central lateral. 
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Neural circuits engaged by heroin vs. cocaine reward and relapse 
So far, it was suggested that heroin and cocaine are two drugs with well-established 
addictive properties, and that according to current psychobiological theories drug abuse 
arises from the interaction of drugs with an interconnected system of brain areas with 
a key role for the striatum, amygdala, PFC and dopamine. This section will elaborate on 
the historical origins of current theories of drug abuse and discuss some key differences 
between heroin and cocaine suggesting that a unified view of addiction should be called 
into question. 
Historically, studies of reward circuits of the brain were influenced by research going 
back as far as the 1950s. At that time, intracranial electric stimulation was used to 
identify the role of different brain areas in particular behaviours. The discovery of the so 
called “pleasure centre” through this method can be attributed to James Olds and 
colleagues. 
In a somewhat serendipitous manner, Olds and Milner found that electrical stimulation 
of the medial forebrain bundle produced what is now referred to as CPP (Olds, 1956). 
That is, rats would develop a preference towards a particular place where that brain 
area was stimulated. Olds and Peters also demonstrated an operant reinforcement 
effect of this stimulation (Olds & Milner, 1954). The obvious question then was why 
stimulation of particularly that area produces rewarding effects. It was suggested that 
the result comes from the involvement of dopamine release produced by the 
stimulation, and the effect that dopamine has on target areas such as the Nacc. This was 
in part because the Nacc receives input from projections from the VTA, and these 
projections are embedded in the median forebrain bundle. In support of this claim, firing 
of VTA neurons was found to be necessary for maintenance of intracranial self-
stimulation (ICSS) (You, Chen, & Wise, 2001). 
Thus, the euphorigenic effects of drugs, which were believed to be the driving force 
behind drug-taking at least initially, were hypothesised to be mediated by the 
dopaminergic system. Indeed, drugs of abuse, including heroin and cocaine, were found 
to interact with the ICSS and the dopamine system (Bozarth, Gerber, & Wise, 1980; Fish 
et al., 2010; Wauquier & Niemegeers, 1974). However, their effects on dopaminergic 
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transmission and associated long-term changes can differ between drug classes, 
specifically opiates and psychostimulants. It is also the case that both increases and 
decreases in dopaminergic transmission may be associated with vulnerability to 
addiction, and ratings of drug-induced high are independent of dopamine release (for a 
review see D. J. Nutt, Lingford-Hughes, Erritzoe, and Stokes (2015)). For the sake of this 
introduction, only several key studies will be summarised suggesting that opiates and 
psychostimulants are processed differently by the brain and produce different 
behavioural effects. 
For example, it has been shown that heroin and cocaine self-administration are 
mediated by separate neurotransmitter systems. Rats treated with opioid receptor 
antagonists tend to compensate for reduced opioid neurotransmission by increasing 
their operant responding for heroin. In contrast, such manipulation has no effect on 
cocaine self-administration. The opposite is true for the effect of pre-treatment with 
dopamine antagonists which leads to a compensatory increase in operant responses for 
cocaine but not heroin (Ettenberg, Pettit, Bloom, & Koob, 1982). These findings clearly 
show that cocaine exerts its reinforcing effects through direct interaction with the 
dopamine system, while heroin might have either indirect effect on dopaminergic 
release or operate through an entirely separate mechanism. It has been shown that it is 
the latter case, rather than the former, at least as far as DA transmission in the Nacc is 
concerned. Destruction of dopaminergic terminals within that brain area reduces 
cocaine self-administration by 70% within 5 trials post-lesion. In contrast, the same 
manipulation has little effect on heroin self-administration which recovers to more than 
70% of its pre-lesion levels within the same amount of time (Pettit, Ettenberg, Bloom, & 
Koob, 1984). If heroin was producing its reinforcing effects through disinhibition of VTA 
dopamine neurons projecting to the Nacc, as some suggest (Devine & Wise, 1994), this 
would not have been the case. Accordingly, reducing DA D1-receptor function in the 
Nacc shell through RNA interference has been shown to impair acquisition of cocaine, 
but not heroin self-administration in rats (Pisanu et al., 2015). 
It must be noted, however, that there is some evidence for opioid receptor activation in 
the VTA being rewarding (Devine & Wise, 1994). In addition, intracranial injections of 
morphine into the VTA lead to release of DA in the NAcc (Leone, Pocock, & Wise, 1991). 
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One possibility is that the projections from VTA have diverse targets, and DA release in 
the Nacc, although a consequence of VTA neuron firing, is not what drives opiate 
reinforcement. One way to examine this hypothesis through existing research (albeit 
indirectly) is to look for patterns of neuronal activity and morphological changes 
following drug administration. That is, if the rewarding effects of both opiates and 
psychostimulants are encoded in the same way, then neural activity in the reward 
circuitry should be similar. Empirical evidence suggests this is not the case either. In vivo 
multichannel singe-unit recordings during cocaine and heroin self-administration has 
revealed that the majority of neurons respond differently to the two drugs in the Nacc 
and the medial prefrontal cortex. That is, out of all neurons that showed an inhibitory 
or excitatory response to at least one of the drugs, only 25% or less showed the same 
response for the other drug as well. This was true for both brain areas and regardless of 
the order in which the drugs were self-administered (Chang, Janak, & Woodward, 1998).  
Even long-term effects of opiates and psychostimulants differ. Repeated exposure to 
psychoactive substances including but not limited to heroin and cocaine can lead to 
structural changes in neurons. These changes are likely to be related to synaptic 
reorganization that serves as the biological basis for learning and memory, and are likely 
to underlie maladaptive behaviour such as drug abuse. It has been found that while 
cocaine increases dendritic branching and spine density in the Nacc core and shell and 
medial PFC, morphine has the opposite effects in these brain areas except Nacc core 
where such data is not available (Robinson & Kolb, 2004). It has been shown that DA is 
involved in this type of plasticity in the PFC (Reynolds et al., 2018), so these findings add 
further evidence against common DA mechanisms for opiates and psychostimulants. 
Also relevant is the finding that prolonged abstinence from cocaine fails to produce 
many of the behavioural changes associated with withdrawal from morphine, nicotine, 
alcohol and THC in mice. Cocaine withdrawal does not produce the impairments in direct 
social interaction, the increase in motor stereotypy, and the exacerbated conflict anxiety 
produced by withdrawal from the rest of the drugs mentioned. These differences in 
behavioural changes are also accompanied by a decrease in markers of neuronal activity 
in the VTA for all other drugs except cocaine. Finally, morphine and cocaine abstinence 
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produced opposite transcriptional changes in the extended amygdala for a set of HTT-
related genes involved in striatal neurotransmission (Becker, Kieffer, & Le Merrer, 2017).  
The differences between heroin and cocaine extend beyond their direct 
pharmacological actions on cell function. The environmental context can modulate the 
reinforcing and subjective effects of opiates and psychostimulants in opposite directions 
(Caprioli, Celentano, Paolone, & Badiani, 2007). For example, the novelty of the 
environment in which the two drugs are administered can be manipulated by either 
keeping rats in the drug-administration chambers at all times (resident rats) or moving 
rats to a physically identical chamber only during testing (non-resident rats). Studies 
using this paradigm have shown that residents will press more for heroin over a range 
of doses, while non-residents will press more for cocaine and amphetamine (Caprioli et 
al., 2008; Caprioli, Paolone, et al., 2007). The same studies show that, as measured by a 
progressive-ratio schedule, residents are more motivated for heroin than non-residents, 
while the opposite is true for cocaine and amphetamine (at least at certain doses). Non-
residents also reinstate cocaine-seeking after a cocaine priming, while residents do not, 
and the opposite is true for heroin-seeking after a heroin priming (Montanari et al., 
2015). Therefore, the environment can modulate the reinforcing properties of opiates 
and psychostimulants in opposite ways, as well as the propensity to relapse to drug 
seeking. There is also some evidence that these environmental effects may extend to 
the subjective/pleasurable effects of the heroin and cocaine. For example, residents are 
better at discriminating morphine from saline than non-residents, while the latter are 
better at discriminating amphetamine from saline than residents (Caprioli, Celentano, 
et al., 2007; Paolone, Palopoli, Marrone, Nencini, & Badiani, 2004), suggesting that the 
salience of the interoceptive effects of the two drugs are modulated in opposite ways 
by the environmental context. Non-residents also emit more 50 kHz ultra-sonic 
vocalisations than residents in response to cocaine, while the opposite is true for heroin. 
Rats emit this type of vocalisations when exposed to rewarding stimuli, suggesting they 
reflect positive affective states (Avvisati et al., 2016).  
Human studies have provided further support for the findings from rodent studies. Both 
rats and humans prefer taking heroin in familiar/home environments, while cocaine is 
taken outside the home (Caprioli et al., 2009). That is, given the choice, resident rats 
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prefer to self-administer heroin, while non-residents prefer cocaine, and experienced 
human addicts report taking each drug predominantly in different environments. Finally, 
humans also report a pleasant experience of the cocaine high in a novel environment, 
but an unpleasant one at home, while the opposite is true for heroin. These self-reports 
are accompanied by opposite changes in activity of the left middle frontal gyrus, left 
dorsal caudate and cerebellum during cocaine vs. heroin imagery at home and outside 
(De Pirro, Galati, Pizzamiglio, & Badiani, 2018). 
It has been suggested that the opposite modulatory effects of novelty on all these 
effects of opiates and psychostimulants results in part from an interaction between the 
interoceptive stimuli produced by heroin and cocaine (e.g. changes in blood pressure, 
heart rate) and the sensory input from the environment (e.g. visual/auditory stimuli) 
which modulate the acute effects of the two drugs (Badiani, 2013). 
In summary, there is ample evidence that the acute reinforcing effects of opiates and 
psychostimulants are processed very differently within the putative reward circuitry. 
Long-term drug-induced neurobiological and behavioural changes also differ between 
drug classes, and the setting of drug-taking can modulate the subjective and rewarding 
effects of heroin and cocaine in opposite directions.  
Finally, there are known differences between circuits engaged in rodent models of 
heroin and cocaine relapse which shouldn’t be overlooked. Drug seeking can be 
reinstated through exposure to drug-associated context and stimuli or the drug itself 
(Crombag, Bossert, Koya, & Shaham, 2008; Stewart, 2000). The circuitry involved in this 
process involves projections from the medial PFC to the Nacc shell and core for both 
heroin and cocaine. However, while activating the projection from ventromedial PFC to 
Nacc shell promotes context-induced relapse to heroin-seeking (Bossert et al., 2012), 
activating this projection seems to inhibit drug-primed relapse to cocaine-seeking 
(Peters, LaLumiere, & Kalivas, 2008). 
To summarise, a vast amount of empirical evidence points towards a separation of the 
neuronal circuits governing heroin vs. cocaine reward and the propensity to relapse. 
Importantly, the separation between these circuits is not absolute in the sense that, 
indeed, heroin and cocaine do engage the same neuromodulators and brain areas to a 
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significant extent. However, there is also significant variation within these brain areas 
and neuromodulator systems in terms of the information being encoded. It is necessary 
to emphasise this point for the sake of improving both the theory and clinical practice 
within the field of substance abuse. For this reason, the project described within this 
thesis aimed to add further evidence for the different ways in which the brain responds 
to heroin and cocaine. 
2. Pharmacology of heroin and cocaine 
Although heroin and cocaine can both lead to the development of pathological drug-
seeking and drug-taking behaviour, their pharmacological properties are very different. 
To some extent, many differences in the acute behavioural and physiological effects of 
the two drugs can be attributed to their interaction with distinct neurotransmitter 
systems. In addition, heroin and cocaine differ greatly in terms of their metabolism and 
pharmacokinetics. 
Chemical structure and metabolism of heroin and cocaine 
Heroin is synthesised through the addition of two acetyl groups to the molecule of 
morphine (fig. 1.2, p. 17). This change in structure brings about significant changes to 
the pharmacokinetics of the drug, making heroin much more lipid soluble and therefore 
able to cross the blood-brain barrier (BBB) more efficiently (Pardridge, 2012). However, 
apart from this improved ability to enter the central nervous system, heroin is not much 
different from morphine in its pharmacological actions. In fact, heroin is rapidly 
metabolised to morphine after crossing the BBB. Of course, the change in 
pharmacokinetics is not irrelevant, because it means that equal doses of the two drugs 
would have very different efficacy, with heroin being much more potent in producing 
analgesia and euphoria when injected. It should be noted that, once heroin enters the 
brain, it is first metabolised into 6-monoacetylmorphine (6-MAM) before it is 
metabolised to morphine. Morphine itself is further broken down to morphine-3- and 
morphine-6-glucuronide. All these metabolites possess their own pharmacological 
effects. The peak concentration of 6-MAM in the blood and brain following a heroin 
injection is much higher than that of morphine, suggesting that many of the immediate 
effects of heroin might in fact be due to the pharmacology of 6-MAM rather than 
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morphine (Gottas et al., 2013). Thus, the physiological and psychological effects of 
heroin are anything but straightforward, and are heavily dependent on route of 
administration and individual differences in metabolism. 
 
Fig. 1.2. Chemical structures of morphine and heroin. 
Cocaine, on the other hand, is most commonly found with its natural chemical structure 
present in the coca leaf. The cocaine molecule is comprised of a six-carbon phenyl ring 
and a nitrogen-containing ring, both necessary for its biological activity (fig. 1.3, below). 
 
Fig. 1.3. Chemical structure of cocaine. 
Cocaine is lipid-soluble and can get into the bloodstream and pass the BBB easily. For 
this reason, it is a very potent drug especially when injected or snorted. There are several 
known cocaine metabolites amongst which are norcocaine, benzoylecgonine and 
benzoylnorecgonine. It is suggested that individual differences in cocaine metabolism is 
an important factor for both the acute and long-term effects of the drug, since it 
determines the duration of cocaine action in the brain (Schindler & Goldberg, 2012; 
Schuelke, Konkol, Terry, & Madden, 1996). Thus, similarly to heroin, the effects of 
cocaine depend on metabolism just as much as they do on the chemical properties of 
the substance. 
Even a brief glance at their chemical and metabolic properties, reveals some important 
differences between heroin and cocaine. The ability of the two drugs to reach the brain, 
together with their metabolism and rate of elimination, point to potential important 
18 
 
differences in their psychobiological effects. The speed at which they reach the brain, 
the amount of time they spend there and exert their effects, and the targets upon which 
they act all combine to produce their effects in the short and long term.  
Heroin and its metabolites interact with the opioid receptors  
Due to its metabolism (as described above), the effects of heroin are in great part the 
result of its metabolites 6-MAM and morphine binding to opioid receptors in the brain 
(Inturrisi et al., 1983). There are four known types of opioid receptor found through the 
mammalian nervous system – mu (µ), delta (δ), kappa (κ) and NOP-R. Out of these, the 
µ- and δ-receptors are perhaps most relevant to the analgesic, euphorigenic and 
addictive properties of heroin for two reasons: they are found in brain areas involved in 
pain processing, motivation, reward and learning (Mansour, Khachaturian, Lewis, Akil, 
& Watson, 1988), and they are readily bound by 6-MAM and morphine (Mignat, Wille, 
& Ziegler, 1995). It has been suggested that the primary effects of heroin are the result 
of 6-MAM and morphine binding to µ-receptors, and 6-MAM having higher efficacy at 
that receptor than morphine (Selley et al., 2001).  
Opioid receptors are metabotropic, coupled to inhibitory G-proteins (Gi), so that activity 
at these receptors usually leads to decreased excitability and neurotransmitter release 
in the neurons carrying them. This is achieved through several mechanisms. The first 
one is opening of potassium channels which promotes depolarization of the cell 
membrane and thus decreases the probability of action potentials occurring (Torrecilla 
et al., 2002). Activity at kappa opioid receptors can also lead to closing of voltage-gated 
calcium channels which reduces pre-synaptic release of neurotransmitter triggered by 
action potentials (Rusin, Giovannucci, Stuenkel, & Moises, 1997). Finally, Gi proteins 
coupled to the receptors inhibit adenylyl cyclase and reduce the synthesis of cyclic 
adenosine monophosphate – cAMP (Minneman & Iversen, 1976). The consequences of 
this reduced synthesis are complex and beyond the scope of this section, but they have 
to do with chronic effects of heroin use such as tolerance and withdrawal. It happens 
when cAMP levels in the locus coeruleus (LC) become elevated after morphine/heroin 
administration has ceased as a compensatory response to cAMP reduction by those 
drugs. This renders the neurons more excitable, leading to more noradrenaline release 
and, presumably, a heightened state of arousal and negative affect (Nestler, 1996). This 
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process is a good example of how the location of µ-opioid receptors can determine the 
action of heroin – discussed in more detail in the following section. 
Opioid receptors are located in circuits which process autonomic functions, pain, and 
reward 
The various opioid receptor types are distributed inhomogeneously across the central 
nervous system (Mansour et al., 1988). The particular region of the CNS where opiates 
(including heroin and its metabolites) will act on the receptors can define particular 
behavioural and physiological effects of this class of drugs. 
To begin with, heroin has profound depressant effects on the respiratory and 
cardiovascular systems, causing decreased respiration rate (Pattinson, 2008), decrease 
in blood pressure and heart rate (Thornhill, Townsend, & Gregor, 1989) and changes in 
body temperature (Chen, Geller, DeRiel, Liu-Chen, & Adler, 1996). Opiate administration 
also causes constriction of the pupils (Larson, 2008). Activation of µ-opioid receptors 
located in the respiratory centres of the brainstem can suppress breathing, which 
represents one of the primary causes of deaths from illicit drug overdose (Eigner et al., 
2017). Heart rate and blood pressure are also regulated by µ- and δ-receptors in the 
brainstem (Sun, Liu, Li, & Ingenito, 1996). Due to its effects on the respiratory and 
cardiovascular systems, heroin can produce parasympathomimetic-like effects (that is, 
effects mimicking the activation of the parasympathetic nervous system). 
It is worth mentioning that a major effect of heroin is pain relief which involves inhibitory 
action mostly through µ-opioid receptors both at the spinal and the supraspinal levels. 
In the spinal cord, µ-opioid receptors are present at projection neurons which transmit 
pain signals from nociceptors to higher brain centres. Supraspinally, periaqueductal grey 
(PAG) neurons synapse onto inhibitory interneurons in the Raphe nuclei and the LC. 
These synapses are rich in opioid receptors too, since the PAG contains endogenous 
opioid-releasing neurons, and disinhibition of the Raphe and the LC leads to release of 
serotonin and noradrenaline that can modulate pain signals. Finally, opioid receptors in 
the thalamus can prevent pain signals from reaching limbic regions such as the anterior 
limbic cortex, which is involved in the affective aspect of pain (Yaksh, 1997). The ability 
of opiate drugs such as heroin to engage pain-controlling systems is remarkable mainly 
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because it is unmatched by other known substances. The “Holy Grail” of opioid research 
has been the search for analgesics with comparable strength, but lower abuse potential, 
tolerance effects and withdrawal symptoms (Kieffer & Evans, 2002). 
The mechanisms underlying both the abuse potential and the tolerance effects of 
opioids are still disputed amongst scientists (Badiani et al., 2011; Bailey & Connor, 2005), 
and a full review on that topic is beyond the scope of this section. However, within this 
context, it is worth mentioning that µ-opioid receptors are also located within the 
ventral tegmental area (VTA) and the nucleus accumbens (Nacc). The former contains a 
significant proportion of all dopamine-releasing neurons in the brain, and the latter is 
believed to be a point of convergence for circuitry involved in the processing of learning, 
motivation and pleasure (i.e. reward). The action of heroin and morphine on receptors 
in these areas has been shown to be necessary for certain types of behaviour in animal 
models of reward (e.g. drug self-administration). A more detailed explanation of these 
actions of opiates and animal models of reward are provided in following sections. At 
this point, it suffices to mention two receptors within this circuit. First, activity at µ-
opioid receptors located on GABAergic inhibitory interneurons within the VTA results in 
disinhibition of dopamine-releasing neurons (Jalabert et al., 2011). Second, κ-receptors 
can inhibit dopamine release at terminals in the Nacc (Britt & McGehee, 2008). 
Supposedly, the first effect has rewarding properties (Devine & Wise, 1994), while the 
latter leads to negative affect (S. R. Ebner, Roitman, Potter, Rachlin, & Chartoff, 2010). 
Note, however, that rats may self-administer κ-opioid receptor agonists (Marinelli et al., 
1998). 
Cocaine blocks monoamine re-uptake transporters 
Cocaine acts by blocking the re-uptake transporters of dopamine (DA), noradrenaline 
(NA) and serotonin (5-HT). It has the highest affinity for the 5-HT transporter, followed 
by the DA and then the NA transporters (Ritz, Cone, & Kuhar, 1990). Contrary to heroin, 
cocaine achieves its effects mainly through its primary structure rather than through its 
metabolites. By blocking the monoamine transporters, cocaine prolongs the presence 
of already released neurotransmitter in the synaptic cleft and thus prolongs its binding 
to receptors. One additional effect of cocaine, in large doses, is the inhibition of voltage-
gated sodium channels which prevents the propagation of action potentials along axons 
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(Matthews & Collins, 1983). This effect is at the base of cocaine’s local anaesthetic 
properties, as it prevents pain-receptor cells from transmitting signals to the brain. 
Considering that cocaine interacts with not one but three neurotransmitter systems, and 
that those neurotransmitter systems involve several types of receptors each, it is safe 
to say that the effects of cocaine are just as multifaceted as those of heroin. Similarly to 
opioids, DA, 5-HT and NA act on metabotropic receptors. However, these receptors are 
organized in groups with often opposing actions in terms of cellular activity. To begin 
with, DA receptors can be subdivided to D1- and D2-like types. The D1-type are coupled 
to Gs proteins which stimulate cAMP and can be said to increase excitability of the cell 
containing them, while D2 inhibit cAMP and decrease excitability through Gi proteins 
similarly to opioid receptors (Vallone, Picetti, & Borrelli, 2000). Receptors for NA are also 
subdivided in two main groups, alpha (α) and beta (β), each of which have several 
members. Generally, however, postsynaptic receptors are involved in signalling 
cascades that stimulate cAMP formation and calcium build-up inside the postsynaptic 
cell (Strosberg, 1993). Finally, 5-HT receptors are the most diverse with at least 15 
different members across 7 main groups. All of these are metabotropic except the 5-
HT3 which is an ionotropic receptor (Kroeze, Kristiansen, & Roth, 2002). Among all 5-HT 
metabotropic receptors exist both inhibitory receptors which function similarly to opioid 
and D2 receptors (e.g. the 5HT1a receptor) but also receptors that engage the 
phosphoinositide second messenger system like adrenergic receptors (e.g. 5HT2a 
receptors). As already shown for the opioid receptor system, the location of all these 
receptors within the central nervous system defines the psychoactive properties of 
cocaine.  
Cocaine enhances monoamine action both in the peripheral and central nervous 
systems 
The acute effects of cocaine include increased blood pressure and heart rate (Foltin, 
Fischman, & Levin, 1995), increased respiration rate (Trippenbach & Kelly, 1994), 
hyperthermia (Crandall, Vongpatanasin, & Victor, 2002) and dilation of the pupil (Pitts 
& Marwah, 1988). Note that the effects on the cardiovascular and respiratory systems 
are in most part opposite to those of heroin, and resemble activation of the sympathetic 
nervous system (i.e. cocaine can be defined as a sympathomimetic drug). The somatic 
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effects of cocaine are likely to be linked to its effects on the noradrenergic and 
serotonergic systems, which are involved in regulation of the cardiovascular system. For 
example, vasodilation is in part regulated through adrenergic receptors on blood vessels, 
and that serves as a primary mechanism for temperature regulation. There is also 
evidence for dopaminergic and serotonergic mechanisms as well, since mice lacking the 
dopamine and serotonin transporters show lower hyperthermia in response to 
methamphetamine (Numachi et al., 2007). 
Sympathetic effects of cocaine and other stimulants notwithstanding, by far the most 
researched effects of cocaine result from its interaction with the dopaminergic system. 
Primary recipients of dopaminergic inputs are the basal ganglia, including the Nacc and 
dorsal striatum, the prefrontal cortex (PFC) and the amygdala (Arias-Carrion, Stamelou, 
Murillo-Rodriguez, Menendez-Gonzalez, & Poppel, 2010). Cocaine increases dopamine 
levels at synapses in all these areas (Hurd, McGregor, & Ponten, 1997; Sorg & Kalivas, 
1993; Stuber, Roitman, Phillips, Carelli, & Wightman, 2005). Dopaminergic activity in the 
amygdala and the Nacc regulates the motivating properties of cocaine; i.e. seeking and 
taking of cocaine are mediated by dopamine D1 receptors in these areas (Hurd et al., 
1997; Maldonado, Robledo, Chover, Caine, & Koob, 1993). It is noteworthy that cocaine 
also has euphorigenic properties, but these are not mediated by dopamine (Leyton, 
Casey, Delaney, Kolivakis, & Benkelfat, 2005). On the other hand, dopaminergic activity 
in the prefrontal cortex has diverse functions depending on the particular circuitry in 
which DA receptors are embedded and the type of receptor in question. A full review of 
PFC dopaminergic function is beyond the scope of this section, but in general, cognitive 
deficits associated with ADHD and schizophrenia both involve PFC dopamine (Arnsten & 
Li, 2005; Knable & Weinberger, 1997). 
Last but not least, cocaine’s action on the dopaminergic system stimulates locomotor 
behaviour, and is central to the attribution of incentive salience to stimuli by which they 
acquire attention-grabbing and motivational properties (Berridge, 2007). 
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3. Arc and homer 1a – two genes related to neuronal activity and drug 
effects in the brain 
The literature reviewed so far describes heroin and cocaine as two substances that differ 
greatly in their chemical properties, as well as physiological and psychoactive effects. 
Both drugs engage highly distributed neurotransmitter systems, and thus modulate 
fundamental functions of the nervous system (pain, motivation, executive function, etc.). 
Therefore, the study of heroin and cocaine has implications for understanding both 
normal and pathological function of the brain, as well as the use of opioids for analgesia. 
In addition to all that stands a number of drug-use-related disorders, amongst which is 
that of drug addiction – a concept with which heroin and cocaine are often associated. 
One approach to understanding how drug use leads to the development of addiction is 
the study of the neuronal circuitry involved in the transition from recreational to 
pathological drug use. Some of the most useful scientific tools in this area of research 
take advantage of immediate-early genes and their connection to neuronal activity and 
plastic changes in the brain. 
Immediate-early genes 
Immediate-early genes (IEGs) are genes that are transcribed in response to particular 
intra- or extracellular events, but otherwise have low expression levels. These properties 
distinguish them from constitutively expressed genes which are transcribed at constant 
levels and maintain basic cellular function. In addition, translational inhibitors do not 
prevent the expression of IEGs; i.e. they are transcribed without the need for new 
protein synthesis, and are therefore the first response of the genetic machinery of the 
cell to external stimuli. IEGs often encode for transcription factors and can regulate a 
great deal of transcriptional events with long-term consequences. The types of external 
stimuli that can trigger IEG expression include stress and UV light, as well as hormonal, 
growth factor and some neurotransmitter signalling. As their name suggests, IEGs are 
transcribed quickly after the triggering event and their expression is elevated only for a 
relatively short period of time. This is in part due to their shorter length and fewer exons 
relative to other types of genes (Healy, Khan, & Davie, 2013). 
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In the brain, IEG expression often begins after a ligand binds to a receptor in the cell 
membrane and leads to the activation of an intracellular signalling cascade (fig. 1.4, next 
page). One such cascade is the MAPK/ERK pathway, which is involved in the expression 
of some of the most well-known IEGs: c-fos, egr1/zif268, and arc as well as homer 1a. 
The MAPK/ERK pathway is activated by mitogens and growth factors and leads to 
activation of CREB, a transcription factor that promotes IEG transcription (Davis, 
Vanhoutte, Pages, Caboche, & Laroche, 2000). CREB can also be activated following 
calcium release within (Hardingham, Arnold, & Bading, 2001) or influx to the cell, which 
links expression of the IEGs mentioned to excitatory neuronal signalling through 
glutamatergic NMDA receptors (Riccio & Ginty, 2002; Xia, Dudek, Miranti, & Greenberg, 
1996). For example, it has been shown that both normal and seizure-induced activity 
can lead to expression of IEGs in the brain (Link et al., 1995; Lyford et al., 1995). Other 
means by which CREB can be activated is the cAMP/PKA pathway which is linked to 
activity at G-protein coupled receptors such as dopaminergic receptors (Dudman et al., 
2003).  
Since IEGs are transcribed in response to neuronal activity, and often encode for 
transcription factors or effector proteins which can have long-term consequences for 
cellular functioning, they have been implicated in molecular events associated with 
experience-dependent plasticity and learning. Indeed, electrophysiological studies have 
shown that IEGs are expressed following stimulation of neurons which strengthens 
synaptic connections – e.g. long-term potentiation (LTP) (Link et al., 1995). Further 
support for the role of IEGs in learning comes from studies where interference with IEG 
transcription has been shown to affect performance on long-term memory tests and 
maintenance of LTP (Guzowski et al., 2000), as well as Pavlovian fear conditioning 
(Mahan et al., 2012).  
In summary, IEGs are a major player in the functioning of the nervous system thanks to 
their link with excitatory neurotransmission, experience-dependent plasticity and 
learning. IEGs represent one mechanism by which neuronal cell functioning responds to 
changes in the environment, and IEGs are therefore major players in adaptive behaviour. 
They are also an important tool for many molecular biology techniques used to study 
the functioning of the nervous system. For example, they have been used as markers of 
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activity, and, more recently, as drivers of expression for artificially introduced 
fluorescent-protein-encoding genes (transgenes) that allow tagging of neuronal 
populations involved in specific functions – i.e. neuronal ensembles (Cruz et al., 2013; 
Kawashima, Okuno, & Bito, 2014). 
 
Fig. 1.4. A simplified representation of some receptors and intracellular signalling 
cascades involved in IEG transcription. Blue arrows represent direction of molecule 
interactions. Please note that some of the molecules in the signalling cascades are 
omitted for the sake of clarity. Following binding of ligands to receptors, second 
messengers (e.g. calcium, Ca, or cyclic adenosine monophosphate, cAMP) initiate 
signalling cascades which lead to phosphorylation of kinases (e.g. calcium-calmodulin 
kinase II, CaMKII, protein kinase A, PKA, extracellular-signal regulated kinase, ERK). 
These kinases in turn phosphorylate transcription factors such as cAMP-response 
element binding protein (CREB), serum response factor (SRF) or Elk-1. Transcription 
factors then bind to promoter regions of genes (e.g. cAMP response element, CRE, 
serum response element, SRE) to initiate transcription. The red line from the AMPA 
receptor (AMPAR) to arc signifies inhibition of transcription. Activation of µ-opioid 
receptors (R) on the other hand may activate the ERK pathway. This is to show that the 
relationship between excitatory neurotransmission and IEG transcription is not straight 
forward. DA D1: dopamine D1 receptor; VGCC – voltage-gated calcium channel; TRKB: 
growth factor receptor. 
Neuronal ensembles and the c-fos IEG 
The idea of neuronal ensembles can be traced back to the work of Charles Sherrington, 
who proposed that the central nervous system is composed of a number of so-called 
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“reflex arcs” that can influence each other and thus integrate information from the 
environment to produce movement (Sherrington, 1906). These arcs, he proposed, 
consisted of three key prototypical components – neurons which receive information 
from the environment, neurons which control muscles to produce movement and 
neurons connecting the two. Thus, Sherrington was one of the first proponents of the 
idea of specialised groups of neurons carrying information-integrating and sensorimotor 
functions: the basic principle of neuronal ensembles. Later on, a similar idea was put 
forward by Donald Hebb, who proposed that repeated stimulation of the nervous 
system gives rise to the so-called “cell assemblies”: diffuse groups of neuronal cells 
capable of acting in a coordinated, independent manner, and capable of facilitating the 
activity of other such groups of cells. A chain of such “cell assemblies” bridging the gap 
between sensory input and motor output Hebb referred to as a “phase sequence” and 
it was suggested to underlie all thought processes (Hebb, 1949).  
Nowadays, the term “neuronal ensembles” is being used widely, and generally refers to 
a population of neurons specialised in the processing of a given brain function. More 
specifically, a neuronal ensemble can be defined as a group of neurons with similar 
afferent and efferent connections, involved in the computation of similar behavioural 
functions, neuroendocrine regulation or sensorimotor gating (Pennartz, Groenewegen, 
& Lopes da Silva, 1994). Note that such a definition focuses on the neuroanatomical 
connections and functional properties of neuronal cells. 
Electrophysiological research defines neuronal ensembles as groups of neurons that fire 
action potentials with the presentation of a given stimulus or during a particular 
behaviour. It is usually required that neurons pertaining to neuronal ensembles in this 
sense exhibit a synchronised (i.e. correlated) change in overall firing rate time-locked to 
the presentation of a stimulus, the execution of a behavioural response, or a change in 
a behavioural task parameter (Cohen & Kohn, 2011; Nicolelis, Baccala, Lin, & Chapin, 
1995).  For example, Hubel and Wiesel found that individual neurons in the cat visual 
cortex respond preferentially to lines of light presented in a particular orientation (Hubel 
& Wiesel, 1959). Their study was one of the first to provide direct evidence for 
preferential responding of neurons time-locked to the presentation of a particular 
stimulus. Such specialised neurons were found in other brain areas and it was believed 
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that they represent specialised “modules” for a given kind of information (Erickson, 
2001). With time, it was accepted that a more accurate representation of the way 
specific functions in the brain are carried out is by population coding - orchestrated firing 
of motor neurons in the monkey cortex could be used to predict the direction of limb 
movements (Georgopoulos, Schwartz, & Kettner, 1986). These were seminal studies 
showing that neuronal activity can reflect (i.e. encode for) specific nervous system 
functions, not only in terms of sensation and perception, but also movement. Two 
features of neuronal ensembles (form an electrophysiological point of view) can be 
deducted from these two and other similar studies. First, the neurons forming a 
neuronal ensemble are expected to change their activity in a synchronised manner 
which is time-locked to the presentation of a stimulus or the expression of a particular 
behaviour; second, it should be possible to predict the behaviour of an animal from the 
activity of the neuronal ensemble encoding for said behaviour (T. J. Ebner, Hendrix, & 
Pasalar, 2009; Laubach, Wessberg, & Nicolelis, 2000).  
Although electrophysiological approaches are indispensable for understanding the 
relationship between neuronal activity and behaviour, there is a limit to the number of 
neurons that can be recorded from simultaneously, especially in deep brain structures. 
Even with recent advances in large-scale recording using silicon electrode arrays 
(Buzsaki, 2004), recording from sparsely distributed neurons across multiple deep brain 
structures is still problematic. For this reason, the relationship between IEG expression 
and neuronal activity has been used to identify and manipulate neuronal ensembles 
across large deep brain areas through histochemical, and optogenetic techniques. A lot 
of focus in this area has been given to the IEG c-fos.  
The insertion of transgenes downstream of the c-fos promoter has made possible 
tagging of strongly activated neurons with fluorescent markers such as GFP in living cells. 
This has allowed for electrophysiological measurements to be taken from neurons 
known to have been active during a specific event. For example, it has been recently 
shown that c-fos-expressing neurons in the nucleus accumbens activated by the 
presentation of sucrose-associated cue are more excitable relative to non-activated c-
fos-negative neurons (Ziminski et al., 2017). Changes in excitability are a particular kind 
of neuronal plasticity which involves changes in receptor functioning (Zhang & Linden, 
28 
 
2003). This indicates that c-fos does not simply reflect any kind of activity, but activity in 
neurons that undergo plasticity. 
Transgenes can also be used to express proteins that allow for manipulation and 
targeted inactivation of neurons active during a specific event in time. Such techniques 
have been indispensable in providing evidence for the causal role of neuronal ensemble 
activity in behaviour. For example, the Daun 02 technique uses a transgenic line of rats 
or mice where the c-fos-promoter is upstream of a lacZ promoter. In these rodents, the 
strongly activated neurons expressing c-fos also express the protein β-galactosidase. 
When the Daun02 drug is injected in a brain area of interest, the β-galactosidase 
produced by c-fos expressing neurons in the area interacts with Daun02 to produce 
daunorubicin and cause apoptosis in these cells. Using this method, it was shown for the 
first time that sparsely distributed neurons in nucleus accumbens (Nacc) are necessary 
for expression of context-specific sensitisation (Koya et al., 2009), and neuronal 
populations in the ventromedial prefrontal cortex (vmPFC) are necessary for context-
induced relapse to heroin-seeking (Bossert et al., 2011). Thus, c-fos is expressed not only 
in neurons that undergo plasticity, but also in neurons that have a causal role in 
expression of behaviour. This causal role in behaviour is another defining feature of 
neuronal ensembles which is relevant to IEG expression as a marker of neuronal activity 
(Cruz et al., 2013; Koya, Margetts-Smith, & Hope, 2016). 
To summarise, neuronal ensemble research has shown that there are distributed 
populations of neurons across the brain that act in concert to encode functions such as 
perception, movement and conditioned behaviour. A lot of neuronal ensemble research 
has been carried out within the field of electrophysiology, but the use of the c-fos IEG as 
a marker of activity has revealed a relationship of IEG expression with functional 
importance: c-fos is expressed not just in neurons that have been active, but also 
neurons that are crucial for expression of the behaviour for which they encode. In 
addition, they are often neurons that undergo certain types of plasticity. More recently, 
other IEGs have begun to gain popularity in ensemble research such as arc and homer 
1a.  
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The arc gene 
Characteristically of IEGs, arc is normally expressed at low levels, but is elevated 
following administration of electrical stimulation sufficient to produce convulsive 
seizures, and stimulation of the type that produces LTP. In addition, arc is expressed in 
response to natural neuronal activity: a monocular injection of tetrodotoxin (a sodium 
channel blocker) leads to reduced arc expression in the contralateral, but not ipsilateral, 
visual cortex (Link et al., 1995; Lyford et al., 1995).  
The arc gene was first described as an IEG with a protein product that accumulates in 
the soma and dendrites of expressing cells. Thus, arc is different from c-fos in that it 
does not encode for a transcription factor, but an effector protein that directly affects 
the functioning of the cell. 
The property of arc to be highly expressed under conditions of glutamatergic 
transmission makes it a useful marker of cellular activity as in the case of other IEGs. 
What makes arc different, however, is that once it is transcribed in response to cell-
stimulating events, both its mRNA and protein products relocate to the dendrites which 
have received the stimulation (Moga et al., 2004). Although LTP-inducing type of 
stimulation leads to expression of arc, its protein is known to be involved in endocytosis 
of AMPA receptors (Chowdhury et al., 2006), and to be necessary for metabotropic 
glutamate receptor-dependent long-term depression (LTD) of synapses (Park et al., 
2008). Arc transcription is also involved in long-term memory formation, but not short-
term memory or learning (Plath et al., 2006). So, it seems that arc mRNA and protein are 
produced in response to events that reflect cellular activity and increased connectivity, 
while at the same time are involved in molecular processes which weaken synapses. To 
resolve this paradox, it has been suggested that arc is most likely involved in 
homeostatic plasticity whereby it weakens relatively inactive synapses onto dendrites 
that are receiving various inputs with different intensity (Minatohara, Akiyoshi, & Okuno, 
2016).  
Although arc mRNA levels are elevated similarly to c-fos and zif268 following learning 
tasks such as the Morris water maze, the levels of arc and c-fos do not always correlate 
within relevant brain areas such as the hippocampus. In addition, arc levels are more 
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strongly correlated with task performance than c-fos (Guzowski, Setlow, Wagner, & 
McGaugh, 2001).  
In summary, arc is similar to other well-known IEGs such as c-fos in that it is expressed 
under conditions of strong neuronal activation, and is involved in synaptic plasticity. 
However, arc seems to be involved in plasticity more directly by restructuring synapses 
through AMPA receptor trafficking. Finally, although correlated, c-fos and arc patterns 
of expression are not identical following learning tasks. 
The homer 1a gene 
The mRNA of the whole homer 1 gene has four splice variants in total, two of which are 
constitutive (homer 1b and 1c) and two are IEGs (homer 1a and ania 3). The homer 1 
gene spans ~100 kbp, and its constitutive forms are longer, encoded by exons 1-10, while 
the IEG forms are shorter spanning about half that length: exons 1-5 and parts of intron 
5. The unique sequence that distinguishes the two IEG forms is found in the 3’ UTR. The 
homer 1 gene is constitutively expressed in its 1b/c forms, but under conditions of 
neuronal activity transcription is terminated early and intronic sequence is converted to 
exonic, which is a unique way of adapting constitutive form of a gene to an IEG (Bottai 
et al., 2002). 
Similar to arc and other IEGs, the transcription of homer 1a is rapidly induced in response 
to neuronal activation, is dependent on calcium influx through NMDA receptors, and the 
MAPK/ERK pathway is responsible for its transcriptional up-regulation (Sato, Suzuki, & 
Nakanishi, 2001).  
Similarly to arc, the protein product of homer 1a has effects on receptor function and 
synaptic transmission. For example, homer 1a modulates endocannabinoid-mediated 
retrograde synaptic inhibition. It potentiates depolarization-induced suppression of 
excitation, and inhibits metabotropic suppression of excitation (Roloff, Anderson, 
Martemyanov, & Thayer, 2010). In addition, the Homer 1a protein reduces the coupling 
of the metabotropic glutamate receptor mGluR5 to postsynaptic effectors, reducing the 
inhibitory effects of the receptor (Kammermeier & Worley, 2007). 
Homer 1a is also involved in some forms of learning. Homer 1a mRNA is expressed in the 
striatum and prefrontal cortex (PFC) during early instrumental training with food, with 
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patterns of expression changing over time: striatum levels are maintained, while PFC 
and cingulate cortex expression is reduced (Hernandez, Schiltz, & Kelley, 2006). Other 
effects on learning are possible through effects on glutamatergic neurotransmission, 
especially effects on the NMDA and metabotropic glutamate receptors: the Homer 1a 
protein disrupts the physical link between group 1 mGluRs and NMDA receptors by 
disrupting the Homer-Shank protein scaffold that links the two receptors. This results in 
inhibition of NMDA current by group 1 mGluR agonists (Bertaso et al., 2010). 
Thus, homer 1a shares the characteristics of arc and c-fos in that it can be used as a 
marker of neuronal activity, because its expression is under the control of the MAPK/ERK 
pathway and the transcriptional factor CREB. It is also involved in learning, at least as far 
as classical conditioning goes, and has an effect on synaptic transmission by interacting 
with metabotropic glutamatergic receptors, the NMDA receptor and cannabinoid 
neurotransmission. However, the mechanisms of homer 1a transcription is unique and 
differs from those of other IEGs, and so do its interactions with receptor and 
neurotransmitter systems.  
Psychoactive drugs induce IEG expression in the brain 
One of many stimuli that lead to IEG expression in the central nervous system are 
psychoactive drugs. This expression is observed in several brain areas following drug 
administration, and the exact pattern and the magnitude of expression can vary 
depending on many factors including dose, type of drug, route of administration, 
environmental factors and behavioural tasks associated with drug administration. In 
addition, different IEGs can exhibit different patterns of expression under the same 
circumstances (Harlan & Garcia, 1998). 
The definition of psychoactive drugs covers a vast amount of substances. The focus of 
this thesis is on heroin and cocaine for reasons elaborated in previous sections. For the 
sake of conciseness, this section will provide examples for these two drugs and their 
effects on c-fos, arc and homer 1a expression. 
Acute intraperitoneal administration of cocaine induces significant increase of c-fos 
mRNA in the Nacc, but the this effect disappears after chronic treatment with the drug 
(Hope, Kosofsky, Hyman, & Nestler, 1992). Cocaine also increases c-fos mRNA in the 
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dorsal striatum and medial PFC. There the amount of expression varies from rostral to 
caudal areas, and across all areas the magnitude of the effect varies as a function of 
environmental context: novel environments increase IEG expression in response to 
cocaine and amphetamine (Uslaner et al., 2001).  
Subcutaneous administration of heroin leads to elevation of c-fos protein levels in the 
shell of the Nacc, and this effect disappears with chronic treatment. Conversely, the 
opposite is seen in the dorsal striatum where elevated c-fos protein levels are seen only 
after chronic treatment (D'Este, Scontrini, Casini, Pontieri, & Renda, 2002). 
Intraperitoneal injections of cocaine elevate arc mRNA in the PFC, striatum, 
hypothalamus and hippocampus of rats, and, importantly, this effect differs in 
magnitude from that of zif268 expression as a function of brain area (Caffino, Racagni, 
& Fumagalli, 2011). While cocaine induces arc mRNA in the PFC and the magnitude of 
the effect depends on interactions with restraint stress, there was no elevation of zif268 
mRNA levels in this brain area regardless of stress treatment. In the striatum, expression 
of both IEGs was induced by cocaine, but the magnitude of the effect was higher for arc. 
There are no studies looking at the acute effects of heroin on arc mRNA expression, at 
least according to this author’s knowledge.  
Studies on the effect of cocaine on homer 1a expression are scarcer, but there is 
evidence that an intraperitoneal injection of cocaine elevates expression of the gene in 
the dorsal striatum, and the effect differs in magnitude from that seen with zif268 (Unal, 
Beverley, Willuhn, & Steiner, 2009). Studies looking at the effect of heroin 
administration on homer 1a expression are also not known to this author. 
In summary, it is evident that heroin and cocaine administration can induce the 
expression of IEGs in the brain, and the effect differs in magnitude depending on the 
brain area, IEG, and drug administered. There also appears to be a lack of studies on the 
effect of acute heroin administration on arc and homer 1a expression. Given that IEGs 
can serve as markers of activity to identify neuronal ensembles, and that they are 
involved in long-term effects of stimuli on cell functioning, it follows that IEG expression 
triggered by heroin and cocaine administration can be an informative area of research. 
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The relationship between these drugs and IEG expression is closely related to their 
pharmacology and their effects on neuronal systems and behaviour. 
4. Using IEGs to identify neuronal ensembles activated by heroin and 
cocaine. 
So far it was argued that heroin and cocaine act on brain areas including the striatum, 
amygdala, prefrontal cortex, where they interfere with activity of motivational systems 
and affect learning processes. Evidence was also presented that these two drugs induce 
IEG expression in these brain areas (among others) and these IEGs can be used as 
markers of neuronal activity and to identify specialised neuronal ensembles. There is 
also a substantial number of studies suggesting separate mechanisms of action of heroin 
and cocaine on the same neuronal circuits. One step closer towards clarifying the 
commonalities and differences between heroin and cocaine action in the brain would 
be identifying the neuronal ensembles responding to each drug in key brain areas where 
they act to produce their behavioural effects. One way to achieve this would be to take 
advantage of IEG expression and molecular techniques used to detect them in brain 
tissue at the cellular and subcellular resolution. 
In situ hybridisation (ISH) 
In situ hybridisation is a technique which allows for the detection and quantification of 
nucleic acids in intact tissues and cells. The techniques takes advantage of the natural 
property of DNA and RNA strands to bind to strands with complementary nucleotide 
bases (i.e. annealing or hybridisation). When a nucleotide sequence of interest has to be 
detected, and the code of this sequence is known, a “probe” can be synthesised using 
in vitro transcription of such that the probe is complementary to the RNA or DNA strand 
of interest (the “target”). Probes can be synthesised using nucleotides conjugated to 
fluorescent molecules which are then detectable using fluorescence microscopy 
(fluorescence ISH or FISH). More than one probe can be used simultaneously targeting 
several different sequences of interest within the same tissue. 
Introducing the probes to the tissue where they bind their target happens after the 
tissue in question has been extracted from the organism that is subject of study. In the 
case of brain tissue the technique is therefore carried out post-mortem, as the sample 
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needs to be preserved and pre-treated chemically to provide optimal conditions for 
hybridisation. 
CatFISH 
Since FISH is a post-mortem analysis of gene expression, it usually allows for the 
quantification of gene expression resulting from a single event in time (usually up to a 
few hours before tissue extraction). This presents a limitation when the objective is the 
identification of gene expression within the same specimen resulting from two separate 
events. To overcome this limitation, Guzowski, McNaughton, Barnes, and Worley (1999) 
devised a variation of the standard FISH technique which takes advantage of the changes 
in mRNA location within cells as a function of time. This variation of the technique was 
named cellular compartment analysis of temporal activity by fluorescent ISH (catFISH). 
Immediately following gene expression, mRNA is mostly concentrated around the site 
of transcription within the cell nucleus, but then gradually diffuses to the cytoplasm 
where it takes part in other processes (e.g. translation). Since FISH can provide enough 
resolution to distinguish the two types of signal (i.e. nuclear vs. cytoplasmic), if the 
precise timing of the relocation of a given mRNA was determined empirically, it becomes 
possible to determine how long ago a cell has expressed a given gene. When this logic is 
applied to an IEG such as arc, which is expressed in response to cellular activation, 
conclusions can be made about whether a given neuron was activated by two separate 
events. Arc mRNA appears in the cell nucleus within 5 min following neuronal activation 
and relocates to the cytoplasm within ~30 min. Thus, if two discrete events are 
administered 30 and 5 min before brain tissue is collected for FISH, cells which are found 
to contain only nuclear arc mRNA would have been activated by the more recent event, 
while cells containing only cytoplasmic mRNA would have been activated by the more 
distant event, and cells expressing both nuclear and cytoplasmic signal would have been 
activated during both events. On theory, similar logic can be applied to any IEG. For 
example, homer 1a appears in the cell nucleus ~30 min following cell activation and 
moves to the cytoplasm within ~60 min. Therefore, using double-staining FISH for both 
arc and homer 1a, cells containing nuclear arc would represent activity 5 min before 
brain tissue has been collected, while cells containing nuclear homer 1a would represent 
activity 30 min before tissue collection, and the presence of both types of mRNA within 
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the nucleus would signify a cell was active during both events (Vazdarjanova, 
McNaughton, Barnes, Worley, & Guzowski, 2002). This double-staining variation of the 
catFISH technique makes it easier to detect cells activated twice on two separate 
occasions, as sometimes it might be difficult to distinguish between nuclear and 
cytoplasmic arc signal within the same cell. Nuclear signal appears as one or two bright 
dots at 20x to 60x magnification, while cytoplasmic signal is usually more diffuse and 
can occlude intranuclear signal especially given that the colour of the signal is the same. 
With two different types of mRNA being detected in two separate colour channels, such 
problems in detection are avoided. 
Combining detection of arc and homer 1a with the logic behind catFISH allows to not 
only quantify the amount of activity associated with two separate events, but also to 
determine the overlap between the neuronal populations engaged by each event (as 
measured by amount of co-expressing cells). For example, when animals are exposed to 
the same novel environment twice, the two IEGs are expressed coincidentally in the 
same hippocampal neuronal population (Vazdarjanova et al., 2002), while exposing 
them to two distinct novel environments results in much less co-expression in 
hippocampal neurons (Vazdarjanova & Guzowski, 2004). 
5. The aims of this thesis 
A great deal of research on c-fos has shown that IEG expression is an important part of 
drug effects in the brain. Less attention has been paid to more recently discovered IEGs 
such as arc and homer 1a. Given that arc and, to some extent, homer 1a have proven to 
be involved in experience-dependent plasticity, it is worthwhile to characterise their 
expression in the brain following administration of heavily abused drugs such as heroin 
and cocaine. Some studies on the topic have already been undertaken, but most of them 
have studied heroin and cocaine separately, have used molecular techniques that have 
less than cellular resolution, and have mostly used the intraperitoneal route of 
administration. 
The aims of this thesis were to expand on previous findings in three ways. First, we used 
fluorescent in situ hybridisation technique to quantify the expression of arc and homer 
1a mRNA with a cellular (and even subcellular) resolution following non-contingent 
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intravenous injections of heroin and cocaine at doses self-administered by laboratory 
animals. Second, this allowed us to apply the logic of the catFISH technique to look for 
neuronal ensembles encoding for heroin and cocaine effects in the basolateral amygdala, 
striatum, or prefrontal cortex. Third, we applied this paradigm to a drug self-
administration setup. Thus, there were three empirical questions to be answered. 
First, can standard self-administration doses of heroin and cocaine elicit arc and homer 
1a expression in the striatum and BLA if administered non-contingently? This empirical 
question is addressed in chapter 3. Cocaine self-administration doses have been shown 
to induce expression of arc following operant training with cocaine (Fumagalli et al., 
2009). However, these findings cannot automatically be generalised to homer 1a and 
heroin, and it is not clear whether the effect is the result of a single dose within the self-
administration session, or whether it is a cumulative effect. In addition, experimenter 
vs. self-administered morphine can cause different magnitude of plastic changes in the 
accumbens (Robinson, Gorny, Savage, & Kolb, 2002), and if IEG expression is linked to 
plastic changes, it is not unreasonable to expect differences there too. 
Second, are there neuronal ensembles in the striatum encoding for non-contingently 
administered heroin and cocaine, can they be identified using arc and homer 1a as 
markers of activity, and are they overlapping or distinct? One Daun 02 study has shown 
that cocaine administration leads to IEG expression in specific accumbens neurons that 
encode for drug-context associations rather than random neuronal populations (Koya 
et al., 2009). Thus, it is reasonable to expect that there are neurons that will respond 
repeatedly to cocaine when the context is held constant, at least in the accumbens. 
Whether this is the case for heroin remains an open empirical question, and it is 
addressed in the study described in chapter 4.  
Finally, can findings from non-contingent drug administration experiments be 
generalised to the case of self-administration. This question was addressed in the study 
described in chapter 5.  
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Chapter 2 – General methods 
 
To avoid repetition, identical aspects of the methodology used for all experiments 
reported further on are presented here. Additional materials and procedures and/or 
alterations to procedures are described in the corresponding chapters wherever 
necessary. 
Subjects 
Male Sprague-Dawley rats were used in all of the reported experiments. The animals 
were supplied by ENVIGO (Harlan) breeding facilities in Italy and the Netherlands. 
Animals weighed 250-275g upon arrival and were tested at a weight of 300-375 g. The 
rats were housed and tested in a temperature- and humidity-controlled room (21±1°C, 
50%) with a reversed 12 h light cycle (lights on at 7:00 pm). Food and water were 
provided ad libitum except during testing sessions and self-administration training. 
Initially, they were housed three per cage, then, after the implantation of intravenous 
catheters, the animals were housed individually. All regulated procedures were carried 
out in accordance with the A(SP)A 2013.  
Materials 
Housing cages. Following i.v. catheter surgery, rats were housed in cages measuring 40 
x 22 x 22 cm in length, width and height, respectively. The cages had opaque plastic 
bottom and a removable metal cage top with slots for water and food. Sawdust bedding 
and shredded paper nesting were provided at all times.  
Operant chambers. Most of the testing sessions were carried out in operant chambers 
(PRS Italia). These chambers measured 30 x 30 x 30 cm, had a wire mesh floor, two metal 
walls and a transparent Plexiglas front and back walls. Each chamber was placed in a 
sound-insulating wooden cabinet and was equipped with two retractable levers with 
white LED lights placed on the moving part of the levers. These were used only in self-
administration sessions. A counterbalanced metal arm was attached to each chamber 
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which supported the spring and infusion line attached to the animals’ catheter for drug 
delivery. The infusion line was connected to a remotely controlled infusion pump.  
RNAscope®. All in situ hybridisation and catFISH procedures were carried out using 
commercially available kits from RNAscope (Advanced Cell Diagnostics, ACDbio). 
Currently, many probes targeting well-studied genes and mRNA sequences are 
commercially available, and the RNAscope brand has provided a significant 
improvement to the quality of the signal coming from fluorescent probes. A common 
issue with FISH is that probes are never 100% specific in binding to their target and can 
often produce background signal. This is most often the result of binding to partially 
complementary sequences. RNAscope overcomes this issue by using several separate 
stages of target detection and signal amplification (fig. 2.1., p. 39).  
First of all, each RNAscope probes consist of 20 separate Z-shaped nucleic acid 
sequences. The lower part of those Z-shaped elements is complementary to a part of 
the target sequence such that there will always be two Z-probes that can bind next to 
each other (a Z-pair). The intermediate part is a spacer sequence and the top part of the 
Z-probe serves as one half of a binding site which will be bound by a pre-amplifier 
molecule via a hybridization process. The pre-amplifier molecule can only bind a site 
formed by a complete Z-pair. If only one Z-probe has bound non-specifically, 
amplification will not occur. Pre-amplifier molecules bound to a Z-pair are then bound 
by an amplifier molecule which in turn is bound by a fluorescent label. The Z-pair binding 
required for amplification provides very high specificity, while the amplification steps 
provide signal strength such that a single mRNA molecule can be visualised using 
standard fluorescence microscopy.  
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Fig. 2.1. RNAscope probe binding and signal amplification. Black lines on schematic 
represent target mRNA. 
 
Arc and h1a hybridization probes (ACDbio, cat. No. 317071-C2 & 433261, respectively) 
were hybridized to fresh frozen brain coronal sections sliced on a Leica CM1900 cryostat. 
The signal was amplified with an RNAscope® Multiplex Fluorescent Reagent Kit (ACDbio, 
cat. No. 320850). Fluorescent signal was detected using a Zeiss Axioskop 2 plus 
epifluorescent microscope, and images were acquired using an Axiovision software 
(Zeiss). 
The arc probe targeted the region spanning 1519-2621 base pairs of the arc gene mRNA, 
accession No. NM_019361.1.  
The h1a probe targeted the 3’ untranslated region of the homer 1a (h1a) gene mRNA, 
spanning 5001-5625 base pairs, accession No. U92079.1. 
Procedures 
Intravenous catheter surgery. All rats were acclimatized to the housing facilities for a 
period of 1 week, during which they were handled gently every other day. Following 
Probe hybridisation Amplification Fluorescent labelling 
Z-probe Pre-amplifier Amplifier Fluorescent label 
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acclimatization, all rats underwent intravenous catheter surgery. They were 
anesthetised with 110 mg/kg ketamine (Anesketin) and 12 mg/kg xylazine (Rompun). A 
small incision was made on the top of the head, the skull exposed, and four surgical 
screws were positioned around bregma. Another small incision was made just above the 
right clavicle to expose the jugular vein. The vein was separated from surrounding tissue 
and a small incision was made into it to allow for insertion of the catheter. Catheters 
consisted of a 10.5 cm piece of silastic tubing with a silicon bead at 3.2 cm from the end 
entering the right jugular vein. The catheter was secured to the vein with surgical thread 
on both sides of the bead. Then, the free end of the catheter was passed subcutaneously, 
exiting through the skin at the nape of the neck, and was attached to an L-shaped 
cannula, and secured to the animals’ head via the surgical screws and dental cement. 
Following surgery, animals were left to recover for 7 days. Analgesic in the form of 
Metacam oral suspension (2 mg/kg) was given immediately after, and on the day after 
the surgery. Catheters were flushed daily with saline. 
In situ hybridization. Coronal sections of brain tissue were mounted on Superfrost Plus 
slides, the coordinates and thickness of the slices is reported separately for each 
experiment in the corresponding chapters. On the first day of staining, the slides with 
sections were incubated in 10% neutral buffered formalin (Sigma, cat. No. HT501128-4L) 
for 20 min at 4°C, followed by 2x1 min washes in 1xPBS, and then serial dehydration in 
ascending concentrations of ethanol – 50%, 70%, and 2x 100%, 5 min incubation in each. 
Following this, tissue was stored in 100% ethanol overnight. On day 2, the tissue was air 
dried, and then incubated with protease for 20 minutes, followed by 2x1 min washes in 
dH20. Protease, probe and amplifier solutions were supplied by ACDbio as part of a 
commercially available RNAscope assay kit. The arc and h1a probes were then applied 
(50 µl per section), and the sections were incubated for 2h at 40°C in a humidity-
controlled oven. After incubation with the probes, the signal was amplified at 4 separate 
stages with 15 min, 30 min, 15 min and 30 min of incubation in between (respectively) 
at 40°C in the hybridization oven. The probe and amplifier solutions were applied to the 
sections with the help of a hydrophobic pen barrier. There were 2x2 min washes in wash 
buffer after each incubation (including after probe hybridization). Finally, sections were 
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coverslipped and counterstained with DAPI mounting medium (Vector Laboratories, cat. 
No. H-1500) and left at 4°C overnight.  
Image acquisition and analysis. Regardless of brain area studied, greyscale images were 
taken from both hemispheres of 2 adjacent sections for each animal at 20x 
magnification. This yielded 4 images per animal per brain area. Final counts of DAPI-, 
arc-, and h1a-positive nuclei were averaged from these 4 images for each animal and 
each brain area. 
The resulting eight-bit images measured 1300 x 1030 pixels and represented a region of 
interest (ROI) of 700 x 550 µm. These images were analysed using the RIO Montpelier 
extension of the ImageJ software (Baecker & Travo, 2006). Greyscale images were 
analysed separately for each channel: DAPI, Alexa 488 (H1a) and Cy3 (Arc).  
First, each DAPI image was analysed by applying a Gaussian blur filter (sigma = 2), then 
a “rolling ball” background subtraction algorithm (ball radius = 20), followed by the 
application of the default automatic global thresholding algorithm. This yielded a binary 
image which was then used to count objects selected on the basis of their size and 
circularity using the “analyse particles” function of ImageJ. The size criterion was set to 
0.0045-0.045 square inches, and the circularity - to 0.7-1.00. This analysis resulted in a 
mask image containing only object fulfilling the aforementioned criteria. This image was 
used to estimate the total number of DAPI-positive nuclei, and was merged with the 
Alexa 488 and Cy3 images for counting of nuclear mRNA signal. 
The images from the Alexa 488 and Cy3 channels were first adjusted for brightness so 
that the most visible signal was that coming from nuclear staining for arc and h1a. This 
was defined as any signal representing one or two bright dots close to each other, as 
opposed to cytoplasmic signal which is less bright and more diffused (Guzowski et al., 
1999). A global threshold was then applied to the images (default algorithm), and the 
“analyse particles” function was used again to select only objects of 4-90 square pixels, 
and to create a mask of the images showing only the defined particles. These masks of 
the h1a and arc images were then merged with the DAPI mask image, and only those 
particles which coincided with DAPI-stained nuclei were counted. 
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Blinding procedures. All rats were assigned a number upon arrival to the animal 
housing/testing facilities. Following intravenous catheter surgery, rats were assigned to 
experimental treatment groups randomly, and the treatment they received was 
associated to their number by recording it on an Excel spreadsheet. This sheet was 
stored separately from spreadsheets containing behavioural and in situ data associated 
with the number of each rat. Thus, the video recordings of behaviour and microscopy 
image data analysis was carried out by experimenters blind to the experimental 
treatment of the animals, and the group membership of each animal was revealed only 
for the sake of statistical analyses.  
Statistical analyses. All statistical analyses were carried out using the SPSS software. In 
all cases where between-group comparisons were made, the following procedure was 
used. First, a Shapiro-Wilk test was used to assess normal distribution of scores within 
each group. If the assumption for normal distribution of scores was met, a Levene’s test 
was run to check for homogeneity of variance across groups. If this assumption was met 
as well, a one-way ANOVA was run to test for a significant main effect of treatment. 
Where there was more than one dependent variable (e.g. arc- and h1a-positive nuclei, 
single labelling analyses, chapters 3, 4 and 5), multiple one-way ANOVAs were run rather 
than factorial ANOVAs. This was done because the comparisons of interest in those 
cases were between treatment groups for each IEG in isolation, rather than main effects 
of treatment on average IEG expression levels (averaging arc and h1a), which a factorial 
ANOVA provides. Although in theory it is possible to obtain the former kind of 
information from a factorial ANOVA, the SPSS set-up does not allow it without the use 
of syntax. It was decided that such analysis does not provide a substantial advantage 
over a one-way ANOVA.  
Provided that a one-way ANOVA revealed a significant difference between treatment 
groups, either Gabriel post-hoc tests, or Dunnett’s tests were run to look for specific 
between-group differences. Gabriel’s test is adequate when the assumption for 
homogeneity of variance is met, but group sizes differ (Field, 2017). However, the SPSS 
module for this test does not allow specific comparisons, but rather all possible group 
comparisons are made which results in loss of power. Thus, the test was used when all 
comparisons were of interest (e.g. in ch. 3, when the timing profile of IEG expression 
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was being established, and it was necessary to compare all time groups; also ch. 4, 
comparison of overlap measures across treatment groups). When only specific 
comparison was necessary, Dunnett’s tests were chosen because SPSS allows for 
comparisons to be made only relative to a single reference group which serves as a 
control. This was suitable for single-labelling analyses in chapter 4, where it was 
sufficient to show that arc and homer 1a expression increase following drug treatment 
relative to saline.  
For between-group comparisons where scores were not normally distributed in at least 
one group, Kruskal-Wallis tests were run instead of one-way ANOVAs. This was done 
because ANOVA is particularly sensitive to normality violations (Field, 2017). Provided 
that the Kruskal-Wallis test yielded a significant result, differences between particular 
groups were assessed using the Dunn-Bonferroni tests or Mann-Whitney tests, applying 
a Bonferroni correction. Similarly to the case of ANOVA, the Dunn-Bonferroni tests are 
included in the SPSS Kruskal-Wallis module, and are run for all possible comparisons. 
When only specific comparisons were necessary, the Mann-Whitney tests were used to 
avoid loss of statistical power. 
If the normality assumption was met, but homogeneity of variance was violated, a Welch 
test was carried out in conjunction with a one-way ANOVA. If the Welch tests yielded 
significant result, it was followed up by Games-Howell post-hoc tests, if all between-
group comparisons were of interest, or by Mann-Whitney tests (Bonferroni correction), 
if only some comparisons were made (following the logic explained above). The Games-
Howell post-hoc tests are appropriate in cases where heterogeneity of variance across 
conditions is present (Field, 2017). 
For within-group comparisons (e.g. self-administration data, ch. 5), the same logic was 
followed, using Friedman’s ANOVA as the equivalent of the Kruskal-Wallis tests for 
within-group comparisons. Specific group comparisons were done using Wilcoxon’s 
tests. None of the data for within-subject comparisons met the assumptions for a 
parametric ANOVA. 
Where only two groups were compared (e.g. latency to lever press, ch.5), a t-test was 
used provided that the normality assumption was met, and the value of the t-test was 
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reported taking into account the result from Levene’s test (SPSS includes it in the t-test 
analysis automatically and provides a p-value for each possible outcome). 
Finally, categorical data was assessed using Fisher’s exact tests due to small group sizes 
which make the use of chi-square tests problematic (Field, 2017). A Bonferroni 
correction was applied to correct for multiple comparisons. 
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Chapter 3 – Temporal profile of homer 1a and arc 
expression following a single intravenous injection of 
heroin or cocaine 
 
Introduction 
The aim of the experiment described in this chapter was to address several 
methodological issues surrounding the use of catFISH to study acute effects of heroin 
and cocaine. Previous studies have used the technique to identify ensembles activated 
after exposure to an environment or a discrete cue, where stimulus presentation is 
easily controlled by the experimenter (Grosso et al., 2015; Vazdarjanova & Guzowski, 
2004). Drug effects are not so easily controlled in terms of either duration or magnitude. 
Thus, the main issue arising from using catFISH with drug stimuli is the issue of stimulus 
onset and offset. Additionally, drug-induced IEG expression patterns may differ between 
IEGs: for example, cocaine increases zif268 but not homer 1a expression in the cortex 
(Unal et al., 2009). Such differences would inevitably affect measures of overlap with 
catFISH. These issues were addressed by choosing an appropriate dose, route of drug 
administration, and by measuring IEG expression over time and in several brain areas.  
To reiterate briefly, catFISH is used to assess whether the same population of neurons 
respond to two separate stimuli using IEGs as markers of activity. The logic behind the 
technique requires that, timewise, the peak of nuclear expression of the IEGs used 
coincides with the exposure to the two stimuli of interest. Considering that arc and 
homer 1a were used as markers of activity, and arc peaks at 5 min following cell 
activation, while homer 1a peaks 30 min after activation, the stimuli of interest must be 
presented around 30 and 5 min before brain tissue collection, respectively. Then, cells 
activated only by the first stimulus would express homer 1a, but not arc. On the other 
hand, cells activated by both stimuli would express both arc and homer 1a.  
However, if the first stimulus were to influence cell activity for too long (e.g. >20 min), 
then there is a chance that arc would be expressed in cells activated by that stimulus as 
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well. In that case, it would be impossible to distinguish cells activated by the first 
stimulus only, or by both stimuli. This constitutes the importance of properly controlled 
stimulus offset. 
Alternatively, the first stimulus may have its effect on cellular activity with a delay. Then, 
there will not be enough time for homer 1a to be expressed before tissue is collected 
for analysis. In that case, cells activated by the first stimulus will not be detectable. This 
constitutes the importance of properly controlled stimulus onset.  
When the stimuli of interest are exposure to a particular context or a discrete cue, the 
definitions of stimulus on- and offset is arguably straightforward, and control over them 
is easier. The experimenter can place an animal in a novel environment and remove it 
at a precise moment in time. Light cues and tones can be switched on and off at a precise 
time. However, when the stimuli of interest are systemic administrations of a drug, the 
issues of on- and offset become more apparent. The onset of the acute drug effect in 
this study was defined as the moment when the drug is binding to its target in the brain 
and causing changes in neuronal activity. Thus, the onset is not necessarily the moment 
in which the drug is injected (which is what the experimenter has direct control over), 
but when it reaches the brain. Even more so, the time it takes for the drug to stop acting 
at its target in the brain, the offset, is also out of the direct control of the experimenter. 
For example, there is always the possibility that if heroin was injected first, and cocaine 
was injected 25 min later, then cells responding to heroin might still be doing so at the 
time of the cocaine injection. 
Finally, there is the issue of whether both heroin and cocaine can trigger the expression 
of both IEGs, arc and homer 1a, within the same brain area. Although many IEGs are 
expressed in response to cellular activity, they do not necessarily overlap completely in 
their pattern of expression between brain areas, or between tasks and stimuli that 
trigger their expression (Guzowski et al., 2001). If heroin or cocaine injections trigger the 
expression of only arc or homer 1a but not both, then it would be impossible to measure 
the degree of overlap between neuronal populations engaged by the two drugs: one of 
the populations will be technically undetectable. 
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There is some empirical evidence to suggest that cocaine administration can induce arc 
and homer 1a expression across the striatum. Fosnaugh et al. have shown that a single 
cocaine i.p. injection induces arc expression in the striatum, an effect mediated through 
dopaminergic receptors (Fosnaugh, Bhat, Yamagata, Worley, & Baraban, 1995). A brief 
history of i.v. self-administration (a single 2h session) can also elevate arc levels in the 
striatum (Fumagalli et al., 2009). Finally, it has been shown that cocaine-induced arc 
expression is dose-dependent, with higher doses leading to higher expression in the 
striatum, PFC and hippocampus, but the effect is dependent on drug-treatment history 
(Fumagalli et al., 2006). Single and repeated i.p. injections of cocaine are also capable of 
inducing homer 1a expression in the striatum, and the magnitude of the effect decreases 
with repeated treatment (Unal et al., 2009).  
In contrast to cocaine, the literature on the acute effects of heroin administration on arc 
and homer 1a is scarce. In fact, there are no known studies to date that directly address 
the topic. The only studies pointing towards the possibility of opiate effects on arc and 
homer 1a expression have used morphine. One of them has shown elevated arc mRNA 
and protein levels in the rat striatum after repeated exposure to relatively high 
morphine doses (Marie-Claire, Courtin, Roques, & Noble, 2004). Another study has 
shown arc expression in mouse striatum following single morphine injections, an effect 
dependent on direct action on the µ-receptor (Ziolkowska, Urbanski, Wawrzczak-
Bargiela, Bilecki, & Przewlocki, 2005). These findings suggest that arc expression in 
response to morphine action on the µ-receptor might reflect cellular processes that are 
not a direct consequence of cellular activity. However, it must be noted that the effect 
was evident 3 hours after morphine treatment, so any immediate arc response is still 
likely to be indicative of cellular activity. Such immediate response to opiates has not 
yet been demonstrated. Whether this is because of a lack of such a response or because 
studies up to date were not designed to look for it, remains an open empirical question. 
In summary, existing literature suggests that cocaine treatment induces arc and homer 
1a expression in the striatum, and an opiate drug (morphine) acting through the µ-
receptor can also induce arc expression. However, one common feature between all 
studies cited is that they used almost exclusively the intraperitoneal route of 
administration, and molecular techniques that do not allow for high temporal and 
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spatial resolution of mRNA expression such as real-time PCR. Thus, although these 
studies suggests that homer 1a and arc can be used to identify neurons activated by 
cocaine and morphine, they do not resolve all the methodological issues associated with 
catFISH. 
To address the issues of stimulus onset, offset and drug-class differences in IEG 
expression, the study presented in this chapter exposed rats to a single intravenous 
injection of either heroin or cocaine. Then, the amount of arc- and homer 1a-positive 
nuclei in the striatum and basolateral amygdala of these animal was quantified at 
several different time points following injection via standard fluorescence in situ 
hybridisation.  
The intravenous route of administration was chosen because it allows for a very quick 
entry of the drug into the brain. As a consequence, the onset of the drug effect becomes 
almost synonymous with the onset of the drug injection. The clearance rate is also 
relatively quick. For cocaine, the peak levels of drug concertation in the brain are 
reached within 2.5 min after injection and decrease steadily afterwards. Even after a 
dose of 7.5 mg/kg i.v. cocaine is cleared out of the brain within 1 hour. The alternative, 
intraperitoneal injections, have a slower onset, reach a lower and delayed peak 
concentration in the brain (about 30 min after injection), and have a slower rate of 
clearance (Pan, Menacherry, & Justice, 1991). Thus, i.p. injections would have presented 
with both stimulus onset and offset issues. The picture gets more complicated with 
heroin due to it having several metabolites active at the µ-receptor. Nevertheless, it is 
known that even at i.v. doses as high as 1.28 mg/kg, heroin and 6-MAM are cleared form 
the brain within 1 hour (Gottas et al., 2013). In addition, it was intended to eventually 
incorporate a catFISH protocol into the rat self-administration paradigm, which also uses 
the i.v. route, so using the same route in this preliminary study was preferable for that 
reason as well. The intention to use catFISH with self-administration was also how the 
testing doses were chosen. Previous studies by Badiani et al. have shown that doses of 
400 µg/kg/infusion cocaine and 50 µg/kg/infusion heroin maintain self-administration 
and have behavioural effects that differ between residents and non-residents (Avvisati 
et al., 2016; Caprioli et al., 2009; Caprioli et al., 2008; Caprioli, Paolone, et al., 2007; 
Montanari et al., 2015). It was of interest whether a single treatment with these doses 
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would be able to induce IEG expression acutely, and, if so, whether the neuronal 
populations expressing IEGs would differ between heroin and cocaine (a question to be 
directly addressed in follow-up experiments). It was expected that these doses would 
be low enough so that the drugs would be cleared quickly, but high enough to induce 
IEG expression. 
The Nacc core and dorsomedial striatum (DMS) were chosen as two parts of the striatum 
known to be involved in reward and learning processes relevant to drugs of abuse (Di 
Ciano & Everitt, 2004b; Eagle et al., 2011). It is also known that opiates and cocaine elicit 
IEG expression in these areas (Harlan & Garcia, 1998). The BLA was studied since it is a 
key structure in the processing of associative learning, but has different roles in heroin 
and cocaine second-order reinforcement (Alderson, Robbins, & Everitt, 2000), and it is 
anatomically connected to the Nacc core and DMS (as discussed in ch.1, see fig. 1.1, p. 
10). In addition, preliminary analysis of imaging data revealed that the central amygdala 
and Nacc shell did not exhibit levels of IEG expression sufficiently high to be analysed 
quantitatively. 
By measuring both arc and homer 1a nuclear expression at different time points after 
an i.v. injection, it was possible to empirically determine their temporal profile of 
expression following drug administration. Based on previous findings on heroin and 
cocaine pharmacokinetics, and their ability to induce IEG expression in the brain, it was 
expected that heroin and cocaine administration under these conditions will produce a 
brief, temporary increase in IEG expression. This brief increase was expected to peak 
around 8 min following drug administration for arc, while for homer 1a (h1a) the peak 
was expected 25-35 min following injection. These predictions were based on previous 
observations with novel environment and cue-induced IEG expression in catFISH studies. 
Methods 
Animals 
The rats used in this experiment, n = 40, were tested at a weight of 350-375g. Supplier, 
weight upon arrival, and housing conditions were as described in general methods. 
 
50 
 
Test chambers and drugs 
The test chambers were the same as the housing cages described in general methods 
(i.e. the animals were housed and tested in the same cages).  
Cocaine and heroin HCL were dissolved in sterile saline at a concentration of 800 µg/ml 
and 100 µg/ml, respectively. Injections (i.v.) were made at doses of 400 µg/kg for 
cocaine and 50 µg/kg for heroin, so that 0.5 ml of drug solution corresponded to the 
dose for 1kg. Thus, the volume of each injection was between 0.15 and 0.19 ml. Saline 
treated animals received the same volume of saline without any heroin or cocaine 
dissolved in it. Drug infusions were delivered by hand using a 0.5 ml syringe attached to 
the catheter cannulas via a piece of silicone tubing. Note that due to this method of drug 
delivery, the speed of drug infusions was not strictly controlled in this experiment. 
However, it is unlikely that the duration of each infusion exceeded 3 sec, because the 
total volume infused was not larger than 0.2 ml. 
Design  
The design was mixed, with drug treatment (heroin vs. cocaine) and time of sacrifice (0, 
8, 16, 25, and 35 min after injection) as between-subject independent variables (IVs). 
Staining was a within-subject IV, so that each rat was used to measure both h1a and arc 
signal at the time point at which it was sacrificed. The DV was the percentage of DAPI-
stained nuclei co-expressing arc or h1a intranuclear signal.  
For the comparison of drug effects with saline, the within-subject IV was brain area, the 
between-subject IV was drug treatment (heroin, cocaine and saline), and the DV was 
only the percentage of DAPI-positive nuclei co-expressing arc. 
Procedure 
Intravenous catheter surgery and drug treatment. All rats underwent intravenous 
catheter surgery as described in general methods. Following the recovery period, each 
rat was assigned to one of 11 experimental conditions. Some rats received an i.v 
injection of 400 µg/kg cocaine (n = 18) and some of them were euthanised a few seconds 
later (0 min, n = 3), 8 min (n = 3), 16 min (n = 4), 25 min (n = 4) or 35 min later (n = 4). 
Another group of rats received a 50 µg/kg injection of heroin (n = 19), and different 
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number of them were euthanised at equivalent time points (n = 3 for the 0 and 8 min 
groups, n = 4 for the 16 and 25 min groups, and n = 5 for the 35 min group). A final group 
was treated with saline and euthanised 8 min later (n = 3). Animals were euthanised 
using a 0.15 ml i.v. injection of pentobarbital. Immediately after the pentobarbital 
injection, rats were decapitated, their brains extracted, and fresh brain tissue was snap-
frozen in a 400 ml of isopentane cooled to -50°C. The tissue was stored at -80°C for later 
processing. 
RNAscope FISH. The RNAscope probes and reagents, the in situ hybridisation and image 
acquisition and analysis protocols were as described in general methods. Whole brains 
were sectioned at 16 or 20 µm thickness, with tissue collected from two main brain areas 
– striatum (+2.10 to +1.90 mm from bregma) and amygdala (-1.80 mm to -2.00 mm from 
bregma, Paxinos & Watson, 1984). These sections contained the Nacc core and DMS, 
and the basolateral amygdalar nucleus, respectively, where images were taken for 
analysis (see Appendix 1). To ensure consistency, tissue sampling was always conducted 
as follows. Sectioning started from the tip of the olfactory bulbs and brain sections were 
removed until their ventral part (the olfactory bulbs and the basal forebrain region) 
became attached to their dorsal part. At this point, the anterior forceps of the corpus 
callosum (fmi) was visible, and the lateral fissure reached halfway to the midline. This 
was defined as the +3.70 mm from bregma rostrocaudal level (fig. 3.1, next page). At 
this point, either a 100 or 80 sections were removed (when sectioning at 16 µm and 20 
µm, respectively) to reach approx. +2.10 mm from bregma. Then a few sections were 
removed if necessary (no more than 5) to reach the rostrocaudal level where the rostral 
end of the lateral ventricles, the anterior commissure, the fmi and the striatum were all 
visible in the same coronal plane. The fmi formed an inverted C-shape. This was defined 
as +2.00 mm from bregma (fig. 3.2, next page). Here, images of the accumbens core 
were taken by positioning the microscope field of view (MFV) so that its centre was at 
equal distances from the ventral end of the lateral ventricle, and from the anterior 
commissure. If any sections were damaged during collection, the first two intact sections 
were collected. Images of the DMS were taken by positioning the MFV so that its left 
margin coincided with the dorsal part of the lateral ventricle and the medial side of the 
corpus callosum. Then, brain sections were removed until the anterior commissure 
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crossed the midline of the brain, and was seen as a continuous bundle of white fibres as 
opposed to two separate white matter fibre tracts in each hemisphere. This was defined 
as 0.00 mm from bregma. From there, a 110 or 85 sections were removed to reach 
approx. -1.76 from bregma. Then, a few sections were removed if necessary to reach 
the rostrocaudal level where the rostral tip of the hippocampal formation was visible, 
but the CA1-3 regions had just begun to become distinguishable. This was defined as -
1.80 mm from bregma (fig. 3.3, next page). There, the white matter tract of the posterior 
corpus callosum was followed in ventrolateral direction to reach its tip. The centre of 
the MFV was positioned slightly below that tip, where images of BLA were taken. 
 
Fig. 3.1. Schematic representation of the rostrocaudal level defined as +3.70 mm from 
bregma during sectioning. The anterior forceps of the corpus callosum (fmi) is just 
visible, and the lateral fissure extends only halfway to the midline. The olfactory bulbs 
are attached to the ventral prefrontal cortex. This schematic is an approximation. 
 
Fig. 3.2. Schematic representation of the rostrocaudal level defined as +2.00 mm from 
bregma. The Lateral ventricles, anterior commissure (AC), fmi and striatum are visible 
on one section. Green circles represent ROI where images of the Nacc core (1) and 
DMS (2) were taken. This schematic is an approximation.  
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Fig. 3.3. Schematic representation of the rostrocaudal level defined as -1.80 mm from 
bregma during sectioning. The anterior tip of the hippocampus is visible, and the 
posterior corpus callosum is visible as an arc that extends ventrally towards the BLA 
(green circle), where images were taken, from both hemispheres. 
Results 
Nacc core – cocaine 
Figure 3.4 (next page) shows the amount of arc- and h1a-positive nuclei in the Nacc core 
as a function of time following an i.v. injection of cocaine. The highest amount of arc-
positive nuclei was found in the 8 min group (M = 3.55%, SE = 0.51), followed by the 0 
min, 16 min, 35 min and the 25 min groups (M = 2.41%, SE = 0.13; M = 2.35%, SE = 0.34; 
M = 1.66%, SE = 0.23 and M = 1.45%, SE = 0.33, respectively). For h1a, the highest 
amount was found in the 35 min group (M = 3.98%, SE = 0.78), followed by the 25 min, 
16 min, 0 min and 8 min groups (M = 2.75%, SE = 0.35; M = 2.20%, SE = 0.14; M = 1.50%, 
SE = 0.47 and M = 1.38%, SE = 0.27, respectively). 
Shapiro-Wilk tests revealed normal distributions of the scores for arc-positive nuclei 
following a cocaine injection in all 5 time groups. Levene’s statistic was also non-
significant showing homogeneity of variance across groups, F(4,13) = 1.02, p = .433. A 
one-way ANOVA showed a significant effect of time, F(4,13) = 6.09, p = .005. Gabriel’s 
post hoc tests revealed that the 8 min group had significantly higher amount of arc-
positive nuclei relative to the 25 and 35 min groups.  
hippocampus 
posterior 
corpus callosum 
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Shapiro-Wilk tests for the scores of h1a-positive nuclei also revealed normal 
distributions in all conditions, and Levene’s test showed homogeneity of variance, F(4,13) 
= 2.27, p = .117. A one-way ANOVA indicated a significant main effect of time, F(4,13) = 
4.87, p = .013. According to Gabriel’s post-hoc tests the 35 min group had significantly 
more h1a-positve nuclei than the 0 and 8 min groups. 
 
Nacc core – heroin 
The IEG expression in the Nacc core following an i.v. injection of heroin (fig. 3.5, next 
page) was similar to that following cocaine. On average, the highest amount of arc-
positive nuclei was again found in the 8 min group (M = 3.56%, SE = 1.45). This was 
followed by the 0 min, 25 min, 16 min and 35 min groups (M = 2.55%, SE = 0.72; M = 
2.50%, SE = 0.49; M = 2.18%, SE = 0.58 and M = 1.22%, SE = 0.34, respectively). In the 
case of h1a, the 25 min group had the highest amount of mRNA-positive nuclei (M = 
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Fig. 3.4. mRNA expression in the Nacc core following an i.v. injection 
of cocaine as a function of time. Error bars represent ± 1SE. * 
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2.62%, SE = 0.64), followed by the 35 min, 0 min, 16 min and 8 min groups (M = 2.19%, 
SE = 0.58; M = 1.67%, SE = 0.33; M = 1.39%, SE = 0.5; and M = 1.25%, SE = 0.37, 
respectively). 
Shapiro-Wilk tests revealed normal distributions of scores for arc-positive nuclei in all 
conditions except the 16 min group. A Kruskal-Wallis test revealed non-significant 
differences between time groups, H(4) = 5.25, p = .262.  
The Shapiro-Wilk tests for h1a-positive nuclei scores revealed a non-normal distribution 
in the 35 min group. A Kruskal-Wallis test revealed no significant differences between 
groups H(4) = 3.97, p = .41.  
 
DMS – cocaine 
The expression profile of arc an h1a in the DMS following an injection of cocaine was 
similar to that in the Nacc core, but the total amount of mRNA-positive nuclei was about 
twice as high (fig. 3.6, p. 57, note the range of values on the Y axis). Again, the highest 
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Fig. 3.5. mRNA expression in the Nacc core following an i.v. 
injection of heroin as a function of time. Error bars represent ± 1SE. 
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number of arc-positive nuclei was found in the 8 min group (M = 7.17%, SE = 0.97) 
followed by the 0, 16, 25 and 35 min groups (M = 4.26%, SE = 0.35; M = 3.52%, SE = 0.36; 
M = 2.39%, SE = 0.56 and M = 1.81%, SE = 0.25, respectively). On average, h1a levels 
were highest in the 35 min group (M = 9.39%, SE = 0.39), followed by the 25, 16, 0, and 
8 min groups (M = 7.83%, SE = 0.61; M = 5.21%, SE = 0.4; M = 2.35%, SE = 0.86, and M = 
1.9%, SE = 0.32). 
Shapiro-Wilk tests revealed a non-normal distribution of the scores for arc-positive 
nuclei in the 25 min group. A Kruskal-Wallis test revealed a significant difference 
between time groups, H(4) = 13.08, p = .011. Dunn-Bonferroni tests revealed that the 8 
min group had significantly more arc-positive nuclei than the 35 min group. 
All distributions of scores for h1a-positive nuclei across the time groups were normal, as 
assessed by Shapiro-Wilk tests. Levene’s statistic revealed homogenous variance across 
time groups F(4,13) = 0.47, p = .76. A one-way ANOVA indicated a significant effect of 
time, F(4,13) = 35.97, p < .001. Gabriel’s post-hoc tests revealed that the 25 and 35 min 
groups had significantly more h1a-positive nuclei than all other groups, but did not differ 
significantly between each other. The 16 min group was significantly different from the 
rest of the time groups, and the 0 and 8 min groups did not differ from each other. 
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DMS – heroin 
An injection of heroin seemed to produce much lower levels of IEG expression relative 
to cocaine (although no inferential statistics were carried out to compare the two). 
There was still a trend of higher amounts of arc-positive nuclei in the early time groups 
and higher amounts of h1a-positive nuclei in the later time groups (fig. 3.7, next page). 
On average, the highest amount of arc-positive nuclei was found in the 8 min group (M 
= 3.99%, SE = 0.89), followed by the 0, 25, 16, and 35 min groups (M = 3.39%, SE = 0.77; 
M = 2.37%, SE = 0.58; M = 2.10%, SE = 0.55, and M = 1.26%, SE = 0.42). The highest 
amount of h1a-positive nuclei was found in the 35 min group (M = 4.6%, SE = 0.63), 
followed by the 25, 16, 0 and 8 min groups (M = 4.46%, SE = 0.96; M = 3.65%, SE = 1.1; 
M = 2.47%, SE = 0.11, and M = 2.34%, SE = 0.88). 
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Fig. 3.6. mRNA expression in the DMS following an i.v. injection of 
cocaine as a function of time. Error bars represent ± 1SE. *significantly 
different from the 35 min group; #significantly different from the 0, 8, 
and 16 min groups. & - significantly different from all other time 
groups for h1a. Numbers on bars refer to n for each time group.
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Shapiro-Wilk tests revealed a non-normal distribution of scores for arc-positive nuclei in 
the 16 min group. There was also one case of extreme score on this variable in the 35 
min group as assessed by a box-plot. This case was excluded from the Kruskal-Wallis test 
analysis, which revealed a significant difference between groups, H(4) = 11.17, p = .025. 
Dunn-Bonferroni tests revealed that the 8 min group had significantly more arc-positive 
nuclei than the 35 min group. 
Scores for h1a-positive nuclei were not normally distributed in the 25 min group. A 
Kruskal-Wallis test revealed no significant differences between groups for this variable, 
H(4) = 4.49, p = .343. 
 
BLA – cocaine 
The IEG expression profile in the BLA following an injection of cocaine was somewhat 
different from the other two brain areas, mostly because of the high amount of h1a-
positive nuclei in the 16 min group (fig. 3.8, next page). The highest amount of arc-
positive nuclei was still found in the 8 min group (M = 2.49%, SE = 0.93), followed by the 
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16, 0, 25 and 35 min groups (M = 2.14%, SE = 0.35; M = 1.75%, SE = 0.72; M = 1.64%, SE 
= 0.39, and M = 1.57%, SE = 0.53). For h1a, the highest amount of mRNA-expressing 
nuclei was found in the 16 min group (M = 4.21%, SE = 1.11), followed by the 35, 25, 8 
and 0 min groups (M = 4.12%, SE = 1.45; M = 3.52%, SE = 0.32; M = 2.74%, SE = 0.97, and 
M = 2.45%, SE = 0.99). 
Shapiro-Wilk tests revealed a normal distribution of scores for amount of arc-positive 
nuclei across time groups. Levene’s statistic was also non-significant, F(4,13) = 1.28, p 
= .327, suggesting homogeneity of variance. A one-way ANOVA revealed no significant 
differences between groups, F(4,13) = 0.45, p = .774. 
The distribution of scores for the amount of h1a-positve nuclei was also normal as 
assessed by Shapiro-Wilk tests. Variance was homogenous across groups, F(4,13) = 1.19, 
p = .362. A one-way ANOVA revealed no significant main effect of time, F(4,13) = 0.53, 
p = .714. 
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BLA – heroin 
Finally, following an i.v. injection of heroin, the IEG expression in the BLA was as follows 
(fig. 3.9, next page): the highest amount of arc-positive nuclei was found in the 25 min 
group (M = 1.76%, SE = 0.49), followed by the 16, 0, 35 and 8 min groups (M = 1.74%, SE 
= 0.44; M = 1.47%, SE = 0.21; M = 1.26%, SE = 0.41, and M = 1.16%, SE = 0.48). The highest 
amount of h1a-positive nuclei 16 min group (M = 4.05%, SE = 1.09), followed by the 35, 
0, 25 and 8 min groups (M = 3.44%, SE = 0.46; M = 2.78%, SE = 0.28; M = 2.54%, SE = 
0.26, and M = 2.47%, SE = 0.97). 
Shapiro-Wilk tests revealed a normal distribution of scores for amount of arc-positive 
nuclei across time groups. Levene’s statistic was also non-significant, F(4,13) = 1.13, p 
= .381, suggesting homogeneity of variance. A one-way ANOVA revealed no significant 
differences between groups, F(4,13) = 0.38, p = .814. 
The distribution of scores for the amount of h1a-positve nuclei was also normal as 
assessed by Shapiro-Wilk tests. Variance was homogenous across groups, F(4,13) = 1.44, 
p = .273. A one-way ANOVA revealed no significant main effect of time, F(4,13) = 0.96, 
p = .459. 
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Arc expression relative to saline 
Figure 3.10 (next page) shows the increase of arc expression 8 min following a drug 
injection relative to saline as a function of brain area. The percent of cells expressing arc 
following saline was highest in the DMS (M = 2.38%, SE = 0.18), followed by the Nacc 
core (M = 1.25%, SE = 0.11) and the BLA (M = 1.25%, SE = 0.19). Arc expression following 
heroin and cocaine is represented by the same data which were reported above.  
Shapiro-Wilk tests revealed normal distribution of scores for arc expression in all 
conditions. Levene’s statistics revealed homogenous variance in the DMS, F(2,6) = 2.28, 
p = .184, and a one-way ANOVA revealed significant differences between groups in this 
brain area, F(2,6) = 10.07, p = .012. Gabriel’s post-hoc tests revealed that there was a 
difference between the cocaine and saline groups, p = .012. Levene’s test was significant 
for the Nacc core, F(2,6) = 7.42, p = .024, indicating lack of homogeneity of variance. The 
one-way ANOVA was non-significant (F(2,6) = 2.29, p = .187), but the Welch tests 
approached significance, F(2,2.78) = 8.98, p = .061. Finally, Levene’s test approached 
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significance in the BLA, F(2,6) = 5.11, p = .051, and the one-way ANOVA revealed no 
significant differences between groups for this brain area, F(2,6) = 1.45, p = .307. 
 
Discussion 
The present study revealed that single intravenous injections of heroin or cocaine are 
followed by a quick and transient expression of arc and h1a in the striatum. This 
expression had a different temporal profile depending on the IEG in question, as well as 
a different magnitude depending on the drug administered and the brain area of interest. 
Cocaine – Nacc core and DMS 
The nuclear arc expression in the Nacc core and DMS following cocaine reached its 
highest levels 8 min after injection, and was lowest ~30 min after the injection. This 
temporal profile of expression mimics closely that of arc expression in response to 
conditioned cues or a novel environment (Grosso et al., 2015; Vazdarjanova et al., 2002). 
Similarly, h1a nuclear expression followed its predicted temporal profile – its levels were 
low soon after an injection of cocaine (0-16 min), but increased sharply after ~30 min. 
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However, there appeared to be subtle differences between the magnitudes of IEG 
expression between areas (i.e. the Nacc vs. the DMS), but these differences were not 
assessed using inferential statistics. However, it is notable that almost twice as large a 
proportion of observed neurons in the DMS were IEG positive compared to the Nacc 
core. This difference cannot stem from differences in total number of neurons observed, 
since IEG-positive nuclei were quantified as a percentage of all DAPI-positive nuclei. 
Similar findings have been reported before for c-fos (Steiner & Gerfen, 1993). In addition, 
h1a levels in the DMS were significantly elevated 16 min after cocaine, which is quicker 
from its previously reported speed of expression in the hippocampus (Vazdarjanova et 
al., 2002). In summary, the response to cocaine in the striatum met the expectations 
based on previous research with arc and h1a, and there was a slight tendency for a more 
pronounced response in the dorsal vs. ventral parts of this brain area. The magnitude 
and regional differences of mRNA expression reported here was similar to studies with 
c-fos. For example, it has previously been shown that only 2-3% within the NAcc express 
c-fos in response to cocaine (Koya et al., 2009).  
Heroin – Nacc core and DMS 
On average, the highest levels of arc nuclear expression in response to heroin occurred 
at about the same time as in the case for cocaine (8 min), although there was no 
statistically significant effect of heroin on arc expression in the Nacc core. Similarly, on 
average, h1a peaks of nuclear expression occurred at a delayed time after a heroin 
injection (~30 min), but no statistically significant main effect of time was found. There 
seemed to be a difference between heroin and cocaine in the magnitude of these 
expression levels in the DMS, where heroin seemed to have a weaker effect (however, 
this difference was not assessed using inferential statistics). Although heroin and 
cocaine have not been compared directly before, there is some evidence for lower c-fos 
levels in dorsal striatum following morphine vs cocaine (Harlan & Garcia, 1998). In 
addition, there was much higher variability in the levels of arc and h1a in the Nacc core 
and DMS after heroin, to the extent that a main effect of time was observed only in the 
DMS, and only for arc expression.  
In summary, there was a trend for heroin to produce the expected temporal pattern of 
arc and h1a expression in the striatum, but the effect was much less evident in 
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comparison to cocaine. In fact, for heroin the only statistically significant change in 
expression over time was found in the DMS. Clearly, a direct comparison between the 
two drugs is impossible without a full dose-response analysis due to their differences in 
terms of pharmacology. Nevertheless, it is not unreasonable to aim for a similar effects 
on the temporal profile of IEG expression between the two drugs. One likely way of 
achieving that would be increasing the dose of heroin. Further arguments for this are 
presented in following sections with discussion of saline control results.  
Cocaine and heroin - BLA 
The expression of arc and h1a in the BLA following either heroin or cocaine did not 
produce similar temporal profile to the one seen in the striatum. Overall, there was a 
large amount of variability in the average levels of arc and h1a expression in this area 
for both drugs. Thus, any conclusions and generalisations about the results must be 
made with caution. Interestingly, h1a reached its peak levels 16 min following an 
injection of either heroin or cocaine, which was earlier than expected. This increase was 
maintained, on average up to 35 min following drug injections. Conversely, peak levels 
of arc were almost indistinguishable in the BLA for both drugs: arc expression was low 
across all time points with very little change between. Such inconclusive results are 
somewhat surprising given the previous findings of drug-induced c-fos expression in this 
brain area (Day et al., 2001), and the shared MAPK/ERK pathway of arc, h1a and c-fos. 
One possible explanation would be that arc, h1a and c-fos expression in this brain area 
arise after different type of electrophysiological activity. Only strongly activated neurons 
express c-fos, but no electrophysiological profile has been defined for arc and h1a. 
Saline controls 
A comparison was made between arc expression following drug and vehicle 
administration to examine the possibility that temporal changes in the level of IEG 
expression are the result of handling animals rather than a consequence of drug actions 
on neuronal activity. There was a clear effect of cocaine on arc expression in the DMS 
relative to saline. However, the effect of cocaine in the Nacc core and the effect of heroin 
across both areas of the striatum was more subtle and did not reach statistical 
significance. Given the small sample size, it is possible that the effect is genuine, but 
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small, or that the differences found are random variation. Although the latter possibility 
is less likely given that the effect was visible across several brain areas (suggesting it is 
in some way reliable), it is admittedly the case that higher doses should be used in the 
future to reach a more robust effect.  
Implications for catFISH 
The main goal of the present study was to examine the possibility of applying the catFISH 
method to the study of heroin and cocaine’s acute effects. The main obstacles in such a 
task were the issues surrounding stimulus on- and off-set. The data presented here show 
that the use of the i.v. route of administration resolves these issues to a great extent. 
That is, the highest levels of arc expression were seen soon after drug injection, while 
the highest levels of h1a expression were seen about 25 min later. However, it must be 
noted that this was not true for all brain areas or both heroin and cocaine. There were 
no statistically significant effects of heroin on h1a expression in this study, which 
warrants the use of higher doses in following experiments. In addition, there was no 
statistically significant change in IEG expression in the BLA following any drug treatment.  
When present, the IEG response was transient, so that if two injections were 
administered in succession, there wouldn’t be substantial carry-over effects from the 
first to the second. Indeed, there are some notable differences in the magnitude of IEG 
expression between drugs and brain areas, and these can affect estimates of overlap 
measured by catFISH. Nevertheless, these differences can be controlled for statistically. 
Overall, given the data shown here, it should be possible to use catFISH to measure the 
overlap between neuronal populations activated by heroin and cocaine. 
One obvious caveat is the small difference between drug-induced IEG expression and 
IEG expression in the saline-treated animals. These small differences raise the possibility 
that some of the IEG expression seen here is an artefact of the drug administration 
procedure, at least in the case of heroin. It is not possible to conclude whether the cells 
expressing IEG following heroin and saline are the same or different, so the possibility 
of a genuine heroin effect still remains. This issue will be addressed by increasing the 
doses of heroin and cocaine in following experiments. Regardless of this limitation, the 
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present study clearly showed that the IEG response to drug injections under these 
conditions is quick and transient, which was the main goal of this particular study. 
In summary, intravenous injections of heroin and cocaine trigger transient expression of 
the arc and h1a in the striatum. The temporal profile of this expression is similar to the 
one seen in studies using conditioned stimuli and exposure to a novel environment. 
Although there are regional and drug-specific differences in the magnitude of this effect, 
it is an indication that it would be possible to incorporate the catFISH technique into the 
study of heroin and cocaine’s acute effects in parts of the striatum. At the same time, 
the BLA is not a suitable target for such an investigation, because IEG expression there 
was markedly different from that of the striatum in terms of both temporal profile and 
magnitude.  
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Chapter 4 – Distinct neuronal populations respond to 
heroin and cocaine across the striatum 
 
Introduction 
In the previous chapter it was established that i.v. injections of heroin and cocaine at 
doses known to be self-administered by animals lead to a quick and transient IEG 
response in the Nacc core and DMS, albeit with some caveats regarding the effects of 
heroin (see discussion in previous chapter). It was concluded that the catFISH technique 
can be applied to the study of pharmacological stimuli. This chapter describes a follow-
up experiment where catFISH was used to measure the overlap between neuronal 
populations active after two consecutive injections of either saline, cocaine or heroin (in 
different combinations). Here it was possible to find out if these neuronal populations 
are overlapping or distinct, and if there are neurons that reliably respond to heroin and 
cocaine on two separate occasions across the striatum (defined as neuronal ensembles). 
Note that, in view of the various theoretical definitions of a neuronal ensemble reviewed 
in ch. 1, a distinction was made between activated neuronal populations and neuronal 
ensembles. The former was defined as a group of any neurons active at the time of a 
particular drug or saline injection, while the latter was defined as a group of neurons 
activated by the same type of injection on two consecutive occasions. This latter 
definition for a neuronal ensemble has previously been used by Xiu et al. (2014), and it 
implies that since neuronal ensembles are activated by a particular stimulus, then the 
presentation of that stimulus on two separate occasions should activate more or less 
the same neurons.  
Using this definition, Xiu et al. have previously found neuronal ensembles activated by 
morphine in the NAcc shell (Xiu et al., 2014). The technique used in that study took 
advantage of the temporal difference between c-fos mRNA transcription and protein 
translation (TAI-FISH). Effectively, the logic behind the TAI-FISH technique is identical to 
catFISH: two stimuli are administered in succession, and the neuronal population 
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activated by the first one is labelled by the FOS protein, while for the second stimulus it 
is labelled by c-fos mRNA. The study found that two consecutive i.p. injections of 
morphine or two separate application of a foot shock activate almost exclusively the 
same populations of neurons in the Nacc shell and paraventricular nucleus of the 
thalamus, respectively. In addition, injections of morphine and then cocaine activated 
almost the same populations of neurons in the shell: there were significantly less 
neurons activated by only one stimulus or the other relative to neurons activated by 
both. Finally, neuronal populations in the shell activated by morphine and foot-shock 
were almost completely separated. Thus, there is evidence that pharmacological stimuli 
such as morphine injections reliably recruit more or less the same neurons in the shell, 
at least as long as c-fos-expressing neurons are concerned. The present study expands 
on these findings in several ways. 
First, the present study used i.v. injections of heroin and cocaine instead of i.p. injections. 
The pharmacokinetic differences resulting from the two routes of administration and 
their methodological implications for catFISH were discussed in the previous chapter. In 
addition to those considerations, using one route vs. the other also has implications for 
drug effects on IEG expression. For example, a dose of cocaine administered over 5 or 
25 sec elicits higher arc and c-fos mRNA expression in the Nacc core and shell compared 
to the same dose administered over 100 sec (Samaha, Mallet, Ferguson, Gonon, & 
Robinson, 2004). This indicates that the rate at which cocaine reaches the brain 
determines its effects on IEG expression. Potential reasons for it are that higher rate of 
administration leads to increased ability of cocaine to block dopamine (DA) re-uptake, 
and quicker rise in extracellular dopamine (Ferrario et al., 2008), because both c-fos and 
arc expression are to some extent dependent on DA transmission (Fosnaugh et al., 1995; 
Graybiel, Moratalla, & Robertson, 1990). Thus, it is reasonable to expect that using an 
i.v. route with a quicker rate of drug entry to the brain would result in more robust IEG 
response relative to an i.p. injection. That in turn means a different set of neurons being 
active, and, potentially, a different neuronal ensemble. Whether that would also mean 
a different degree of overlap between neuronal populations is a question addressed 
empirically in the present study. 
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A second difference from the Xiu et al. study is the use of heroin instead of morphine. 
As already mentioned, arc expression is dependent on DA, and so is in fact homer 1a 
(Yamada et al., 2007). There are big differences in DA release following heroin vs. 
morphine injections, heroin producing much higher levels of DA release, most likely 
because of the actions of 6-MAM (Gottas, Boix, Oiestad, Vindenes, & Morland, 2014). 
Thus, heroin is likely to recruit additional if not entirely different neurons across the 
striatum. Again, whether this would affect estimates of overlap between drug-activated 
neuronal populations is an open question.  
Finally, the present study looked at several different parts of the striatum in addition to 
the Nacc shell, and identified the neuronal populations activated following different 
order and combinations of drug administration. More specifically, this study looked at 
the Nacc core, dorsomedial and dorsolateral striatum (DMS and DLS) in addition to the 
shell. All these areas are targets of dopaminergic innervation and are believed to 
undergo functional changes following drug administration (Belin & Everitt, 2008; Volkow 
et al., 2006). Also, each of these four subdivisions of the striatum receive different 
glutamatergic and dopaminergic projections, as discussed in ch.1 (e.g. see fig. 1.1, p.10). 
Additional combinations of drugs administered included consecutive injections of heroin 
as well as consecutive injections of cocaine. In this way it was possible to address the 
question of whether there are neurons that are reliably activated, and across different 
areas, following consecutive administrations of each drug. The order of drug 
administration (heroin-cocaine and cocaine-heroin) was also studied as a possible factor 
in IEG expression and neuronal population overlap measures. Due to the design implied 
by the catFISH technique, injections were administered with a relatively short amount 
of time in between. Thus, it was possible that some changes in the intrinsic properties 
of the cell following the first drug injection could have affected the effect of the second 
one. 
The doses used for this study were increased to 800 µg/kg of cocaine and 100 or 200 
µg/kg for heroin. This is a two-fold increase relative to the doses used in the study 
reported in chapter 3, where the temporal profile of mRNA expression was examined. 
The reason for this change was aiming at a more pronounced IEG response, especially 
in the case of heroin. In the previous chapter it was shown that, although heroin 
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injections produced the same quick and transient IEG response as cocaine, the response 
was much more variable and of a lower magnitude. In addition, elevation of IEG 
expression after cocaine vs. after saline treatment was somewhat subtle at lower doses. 
Making inferences about overlap between neuronal populations activated by heroin and 
cocaine could have been problematic if the number of active cells after each injection 
was too low. To make sure there was to be a reliable increase of IEG expression from 
baseline following heroin, the dose was increased two- and four-fold. Having two 
different doses also helped reveal any expression pattern differences for lower and 
higher doses of heroin. Saline control groups were also added to account for any 
changes in temporal profile of IEG expression due to the increased doses.  
It was expected that the neuronal populations activated by two consecutive injections 
of cocaine would exhibit a high degree of overlap due to having the same stimulus 
administered twice. Considering the evidence that self-administration behaviour is 
mediated by different type of signalling in the NAcc, it was also predicted that an 
injection of cocaine and an injection of heroin would activate populations that overlap 
to a significantly lesser extent. 
Methods 
Animals, housing and testing cages 
The rats used in this experiment (n = 50) were tested at a weight of 300-310g. Supplier, 
weight upon arrival, and housing conditions were as described in general methods. 
Following acclimatization and catheter surgery, until the day before testing, rats were 
placed in the housing cages and were moved to the operant chambers for the night 
before and during the day of testing (details in procedure section). 
Drugs 
Heroin HCL was dissolved in sterile saline at concentrations of either 825 µg/ml or 1.65 
mg/ml. Cocaine HCL was dissolved at a concentration of 6.6 mg/ml. All drug infusions 
had a volume of 40 µl, which corresponded to doses of either 100 µg/kg or 200 µg/kg 
for heroin, and a dose of 800 µg/kg for cocaine. As discussed above, the doses used in 
this study were increased in order to achieve a more robust IEG response. Note that in 
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this case drug infusions were delivered remotely, using a computer-controlled infusion 
pump (more details in procedure section).  
Design  
The study had a between-subject design. The independent variable was the combination 
of drugs administered. For the first two waves of rats (n = 35) these were: saline - saline, 
saline – cocaine, cocaine – saline, cocaine – cocaine, cocaine-heroin 100 µg/kg, cocaine 
– heroin 200 µg/kg. For a separate wave (n = 15) the groups were: heroin – heroin, 
heroin – cocaine, and heroin – saline (heroin given at 200 µg/kg in each case). 
Dependent variables were number of DAPI-positive cellular nuclei, cell nuclei positive 
for h1a mRNA, cell nuclei positive for arc mRNA, and nuclei positive for both types of 
mRNA.  
Procedure 
Acclimatization and catheter surgery were carried out as described in general methods. 
Testing. All rats were moved to the testing chambers 18 hours before the testing session 
in order to habituate them to the novelty of the testing environment. This was done to 
avoid interaction effects between drugs and novelty, which could have influenced the 
final measures of IEG expression (Paolone et al., 2007; Uslaner et al., 2001). Following 
this habitation period animals were tethered to the infusion lines. All stimuli in the 
operant chamber such as levers and lights were inactive. The infusion pumps were 
programmed to begin the testing session automatically, one hour after the tethering. 
This was done to ensure minimum effect of the handling of animals on mRNA expression. 
Thus, in the absence of the experimenter, each animal received one of the following 
combinations of drug infusions, separated by 25 minutes: saline – saline (n = 4), saline – 
cocaine (n = 6), cocaine – saline (n = 6), cocaine – cocaine (n = 6), cocaine – heroin 100 
µg/kg (n = 6), cocaine – heroin (n = 7), and heroin – cocaine (n = 6), heroin – heroin (n = 
6), heroin - saline (n = 3). For the last 4 experimental groups heroin was given at a dose 
of 200 µg/kg. Five minutes after the second injection, rats were given an overdose of 
pentobarbital i.v., decapitated, brains were snap-frozen in isopentane at -80°C, and 
stored for cryosectioning.  
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To achieve the administration of two separate injections through the same catheter, the 
infusion lines were back-filled with the appropriate drug solutions for each condition, 
just before tethering of the animals. The volume of drug solutions in each line was 40 µl 
for both heroin and cocaine, with the corresponding drug concentration. The rest of the 
lines were filled with saline. Each drug solution was separated from the rest of the saline 
in the infusion line by a small air bubble. The infusion pumps operated at a default 
infusion rate of 10 µl/sec (±1.5 µl/sec). Thus, each drug infusion was delivered over 4 
sec. The two drug solutions were separated by 90 µl of saline, and the pumps were 
switched on for 10 sec during each of the two infusions. This way two potential issues 
were avoided: first, the possible mixing of the first and second drug infusions due to 
slight infusion rate variability between infusions and between pumps. Second, the issue 
of a small amount of drug solution remaining in the catheter itself. For the saline-saline 
group, the whole set-up was kept the same except no drugs were dissolved in the saline. 
Thus, in this experiment the infusion rate was controlled more strictly than in the study 
described in chapter 3, where duration of infusions might have varied by up to 2 sec. It 
was not suggested that this might have had a substantial effect on overall levels of IEG 
expression in response to heroin and cocaine. Effects of infusion rate on IEG expression 
have been shown for much greater differences between infusion rates such as 5 vs. 100 
sec, but not 5 vs 25 sec (Samaha et al., 2004). In addition, there is no reason to expect 
systematic variability between groups as a result of the drug administration procedure. 
Nevertheless, it was expected that better control over infusion rates might reduce 
within-group variability of IEG expression scores.  
CatFISH, image acquisition and analysis. Whole brains were sectioned at 16 µm 
thickness, at the level of the anterior striatum containing the Nacc core and shell, DMS, 
and DLS, where images were taken for analysis (+1.70 mm from bregma (Paxinos & 
Watson, 1986), fig. 4.1 on next page, see also Appendix 2). As described in chapter 3, 
sectioning started from the tip of the olfactory bulbs and brain sections were removed 
until their ventral and dorsal parts became attached (defined as +3.70 mm from bregma). 
From this point, 120 sections (16 µm thick) were removed to reach approx. + 1.70 from 
bregma. If necessary, a few (no more than 5) additional sections were removed to reach 
the point where the dorsal tip of the corpus callosum formed a pointed angle. Then, 
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images of the accumbens core were taken by positioning the microscope field of view 
(MFV) so that its centre was at equal distances from the ventral end of the lateral 
ventricle, and from the anterior commissure. Images of the DMS were taken by 
positioning the MFV so that its left margin coincided with the dorsal part of the lateral 
ventricle and the medial side of the corpus callosum. Then, images of the DSL were taken 
by moving the MFV laterally so that its right margin coincided with the lateral part of the 
corpus callosum. For the Nacc shell, the centre of the MFV was positioned over the 
anterior commissure and moved in a medial direction until the left margin of the MFV 
reached the medial border of the Nacc shell, recognised as a less dense staining for cell 
nuclei by DAPI. The RNAscope probes and reagents, the in situ hybridisation and image 
acquisition and analysis protocols were as described in general methods. 
 
Fig. 4.1. Schematic representation of regions of interest (ROI) where microscopic 
images were taken: Nacc shell (1), Nacc core (2), DMS (3) and DLS (4). 
Results 
Homer 1a and arc expression – saline controls 
The total amount of h1a expression in each condition was measured by adding up the 
number of nuclei expressing only h1a and the number of nuclei expressing both arc and 
h1a mRNA. Similarly, the total amount of arc expression was measured by adding up 
only arc-expressing nuclei and co-expressing nuclei. For simplicity, mRNA expression in 
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the cocaine-saline, saline-cocaine and heroin-saline control conditions is presented 
separately, before all other conditions. 
Nacc core and shell  
Figure 4.2 (next page) shows the average number of h1a- or arc-positive nuclei in the 
Nacc core and shell as a function of drug treatment. The punctuated lines represent 
mRNA levels in the saline-saline group for each brain area. 
In the Nacc core, h1a expression was high in the cocaine-saline (M = 22.92, SE = 4.59) 
and heroin-saline (M = 20.67, SE = 2.48) groups, and much lower in the saline-cocaine 
group (M = 4.54, SE = 0.81). In the shell, on the other hand, h1a expression remained 
somewhat low in the cocaine-saline condition (M = 10.33, SE = 2.59), but was higher in 
the heroin-saline condition (M = 26, SE = 2.04). The saline-cocaine condition had low 
levels of h1a in the shell as well (M = 7.75, SE = 1.37). 
Arc expression was relatively high only in the saline-cocaine conditions in both the core 
and shell (M = 37.17, SE = 9.21, and M = 21.88, SE = 3.49, respectively). The cocaine-
saline and heroin-saline conditions had low levels of arc both in the core (M = 5.71, SE = 
0.75, and M = 3.92, SE = 0.85, respectively) and shell (M = 4.79, SE = 0.92, and M = 4.58, 
SE = 1.08, respectively). 
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Shapiro-Wilk tests revealed normal distributions of h1a and arc expression scores in the 
core. H1a score distribution was normal in the shell as well, but there was deviation 
from normality of the arc scores in the cocaine-saline condition. Levene’s tests revealed 
heterogeneity of variance across groups for both h1a and arc scores in the core, F(3,15) 
= 4.57, p =.018, and F(3,15) = 19.93, p < .001, respectively. In the shell, the variance of 
h1a scores was homogenous F(3,15) = 2.56, p = .094, but the variance of arc scores was 
not F(3,15) = 10.04, p = .001.  
A Welch test revealed significant differences between groups for h1a expression in the 
core, F(3,6.29) = 14.68, p =.003, as well as for arc expression, F(3,7.36) = 5.59, p =.026. 
Mann-Whitney tests with a Bonferroni correction (α = .017) showed that the cocaine-
saline and heroin-saline groups had significantly higher levels of h1a expression than the 
saline-saline group. Also, the saline-cocaine group had significantly higher levels of arc 
expression than the saline-saline group.  
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Fig. 4.2. Average number of h1a- or arc-positive nuclei in the Nacc core and 
shell as a function of drug treatment. s - saline, c - cocaine, h - heroin. Error 
bars: ±1 SE. *significantly different from saline-saline. N for each group: s/s = 
4, c/s = 6, s/c = 6, h/s = 3.
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A one-way ANOVA revealed significant differences in h1a levels in the shell, F(3,15) = 
14.07, p < .001. Dunnett’s t tests revealed that there was significantly more h1a-positive 
nuclei in the heroin-saline condition relative to saline-saline. A Kruskal-Wallis test 
revealed significant differences in arc scores, H(3) = 12.9, p = .005, where the saline-
cocaine condition was significantly different from saline-saline, U = 24, p = .01. 
Dorsal striatum  
Figure 4.3 (next page) shows the average number of h1a- or arc-positive nuclei in the 
DMS and DLS as a function of drug treatment. The punctuated lines represent mRNA 
levels in the saline-saline group for each brain area. 
In the DMS, h1a expression was highest in the cocaine-saline group (M = 54.71, SE = 
8.31), followed by heroin-saline (M = 29.50, SE = 4.78), and lowest in the saline-cocaine 
group (M = 16.92, SE = 2.57). In the DLS, h1a expression remained high in the cocaine-
saline condition (M = 69.54, SE = 8.59), but was relatively low in the heroin-saline (M = 
21.42, SE = 2.04) and the saline-cocaine conditions (M = 11.54, SE = 2.58). 
Arc expression was relatively high only in the saline-cocaine conditions in both the DMS 
and DLS (M = 76.33, SE = 15.56, and M = 85.38, SE = 12.58, respectively). The cocaine-
saline and heroin-saline conditions had low levels of arc both in the DMS (M = 9.21, SE 
= 1.88, and M = 3.17, SE = 0.36, respectively) and DLS (M = 8.79, SE = 2.13, and M = 2.83, 
SE = 1.45, respectively). 
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Shapiro-Wilk tests revealed normal distributions of h1a scores in the DMS, but not arc 
expression scores, where the deviation form normality was found in the cocaine-saline 
condition. Both h1a and arc score distribution was normal in the DLS. Levene’s tests 
revealed homogeneity of variance across groups for h1a scores in the DMS, F(3,15) = 
1.18, p = .349, while the tests was significant for arc scores F(3,15) = 19.93, p < .001. In 
the DLS, the variance of both h1a and arc scores was heterogeneous F(3,15) = 23.09, p 
< .001, and F(3,15) = 5.77, p = .008, respectively. 
A one-way ANOVA revealed significant differences between groups for h1a expression 
in the DMS, F(3,15) = 14.09, p < .001. Dunnett’s post hoc tests revealed that only the 
cocaine-saline condition differed significantly from the saline-saline condition. In 
addition, a Kruskal-Wallis test revealed significant differences in arc scores between 
groups in this brain area, where the saline-cocaine condition differed significantly from 
saline-saline, U = 24, p = .01. 
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Fig. 4.3. Average number of h1a- or arc-positive nuclei in the DMS and DLS as 
a function of drug treatment. s - saline, c - cocaine, h - heroin. Error bars: ±1 
SE. *significantly different from saline-saline. N for each group: s/s = 4, c/s = 
6, s/c = 6, h/s = 3.
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Welch tests revealed significant differences in h1a and arc scores between groups in the 
DLS, F(3,7.88) = 16.05, p = .001, and F(3,8.05) = 13.35, p = .002, respectively. Mann-
Whitney tests (α = .017) revealed that the cocaine-saline and the heroin-saline 
conditions differed significantly from saline-saline in h1a levels, and the saline-cocaine 
condition differed significantly from saline-saline in arc levels. 
Table 4.1. Summary of homer 1a and arc expression in drug-saline conditions. The 
effect of heroin and cocaine on IEG expression is shown relative to saline in each 
brain area: (↑) significant increase over saline, (−) no sig. difference form saline, (×) 
no data. 
 Core Shell DMS DLS 
 h1a arc h1a arc h1a arc h1a arc 
cocaine ↑ ↑ − ↑ ↑ ↑ ↑ ↑ 
heroin ↑ × ↑ × − × ↑ × 
 
Homer 1a and arc expression – experimental conditions 
Nacc core 
Figure 4.4 (next page) shows the amount of h1a and arc expression as a function of 
experimental condition in the Nacc core.  
Animals in the saline-saline condition had the lowest amount of h1a-positive nuclei, M 
= 5.06, SE = 0.73. In all other conditions, the amount of h1a-positive nuclei was much 
higher: cocaine-cocaine M = 26, SE = 6.15, cocaine-heroin (100 µg/kg) M = 25.33, SE = 
5.21, cocaine-heroin (200 µg/kg) M = 22.11, SE = 4.7, heroin-cocaine M = 21.08, SE = 
3.75, and heroin-heroin M = 16.17, SE = 2.59. In the last two conditions heroin is at a 
dose of 200 µg/kg. 
Shapiro-Wilk tests revealed a non-normal distribution of h1a scores in the cocaine-
heroin (200 µg/kg) group, where W(7) = 0.78, p = .027. A Kruskal-Wallis tests was used 
to examine differences in number of h1a-positive nuclei between experimental 
conditions, and it yielded significant results, H(5) = 11.11, p = .049.  
Multiple comparisons for h1a scores were made using Mann-Whitney tests and a 
Bonferroni correction was applied, so all effects are reported at .01 level of significance. 
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There was a significant difference between the saline-saline group and cocaine-cocaine 
(U = 24, p = .01), cocaine-heroin (100 µg/kg; U = 24, p = .01), cocaine-heroin (200 µg/kg; 
U = 28, p = .006), and heroin-cocaine (U = 24, p = .01). The difference from the heroin-
heroin group was not significant at the .01 level, U = 22, p = .038. 
 
The saline-saline group also had the lowest levels of arc expression: M = 2.5, SE = 0.97. 
Next lowest was the heroin-heroin group, M = 4.46, SE = 0.79. In the rest of the 
conditions, arc expression was relatively higher: cocaine-heroin (100 µg/kg), M = 28.29, 
SE = 10.66, cocaine-heroin (200 µg/kg), M = 15.25, SE = 2.02, cocaine-cocaine M = 13.54, 
SE = 1.3, and heroin-cocaine, M = 17.21, SE = 2.04. Shapiro-Wilk tests revealed normal 
distributions of arc scores in all conditions, but Levene’s statistic was highly significant, 
F(5,29) = 22.56, p < .001. 
A Welch test revealed significant differences between groups, F(5,12.98) = 17.02, p 
< .001. Mann-Whitney tests were used for multiple comparisons and a Bonferroni 
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correction was applied, so all comparisons are reported at α = .01. There were 
significantly less arc-positive nuclei in the saline-saline condition relative to all other 
conditions except the cocaine-heroin (100 µg/kg) and heroin-heroin conditions, where 
U = 22, p = .038, and U = 20, p = .114, respectively. The statistics for the other 
comparisons were as follows: cocaine-cocaine, U = 24, p = .01, cocaine-heroin (200 
µg/kg), U = 28, p = .006, and heroin-cocaine U = 24, p = .01. 
Nacc shell  
Figure 4.5 (next page) shows the amount of h1a and arc expression in the Nacc shell as 
a function of drug treatment. 
Overall, there was noticeably less h1a expression in this brain area relative to the rest 
of the striatum. The average number of h1a+ nuclei in each condition were as follows: 
saline-saline, M = 4.81, SE = 1.68, cocaine-heroin (200 µg/kg), M = 9.32, SE = 2.1, cocaine-
heroin (100 µg/kg), M = 10.5, SE = 2.97, cocaine-cocaine, M = 14.33, SE = 3.28, heroin-
heroin, M = 19.17, SE = 2.22, and heroin-cocaine, M = 20.88, SE = 4.27. Shapiro-Wilk 
tests of normality revealed normal distributions in all conditions. 
Levene’s test revealed homogenous variance across all groups F(5,29) = 0.91, p = .488. 
A one-way ANOVA revealed significant differences between conditions, F(5,29) = 3.86, 
p  = .008. Dunnett’s two-sided tests revealed that the heroin-cocaine and heroin-heroin 
groups had significantly higher amounts of h1a-positive nuclei than the saline-saline 
group. The rest of the groups did not differ significantly from saline-saline. 
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The average number of arc-positive nuclei in the Nacc shell was as follows: cocaine-
heroin (100 µg/kg), M = 21.38, SE = 9.52, cocaine-heroin (200 µg/kg), M = 14.36, SE = 
3.09, saline-saline, M = 2.81, SE = 0.86, cocaine-cocaine, M = 8.45, SE = 1.06, heroin-
cocaine, M = 11, SE = 1.32, and heroin-heroin, M = 6.67, SE = 0.97. Shapiro-Wilk tests 
revealed normal distributions in all conditions. 
Levene’s test revealed a lack of homogeneity of variance, F(5,29) = 8.76, p < .001. A 
Welch test revealed significant differences between groups, F(5,13.29) = 7.03, p = .002. 
Multiple comparisons were carried out using Mann-Whitney tests at α = .01. The 
cocaine-heroin (100 µg/kg) group did not differ significantly from saline-saline (U = 21, 
p = .067), but all other groups did: cocaine-cocaine, U = 24, p = .01, cocaine-heroin (200 
µg/kg), U = 28, p = .006, heroin-cocaine, U = 24, p = .01, and heroin-heroin, U = 24, p 
= .01. 
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Fig. 4.5. Average number of h1a- or arc-positive nuclei in the Nacc shell as a 
function of experimental condition. Error bars represent +1 SEM. */# - significantly 
different from saline-saline. N for each group: sal-sal (4), coc=coc (6), coc-her1 (6), 
coc-her2 (7), her2-coc (6), her-her (6).
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DMS 
Figure 4.6 (next page) shows the amount of h1a and arc expression in the DMS as a 
function of drug treatment. 
The lowest h1a expression was found in the saline-saline group, M = 6.06, SE = 2.19. The 
average amount of h1a-positive nuclei in the rest of the conditions were as follows: 
cocaine-heroin (200 µg/kg), M = 53.79, SE = 7.69, cocaine-cocaine, M = 56.33, SE = 11.39, 
cocaine-heroin (100 µg/kg), M = 62.83, SE = 17.5, heroin-cocaine, M = 21.25, SE = 3.69, 
and heroin-heroin, M = 27.75, SE = 6.43. Shapiro-Wilk tests revealed normal 
distributions in all conditions. 
There was a violation of the homogeneity of variance assumption as indicated by 
Levene’s test, F(5,29) = 3.14, p = .022. A Welch test revealed significant differences 
between conditions, F(5,13.29) = 11.58, p < .001. 
Again, Mann-Whitney tests were used for multiple comparisons and are reported at a 
significance level of .01 following a Bonferroni correction. In all other conditions, there 
were significantly more h1a-positive nuclei than in the saline-saline condition: cocaine-
heroin (200 µg/kg) U = 28, p = .006, cocaine-heroin (100 µg/kg), U = 24, p = .01, cocaine-
cocaine, U = 24, p = .01, heroin-cocaine, U = 24, p = .01, and heroin-heroin, U = 24, p 
= .01. 
The most arc expression was found in the heroin-cocaine group, M = 27.95, SE = 5.26, 
followed by cocaine-cocaine, M = 26.71, SE = 2.96. All other groups had relatively low 
levels of nuclear arc: saline-saline, M = 2.06, SE = 1, cocaine-heroin (100 µg/kg), M = 7.79, 
SE = 1.11, cocaine-heroin (200 µg/kg), M = 8.29, SE = 0.72, and heroin-heroin, M = 3.54, 
SE = 0.68. Shapiro-Wilk tests revealed normal distributions in all conditions. 
Levene’s statistic indicated heterogeneous variance across groups, F(5,29) = 8.17, p 
< .001. A Welch test indicated significant differences between conditions, F(5,12.51) = 
17.73, p < .001. Multiple comparisons were carried out using Mann-Whitney tests at α 
= .01. The saline-saline condition differed significantly from the cocaine-cocaine, U = 24, 
p = .01, cocaine-heroin (200 µg/kg), U = 28, p = .006, and the heroin-cocaine (U = 24, p 
= .01) conditions, but not from the cocaine-heroin (100 µg/kg), U = 23, p = .019, and the 
heroin-heroin (U = 20, p = .114) conditions. 
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DLS 
Figure 4.7 (next page) shows the amount of h1a and arc expression in the DLS as a 
function of drug treatment. 
The lowest h1a expression was found in the saline-saline group, M = 8.63, SE = 2.66. The 
average number of h1a+ nuclei in the rest of the groups was: cocaine-cocaine, M = 71.04, 
SE = 7.66, cocaine-heroin (100 µg/kg), M = 69.67, SE = 11.61, cocaine-heroin (200 µg/kg), 
M = 60.39, SE = 8.13, heroin-cocaine, M = 12.67, SE = 2.86, heroin-heroin, M = 17.5, SE 
= 3.01. Shapiro-Wilk tests revealed normal distribution of scores in all conditions. 
Levene’s tests indicated homogenous variance across conditions, F(5,29) = 1.78, p = .148. 
A one-way ANOVA revealed significant difference between groups, F(5,29) = 15.94, p 
< .001. Dunnett’s post hoc 2-sided tests revealed that all conditions where the first 
injection was cocaine had significantly higher levels of h1a expression relative to saline 
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Fig. 4.6. Average number of h1a- or arc-positive nuclei in the DMS as a function 
of experimental condition. Error bars represent +1 SEM. */# - significantly 
different from saline-saline. N for each group: sal-sal (4), coc=coc (6), coc-her1 
(6), coc-her2 (7), her2-coc (6), her-her (6).
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(p < .001). The saline-saline, heroin-cocaine and heroin-heroin groups did not differ 
significantly from each other in terms of h1a expression. 
 
The average amount of arc+ nuclei in the DLS depended on drug treatment as follows: 
cocaine-cocaine, M = 36.67, SE = 8.65, saline-saline, M = 3.88, SE = 1.71, cocaine-heroin 
(100 µg/kg), M = 6.67, SE = 1.88, cocaine-heroin (200 µg/kg) M = 8.25, SE = 2.08, heroin-
cocaine M = 59.13, SE = 7.49, heroin-heroin M = 1.92, SE = 0.49. Shapiro-Wilk tests 
revealed normal distributions in all conditions. 
Levene’s statistic indicated heterogeneity of variance, F(5,29) = 5.99, p = .001. A Welch 
test revealed significant differences between conditions, F(5,11.39) = 14.03, p < .001, 
and was followed by multiple comparisons using Mann-Whitney tests at α = .01 
(Bonferroni correction). There were significantly less arc+ nuclei in the saline-saline 
condition relative to the cocaine-cocaine, U = 24, p = .01, and heroin-cocaine, U = 24, p 
= .01, groups. The saline-saline group did not differ significantly from the cocaine-heroin 
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Fig. 4.7. Average number of h1a- or arc-positive nuclei in the DLS as a 
function of experimental condition. Error bars represent +1 SEM. 
*significantly different from saline-saline. N for each group: sal-sal (4), 
coc=coc (6), coc-her1 (6), coc-her2 (7), her2-coc (6), her-her (6).
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(100 µg/kg), U = 18, p = .257, cocaine-heroin (200 µg/kg), U = 21, p = .230, and the heroin-
heroin groups, U = 28, p = .476. 
Table 4.2. Summary of homer 1a and arc expression after administration of two drug 
injections. The effect of each drug combination on IEG expression is shown relative 
to saline-saline in each brain area: (↑) significant increase over saline, (−) no sig. 
difference form saline. 
 Core Shell DMS DLS 
 h1a arc h1a arc h1a arc h1a arc 
c/c ↑ ↑ − ↑ ↑ ↑ ↑ ↑ 
c/h1 ↑ − − − ↑ − ↑ − 
c/h2 ↑ ↑ − ↑ ↑ ↑ ↑ − 
h2/c ↑ ↑ ↑ ↑ ↑ ↑ − ↑ 
h2/h2 − − ↑ ↑ ↑ − − − 
 
Co-expression (overlap) - saline controls 
Figure 4.8 (next page) shows the average percent co-expressing nuclei (overlap) as a 
function of drug treatment and striatal area. The punctuated line represents the amount 
of co-expressing nuclei in the saline-saline group for each group and area. 
The average percent co-expressing nuclei in each striatal area were as follows: Nacc core, 
cocaine-saline (M = 5.58, SE = 0.75), heroin-saline (M = 4.57, SE = 1.18), and saline-
cocaine (M = 1.79, SE = 0.42). Nacc shell, cocaine-saline (M = 13.29, SE = 2.03), heroin-
saline (M = 5.84, SE = 1.25), and saline-cocaine (M = 4.14, SE = 0.99). DMS, saline-cocaine 
(M = 7.62, SE = 1.02), cocaine-saline (M = 6.06, SE = 0.39), and heroin-saline (M = 1.82, 
SE = 0.06). Finally, DLS, saline-cocaine (M = 5.96, SE = 0.92), cocaine-saline (M = 5.76, SE 
= 1.38) and heroin-saline (M = 3.32, SE = 1.68). 
Shapiro-Wilk tests revealed normal distributions of scores in all conditions across all 
areas. Levene’s tests revealed homogenous variance across groups for all striatal areas: 
Nacc core, F(3,15) = 2.76, p = .079, shell, F(3,15) = 1.41, p = .278, DMS, F(3,15) = 2.42, p 
=106, and DLS F(3,15) = 1.97, p = .162. 
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One-way ANOVAs revealed significant differences between drug treatment groups in 
terms of amount of co-expressing nuclei: Nacc core, F(3,15) = 8.18, p = .002, Nacc shell, 
F(3,15) = 7.32, p = .003, DMS, F(3,15) = 11.02, p < .001, and DLS, F(3,15) = 4.36, p = .021. 
Gabriel’s post hoc tests revealed that the cocaine-saline condition differed significantly 
from the saline-saline and saline-cocaine conditions in the core and shell. In the DMS, 
the saline-cocaine and cocaine saline conditions differed significantly from the saline-
saline and heroin-saline conditions. Finally, in the DLS, saline-cocaine and cocaine-saline 
differed significantly only from the saline-saline condition. 
 
The co-expression of arc and h1a was calculated by dividing the number of nuclei 
positive for both Arc and H1a in each condition by the sum of arc-positive, h1a-positive 
and arc-and-h1a-positive nuclei in each condition. This ratio was then converted to 
percentage. Due to this choice of data representation, the number of h1a- and arc-
positive nuclei in each brain area shown so far was represented in absolute numbers 
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rather than percentage of DAPI-positive nuclei. This way, it was avoided that the overlap 
was represented as percentage of a percentage which makes data interpretation 
somewhat convoluted. 
Co-expression (overlap) - experimental conditions 
Nacc core 
Figure 4.9 (next page) shows the percentage of all mRNA-positive nuclei in each 
condition which were positive for both arc and h1a. The highest percentage of co-
expressing nuclei were found in the cocaine-cocaine group, M = 16.44, SE = 1.98, 
followed by cocaine-heroin (200 µg/kg) M = 9.02, SE = 1.13, and cocaine-heroin (100 
µg/kg) M = 8.27, SE = 2.53, heroin-cocaine, M = 12.71, SE = 0.79, heroin-heroin, M = 6.93, 
SE = 1.98, saline-saline, M = 1.42, SE = 0.86. Shapiro-Wilk tests revealed normal 
distributions of scores in all conditions. 
Levene’s tests revealed that the variance across groups was homogenous, F(5,29) = 1.33, 
p = .278. A one-way ANOVA revealed significant differences between conditions, F(5,29) 
= 7.56, p < .001. Gabriel’s post hoc tests revealed that there was significantly higher 
percentage co-expressing nuclei in the cocaine-cocaine condition relative to all other 
conditions except heroin-cocaine. Only the cocaine-cocaine and heroin-cocaine groups 
were significantly different from saline-saline. All other comparisons were non-
significant. 
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Nacc shell 
Overall, the pattern of co-expression in the shell was somewhat similar to that of the 
core (Fig. 4.10, next page). The highest levels of co-expression were found in the heroin-
heroin, M = 17.92, SE = 3.69, heroin-cocaine, M = 17.79, SE = 2.69, and cocaine-cocaine 
conditions, M = 17.01, SE = 2.75. Co-expression was much lower in the rest of the 
conditions: saline-saline, M = 4.33, SE = 2.14, cocaine-heroin (100 µg/kg), M = 7.53, SE = 
2.54, and cocaine-heroin (200 µg/kg), M = 7.64, SE = 1.3. Shapiro-Wilk tests revealed 
normal distributions in all conditions. 
Levene’s tests was non-significant, F(5,29) = 1.38, p = .261. A one-way ANOVA revealed 
significant differences between groups, F(5,29) = 5.17, p = .002. Gabriel’s post-hoc tests 
revealed that there was significantly more co-expression in the heroin-cocaine and 
heroin-heroin groups relative to saline-saline. The difference between cocaine-cocaine 
and saline-saline only approached significance, p = .059. 
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Fig. 4.9. Co-expressing nuclei as % of all mRNA+ nuclei in the Nacc 
core. Error bars represent +1 SEM. *significantly different from 
saline-saline. #significantly different from all other groups except 
heroin-cocaine. N for each group: sal-sal (4), coc=coc (6), coc-her1 (6), 
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DMS 
In this brain area, only the cocaine-cocaine condition had a noticeable amount of co-
expressing nuclei relative to the overall level of mRNA expression, M = 19.43, SE = 2.57 
(Fig. 4.11, next page). In all other conditions, the percentage of co-expressing nuclei was 
low: saline-saline (M = 1.76, SE = 1.24), heroin-cocaine (M = 7.69, SE = 1.44), heroin-
heroin (M = 3.53, SE = 0.72), cocaine-heroin 100 µg/kg (M = 5.64, SE = 1.28) and cocaine-
heroin 200 µg/kg (M = 5.31, SE = 0.48). Shapiro-Wilk tests revealed normal distributions 
in all conditions except heroin-heroin. 
Levene’s test did not reach significance, F(5,29) = 2.05, p = .101. A Kruskal-Wallis tests 
revealed significant differences between groups, H(5) = 21.3, p = .001, and was followed 
by multiple comparisons using Dunn-Bonferroni. The only significant differences found 
were between cocaine-cocaine and saline-saline, and cocaine-cocaine and heroin-
heroin. 
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Fig. 4.10. Co-expressing nuclei as % of all mRNA+ nuclei in the NAcc 
shell. Error bars represent +1 SEM. *significantly different from 
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DLS 
The co-expression profile in this brain area was similar to that of the DMS (Fig. 4.12, next 
page). Again, the highest measure of co-expression was found in the cocaine-cocaine 
condition, M = 23.81, SE = 4.88. The percent co-expressing nuclei in the rest of the 
conditions was as follows: saline-saline (M = 0.52, SE = 0.52), heroin-cocaine (M = 6.97, 
SE = 1.26), heroin-heroin (M = 1.46, SE = 1.05), cocaine-heroin 100 µg/kg (M = 5.17, SE 
= 1.08) and cocaine-heroin 200 µg/kg (M = 5.87, SE = 1.07). Shapiro-Wilk tests revealed 
non-normal distributions in several conditions. 
Levene’s tests revealed lack of homogeneity of variance, F(5,29) = 17.17, p < .001. A 
Kruskal-Wallis test indicated a significant difference between groups, H(5) = 24.82, p 
< .001. Multiple comparisons were carried out using Dunn-Bonferroni. The only 
significant differences found were between cocaine-cocaine and saline-saline, and 
cocaine-cocaine and heroin-heroin. 
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Fig. 4.11. Co-expressing nuclei as % of all mRNA+ nuclei in the DMS. 
Error bars represent +1 SEM. *significantly different from saline-
saline and heroin-heroin. N for each group: sal-sal (4), coc-coc (6), 
coc-her1 (6), coc-her2 (7), her2-coc (6), her2-her2 (6).
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Table 4.3. Summary of homer 1a and arc co-expression after administration of two 
drug injections. The effect of each drug combination on co-expression is shown 
relative to saline-saline and cocaine-cocaine in each brain area: (↑) significant 
increase, (−) no sig. difference, (↓) significant decrease. 
 Core Shell DMS DLS 
 s/s c/c s/s c/c s/s c/c s/s c/c 
c/c ↑  −  ↑  ↑  
c/h1 − ↓ − − − − − − 
c/h2 − ↓ − − − − − − 
h2/c ↑ − ↑ − − − − − 
h2/h2 − ↓ ↑ − − ↓ − ↓ 
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Fig. 4.12. Co-expressing nuclei as a % of all mRNA+ nuclei in the DLS. Error 
bars represent +1 SEM. *significantly different from saline-saline and 
heroin-heroin. N for each group: sal-sal (4), coc=coc (6), coc-her1 (6), coc-
her2 (7), her2-coc (6), her2-her2 (6).
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Homer 1a and arc co-expression following two consecutive injection of the same drug 
In all brain areas except the Nacc shell, two consecutive injections of cocaine elevated 
the proportion of co-expressing nuclei significantly above chance (i.e. relative to co-
expression in the saline-saline condition). Conversely, two consecutive injections of 
heroin elevated co-expression levels only in the Nacc shell. As an additional measure of 
co-expression above chance, comparisons were made between heroin-heroin and 
heroin-saline in the shell, and cocaine-cocaine and cocaine-saline conditions in all other 
brain areas (fig. 4.13, next page). Where cocaine-cocaine and heroin-heroin did not 
differ from saline-saline, these comparisons were not made (see table 4.3 above). 
Shapiro-Wilk tests revealed normal distributions in all conditions. One-tailed t-tests with 
a Bonferroni correction (α = .013) revealed significant differences between cocaine-
cocaine groups and cocaine-saline in the Nacc core: t(6.41) = 5.13, p = .001, DMS: t(10) 
= 5.15, p < .001, and DLS: t(5.79) = 5.13, p = .007. The comparison between heroin groups 
in the Nacc shell was also significant, t(6.02) = 3.09, p = .011. Note that one-sided tests 
were used because these groups already showed increase above one measure of co-
expression due to chance. 
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Discussion 
Main findings 
The data presented here suggest that, when administered intravenously to the rat, both 
heroin and cocaine elevate levels of h1a and arc mRNA across the striatum. The 
magnitude of this effect varies depending on the particular gene and striatal area in 
question. Since both arc and h1a are markers of neuronal activity, it can be said that 
both heroin and cocaine activate neuronal populations across the striatum. By using the 
catFISH technique it was possible to determine if these neuronal populations represent 
neuronal ensembles, and whether these neuronal ensembles overlap between drugs. 
Indeed, across all examined areas of the striatum, there seems to be a group of neurons 
that are reliably activated by cocaine. Therefore, they likely represent a neuronal 
ensemble encoding for cocaine’s effects. For heroin, this seems to be the case only in 
the Nacc shell, but not other areas.  
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Fig. 4.13. Co-expressing nuclei as % of all mRNA+ cells following two 
consecutive injections of the same drug relative to one injection followed 
by saline. Error bars represent ± 1SE. s - saline, c - cocaine, h - heroin. 
*significantly different from the respective saline group. N for each group 
as follows: c/s (6), c/c (6), h/s (3), h/h (6).
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When cocaine and heroin are administered to the same animal, the neuronal 
populations activated by each drug are more or less distinct, but this depends largely on 
the striatal area and the order in which the drugs were administered. In the dorsal 
striatum, the populations are largely distinct, regardless of order of administration. In 
the Nacc, heroin engages a different population of neurons than cocaine when cocaine 
is administered first. However, when cocaine is administered second, it engages many 
of the same neurons that were activated by heroin.  
Cocaine effects on IEG expression 
H1a expression was significantly elevated following cocaine administration in the Nacc 
core, DMS and DLS. On average, there was also more h1a-positive nuclei in the Nacc 
shell after cocaine relative to a saline injection, but this effect did not reach statistical 
significance. The magnitude of the effect was much more pronounced in the dorsal 
relative to ventral part of the striatum. 
Cocaine also elevated arc expression, and this effect was statistically significant across 
all areas of the striatum, including the NAcc shell. Similarly to h1a, the effect was most 
pronounced in the dorsal relative to the ventral striatum. Note that arc expression 
reflects activity in response to the second injection, and the magnitude of the cocaine 
effect on arc expression depended on whether another drug was administered 
beforehand, and what drug that was. First and second injection interactions are 
discussed further on. 
In summary, cocaine increased activity in all areas of the striatum that were studied, and 
this activity was reflected in elevated h1a and arc expression. Cocaine’s effect was more 
pronounced in terms of arc expression relative to h1a expression, especially in the Nacc 
shell, where h1a mRNA was low after cocaine (figs. 4.2 and 4.3). The most activity (i.e. 
IEG mRNA) following cocaine was observed in dorsal parts of the striatum. 
Heroin effects on IEG expression 
Heroin injections increased h1a expression relative to saline injections in the Nacc core 
and shell. There was also an increase of h1a expression after heroin in the dorsal 
striatum, but it was of comparable magnitude to the accumbens, rather than more 
pronounced as was the case for cocaine. 
95 
 
The effect of heroin on arc expression was not assessed on its own, as there was no 
group of rats which received an injection of saline followed by and injection of heroin. 
However, the cocaine-heroin (200 µg/kg) group differed from saline-saline in levels of 
arc in the Nacc core, shell and DMS, while cocaine-saline did not differ from control in 
any of these areas. Thus, there was a difference between administering heroin vs. saline 
following an injection of cocaine. However, there remains the possibility that this 
increase in arc expression is (at least to some extent) the result of an interaction 
between heroin and cocaine. There was no effect of cocaine on arc expression at the 
time when heroin was administered (i.e. cocaine-saline and saline-saline groups did not 
differ in arc levels), so any such interaction would have resulted from an effect of 
cocaine which is not reflected in IEG expression per se.  
The effect of heroin on arc varied not only as a function of brain area, but also depending 
on dose and the preceding drug infusion. Relative to the higher dose, the lower dose of 
heroin (100 µg/kg) produced higher arc expression in the Nacc core and shell, but not in 
the dorsal striatum. However, these effects were much more variable and did not reach 
statistical significance. There are no other studies that have studied the acute effects of 
heroin on arc expression, especially soon after drug administration. There are studies 
using other opiates. For example, it has previously been shown that arc protein levels 
are elevated in the core but not shell of the NAcc following 10 mg/kg i.p. injections of 
morphine in mice (Lv, Xu, Han, & Cui, 2011), and that arc protein levels are elevated in 
the DMS 1 day after a single i.v. injection of heroin (Li, Liu, Lu, Wang, & Liu, 2013). Taking 
into account both of these findings and the results presented here, it seems that opiates 
can have both short and long-term effects on arc expression in the striatum. 
To summarise, heroin (200 µg/kg) produced a reliable increase in h1a and arc expression 
across the striatum, but, due to the lack of a saline-heroin group, it remains unclear 
whether the effect on arc is unique to heroin, or the result of a cocaine-heroin 
interaction. In contrast to cocaine, there were no stark differences in IEG expression 
(number of activated cells) between dorsal and ventral parts of the striatum. In fact, for 
the lower dose of heroin (100 µg/kg), the difference went in the opposite direction, with 
more active cells on average in the Nacc. There was also a lot of variability in the 
magnitude of arc expression depending on preceding drug or saline injections. 
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Interactions between first and second drug injections 
When heroin (200 µg/kg) was preceded by cocaine, arc levels increased relative to 
saline-saline in the Nacc and DMS. However, this was not the case if two 200 µg/kg doses 
of heroin were administered in succession, suggesting a habituation to the IEG-inducing 
effects of heroin. Arc levels in the cocaine-cocaine group remained elevated above 
saline-saline controls. However, a post-hoc analysis revealed that they were lower 
relative to arc levels in the saline-cocaine group across all areas except the Nacc core (t-
tests with a Bonferroni correction, all p’s < .025, except Nacc core – p = .05). Habituation 
effects to repeated injections of cocaine have been reported previously for the protein 
product of c-fos (Hope et al., 1992).  
There are three possible explanations for the reduced IEG expression following repeated 
drug injections. First, there could have been an adaptive change in the receptors 
involved in arc transcription. One candidate for such change could be the AMPA 
glutamate receptor, activity at which is known to inhibit arc transcription (Rao et al., 
2006), because levels of the receptor are up-regulated in the accumbens following a 
single injection of cocaine. However, AMPA receptor up-regulation is not evident before 
24h following a single cocaine injection, so it is unlikely to have had an effect when the 
two injections were separated by 25 min (Ferrario, Li, & Wolf, 2011). Also, it is not known 
if heroin affects AMPA receptor trafficking in a similar way. Second, there could have 
been negative feedback within the signalling cascade leading to IEG transcription. Both 
arc and h1a transcription are initiated through the MAPK/ERK pathway (Sato et al., 2001; 
Waltereit et al., 2001) which is inhibited by the MKP-1 phosphatase, a product of the 
IEG mkp-1, also transcribed as a result of neuronal activity through ERK, as shown on fig. 
4.14 (Sgambato, Pages, Rogard, Besson, & Caboche, 1998). Thus, a negative-feedback 
loop within intracellular cascades could have resulted in the suppression of arc 
transcription in recently activated neurons. Finally, it should be considered that all 
animals in the present study were drug naïve. The higher levels of IEG expression in the 
case of the first drug injection might simply reflect arousal produced by the novelty of 
the stimulus. For example, the novelty aspect of an environment (i.e. even when 
physical characteristics are controlled for) increases c-fos expression in the striatum 
(Badiani et al., 1998). It is possible that a similar effect occurs with drug stimuli as well. 
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Fig 4.14. A schematic representing a possible negative feedback loop in the ERK 
intracellular signalling cascade. Following glutamatergic action at the NMDA receptor (1) 
calcium enters the postsynaptic cell (2) and activates the ERK pathway which ultimately 
promotes transcription of the gene mkp-1 via CREB (9). This gene’s protein product in 
turn deactivates ERK. Since the ERK pathway is one way in which arc transcription can 
be initiated, this negative feedback loop provides one explanation as to why arc 
expression is reduced with consecutive drug injections. Adapted from Sgambato et al. 
(1998).  
Overlap between neuronal populations engaged by heroin and cocaine 
Methodological considerations 
Before discussing the overlap results reported here, it is necessary to take into account 
several methodological considerations. First, the measure of overlap employed here was 
somewhat different from those employed by other studies using catFISH or similar 
methods. For example, some studies report the amount of cells activated only by one 
stimulus (first or second), and then the amount of cells activated by both stimuli. In such 
cases, if the former type of cells are many and the latter few, it is concluded that the 
two stimuli activate different neuronal populations. Conversely, if there are many cells 
activated by both stimuli, but only a few activated by one stimulus only, then the stimuli 
activate the same neuronal population. This method is perhaps the most straight-
forward, but the least flexible. It assumes that the first and second stimuli always 
activate roughly the same number of cells. It has been used in studies of the 
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hippocampus and exposure to a novel environment (Vazdarjanova & Guzowski, 2004; 
Vazdarjanova et al., 2002), and of the amygdala and fear conditioning (Zelikowsky, 
Hersman, Chawla, Barnes, & Fanselow, 2014). 
Other studies report the amount of all cells active during the presentation of the first 
stimulus and then calculate the percentage of those cells that were also activated by the 
second stimulus – a “re-activation” measure in a sense. This method is useful in cases 
where activated neurons form a more variable pattern, and has been used for studies 
of the cortex (Grosso et al., 2015). Xiu et al. (2014) used a similar approach in their study, 
but instead calculated the percentage of cells activated by second stimulus that were 
also activated by the first. However, this method does not allow for a comparison 
between the degrees of overlap between two pairs of stimuli except under very specific 
circumstances. Namely, it is required that that there are no differences between the 
activity induced by each stimulus in each pair, or at least that the difference between 
the activity induced by each stimulus in each pair is the same. 
In the study presented here there was a difference between the amount of cells 
activated by the first and second stimuli: cocaine-cocaine or cocaine-heroin. In addition, 
there were differences between the amounts of cells activated by each stimulus in 
different pairs of stimuli. Thus, neither of the methods described above was applicable. 
The solution was to calculate the overlap by representing the amount of cells activated 
by both stimuli as a percentage of all active cells (regardless if activated by first, second 
or both stimuli). In this way, any differences in magnitude of IEG response to each 
stimulus was controlled for. In addition, saline groups were added to measure overlap 
by chance. Thus all overlap measures must be considered in relation to saline-saline and 
drug-saline controls. 
A second consideration should be that the reduced response to a second injection of 
cocaine might have led us to underestimate the amount of overlap in the cocaine-
cocaine condition. Perhaps of this reason, the co-expressing cells in that condition did 
not exceed 25% of all mRNA+ cells. Since this experimental condition was used as point 
of comparison when it comes to estimating overlap between cocaine- and heroin-
activated neuronal populations, it is likely that the reduction of overlap between heroin 
and cocaine populations is more substantial than it seems at first glance. 
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Finally, the arc response to a cocaine injection was consistently higher than the h1a 
response across all areas of the striatum. This means that the reduction in the response 
to a second injection of cocaine is quite substantial: arc expression in the saline-cocaine 
condition was almost three-fold higher than that in the cocaine-cocaine condition (e.g. 
figs. 4.3, p.77 and 4.6, p.83). In itself, this is an interesting finding suggesting that arc 
expression is switched on in an additional set of cells to those expressing h1a. Although 
the way overlap was calculated should have controlled for this difference, it is 
nevertheless relevant in interpreting high overlap in some cases where the response to 
the first injection of cocaine was low, such as in the Nacc shell. 
In summary, the overlap measured by catFISH in this study was influenced by interaction 
between the first and second injections, differences between the amounts of cells 
activated by heroin and cocaine, and differences between the amounts of cells 
expressing h1a and arc in response to cocaine. To correct for these factors, overlap was 
calculated by controlling for overall amount of mRNA expression, and saline conditions 
controlled for overlap by chance. 
Evidence for a neuronal ensemble encoding cocaine effects 
Across all striatal areas except the Nacc shell, each of two consecutive injections of 
cocaine elevated mRNA expression levels more than vehicle. Thus, there was 
significantly more activity following a cocaine injection relative to a saline injection. Out 
of all these activated neurons, between 16 and 23% on average were activated by both 
cocaine injections, suggesting they were responding reliably to the drug. The saline-
saline conditions revealed low levels of overlap by chance in these areas (Nacc core, 
DMS and DLS). Cocaine-saline conditions revealed low levels of overlap between drug-
activated neurons and baseline activity (fig. 4.8, p.86 and fig. 4.13, p. 93). Therefore, the 
neurons activated by each of two consecutive injections of cocaine are likely to 
represent a part of a neuronal ensemble encoding for cocaine effects in the striatum. 
The Nacc shell is an exception to this observation. The effect of cocaine on h1a 
expression was small, and did not reach significance. Conversely, there was an effect of 
cocaine on arc expression which was significantly increased (see fig. 4.2, p.75, saline-
cocaine). Thus, cocaine does activate neurons in this area, but this activity is not 
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detected as an increase of h1a expression. This leaves two possibilities: (i) cocaine 
activates cells in the shell, but the activated cells do not express h1a; (ii) cocaine does 
not lead to a change in the amount of h1a-expressing cells relative to saline, but 
determines which cells will be expressing it. In the second case, the pattern of IEG 
expression produced by cocaine as a first injection is specific to the drug, but is 
undetectable as an increase relative to saline. This is possible considering the lower h1a 
response to cocaine relative to arc which is observed across all four areas of the striatum 
(figs. 4.2, p. 75 and 4.3, p. 77, saline-cocaine and cocaine-saline conditions). There is 
further support for this interpretation. Note that there was little activity and overlap in 
the saline-saline condition in the shell, suggesting that baseline activity and random 
overlap in this area are low. However, while there was no more overlap in the saline-
cocaine condition relative to saline-saline, there was much higher degree of overlap in 
the cocaine-saline condition (fig. 4.8, p. 86). Thus, cocaine activates a particular set of 
neurons which do not overlap with baseline activity – hence no overlap in the saline-
cocaine condition. A second injection of cocaine does very little in terms of IEG 
expression in the shell (fig. 4.5, p. 81), and the overlap in the cocaine-cocaine condition 
is not much higher than in the cocaine-saline condition. Therefore, the simplest 
explanation is that when cocaine is administered first, it produces activity that is 
sustained until the time of the second injection (i.e. 25 min later) – hence the overlap in 
the cocaine-saline condition. A more speculative explanation would be that the overlap 
in the cocaine-cocaine condition has been underestimated, while the overlap in the 
cocaine-saline condition has been overestimated due to the way overlap was measured 
(amount of co-expressing cells as a percentage of all mRNA+ cells). However, this is 
unlikely given the big difference between overlap in the cocaine-saline and saline-saline 
conditions in the shell (fig. 4.8, p. 86) which indicates that the overlap in the former 
condition was significantly above chance. In addition, the overall activation in the 
cocaine-cocaine and cocaine-saline conditions was similar (figs. 4.5. p. 81 and 4.2, p.75). 
Thus, the high overlap score in the cocaine-saline conditions is not simply the result of a 
small number of co-expressing cells forming a large percentage of all mRNA-expressing 
cells. 
101 
 
In summary, there is a population of neurons in the Nacc core, DMS, and DLS that 
respond reliably to consecutive injections of cocaine and are likely to represent a 
neuronal ensemble. In the Nacc shell, the existence of such a population of cells cannot 
be ascertained based on the data presented here, but it is safe to say that cocaine 
activates neurons in this striatal area as well. Some of these neurons remain active for 
at least 25 minutes. 
Evidence for a neuronal ensemble encoding heroin effects 
A dose of 200 µg/kg of heroin reliably elevated IEG expression in the Nacc core and shell. 
Heroin also reliably elevated h1a expression in the dorsal striatum, but arc expression 
in response to heroin was significantly elevated only in the DMS, but not DLS. In contrast 
to cocaine, two consecutive injections of heroin did not result in a large proportion of 
neurons activated by both injections in the core, DMS and DLS. The degree of overlap in 
these areas did not differ much from the overlap between neuronal populations active 
after heroin-saline injections or saline-saline injections. Thus, any overlap in these areas 
cannot be attributed to a group of cells that were reliably activated by heroin. However, 
there was relatively high level of overlap after consecutive injections of heroin in the 
Nacc shell. This was the case even though the overlap in the heroin-saline condition was 
low, and very similar to overlap in the saline-saline condition (figs. 4.10, p.89 and 4.8, 
p.86; see also fig. 4.13, p. 93). Thus, it seems there is a neuronal ensemble encoding the 
effects of heroin in the Nacc shell, but not the other areas of the striatum that were 
studied. 
As already mentioned, arc expression was reduced following a second injection of 
heroin relative to an injection of heroin following cocaine. Thus, it is not possible to 
exclude the possibility that the low degree of overlap in the heroin-heroin condition is 
in part due to undetected active neurons. However, the arc expression in the shell 
following a second heroin injection was low as well, and the overlap score was high in 
this area. Thus, it is likely that if arc expression in the other areas was specific to heroin, 
it would have reflected in the overlap score there as well. 
In summary, a 200 µg/kg dose of heroin activated more neurons across the striatum 
relative to saline, but only in the Nacc shell the same neurons responded reliably to the 
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drug. In contrast to the case of cocaine, the methods used here suggest that there are 
no neuronal ensembles encoding for heroin effects in other parts of the striatum. 
Overlap between neuronal populations activated by heroin and cocaine  
When an injection of cocaine was followed by an injection of heroin, the amount of 
neurons expressing both arc and h1a formed a small proportion of all mRNA-positive 
neurons. In fact, the cocaine-heroin conditions and the cocaine-saline conditions did not 
differ significantly in terms of the proportion of co-expressing neurons. Therefore, any 
overlap in the cocaine-heroin conditions can be attributed to the effect of cocaine alone. 
This was true regardless of heroin dose or striatal area. Thus, the neuronal ensembles 
responding to cocaine do so not just reliably, but also preferentially, at least under 
certain conditions. One of these conditions is the order in which heroin and cocaine 
were administered. When heroin is administered 25 min after cocaine, the populations 
of neurons activated by each drug are largely distinct. However, when heroin is 
administered first and cocaine second, there is an increase in the degree of overlap. 
Although this increase was not necessarily statistically significant, it was reliably 
observed across all striatal areas. The increase is most notable in the Nacc shell, where 
the overlap is similar to the overlap following two consecutive injections of heroin.  
In summary, the overlap between the neuronal populations activated by heroin and 
cocaine in the striatum varies as a function of brain area and the order of drug 
administration. It can be said that the overlap is predominantly lower than the overlap 
between neuronal populations activated by consecutive injections of the same drug. The 
only exception is the Nacc shell, where heroin and cocaine activate largely the same 
neurons when cocaine is administered second. 
Summary and conclusions 
The study presented here was first of all an attempt at applying the catFISH technique 
to the study of pharmacological stimuli, and second – a characterisation of the neuronal 
populations activated by heroin and cocaine in different parts of the striatum. The 
results reported suggest that catFISH can indeed be used to study acute drug effects, 
but only with a number of methodological considerations in mind. Even with these 
considerations in mind, the results also point to the existence of a neuronal ensemble 
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encoding cocaine effects in both dorsal and ventral parts of the striatum. Heroin, on the 
other hand, activates a particular subset of neurons only in the Nacc shell, but not other 
part of the striatum. 
There is also a significant separation between the neuronal populations activated by 
heroin and cocaine. These findings could explain why both heroin and cocaine produce 
activity in these areas as measured by IEG expression, while electrophysiological 
recordings from the Nacc core reveal different responses of the same neurons after 
administration of the two drugs (Chang et al., 1998). The order of drug administration 
matters for the amount of overlap between neuronal populations activated in the Nacc 
shell. As discussed earlier, previous studies have found high degree of overlap between 
neuronal populations activated by an injection of morphine and a following injection of 
cocaine in the Nacc shell of mice. Here, the same was found for heroin followed by 
cocaine, but not when cocaine was administered before heroin. Thus, future studies 
comparing the effects of heroin and cocaine in the same animal should take into account 
the order in which drugs are administered. 
It is likely that neuronal activation and the corresponding IEG transcription that 
accompanies it are mostly the result of excitatory glutamatergic transmission. Cocaine-
induced dopamine release potentiates the effects of glutamate on IEG expression, but 
is not sufficient for IEG expression in itself: chloral hydrate abolishes cocaine-induced c-
fos expression by reducing glutamate but not dopamine release in the striatum (Kreuter, 
Mattson, Wang, You, & Hope, 2004). Thus, the separation of the neuronal populations 
found in this study could be the result of distinct glutamatergic afferent inputs to the 
Nacc being activated following cocaine and heroin injections. The three major sources 
of glutamatergic input to the Nacc shell are the hippocampus, BLA and PFC, with the 
hippocampus being the major one of the three. Optogenetic activation of all three inputs 
can sustain operant behaviour suggesting activity of neurons in the shell is sufficient for 
reinforcement (Britt et al., 2012). Both heroin and cocaine seem to engage a specific 
neuronal population in the shell. Thus, the activity elicited by heroin and cocaine in this 
brain area may reflect their reinforcing properties, regardless of whether this activity 
occurs in distinct neuronal populations.  
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In contrast, the separation of neuronal populations encoding for heroin and cocaine in 
the Nacc core could mean that these populations have non-equivalent functions. 
Transmission through the NMDA receptor in the Nacc core is necessary for food (Kelley, 
Smith-Roe, & Holahan, 1997) and cocaine self-administration, but not heroin self-
administration (Pulvirenti, Maldonado-Lopez, & Koob, 1992). In addition, DA 
transmission in the accumbens plays a lesser role in heroin self-administration than in 
cocaine self-administration. The question remains open as to whether the neuronal 
activity in the Nacc core observed here is encoding the reinforcing properties of cocaine 
but not heroin. One way to test this hypothesis would be to selectively disrupt the 
cocaine-activated neuronal ensembles - e.g. using Daun02 (Koya et al., 2016) - and see 
if they would affect the reinforcing properties of heroin.  
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Chapter 5 – Applying catFISH to the context of drug self-
administration 
 
Introduction 
The catFISH technique revealed that non-contingent administration of heroin and 
cocaine leads to the activation of neuronal ensembles that respond to cocaine across 
the whole striatum, while an ensemble for heroin is found only in the Nacc shell. 
Additionally, there was a significant separation of the neuronal populations responding 
to heroin and cocaine, at least under certain conditions. Thus, the striatum is encoding 
the effects of heroin and cocaine differently, at least in terms of neuronal activity 
marked by IEG expression. However, it remains unclear what is the functional 
significance of this activity. This chapter presents an attempt to apply the catFISH 
technique to a self-administration paradigm where rats get the opportunity to press a 
lever to obtain heroin and cocaine. In this way activity reflected in IEG expression could 
potentially be related to behaviours caused and driven by the two drugs. 
Indeed, operant reinforcement has been shown to depend on neuronal activity in the 
striatum. For example, excitotoxic lesions of the Nacc can disrupt both heroin and 
cocaine self-administration (Zito, Vickers, & Roberts, 1985). In addition, optogenetic 
stimulation of dopamine D1 but not D2 receptor expressing medium spiny neurons 
(MSNs) of the dorsal striatum maintains operant responding in mice (Kravitz, Tye, & 
Kreitzer, 2012). Thus, activity across the striatum can be both necessary and sufficient 
to maintain operant conditioning, and this activity occurs in specific neurons. For this 
reason it is of special interest that heroin and cocaine activate largely distinct neuronal 
populations across the striatum: it is possible that dissociated circuitries underlie the 
operant reinforcing properties of the two drugs. However, it is also possible that the 
early encoding of heroin and cocaine effects does not reflect encoding following 
prolonged exposure to the two drugs. This is especially the case when activity is 
measured by IEG expression. The expression levels of c-fos, for example, can increase or 
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decrease (depending on brain area) from day 1 to day 6 of cocaine self-administration 
(Zahm et al., 2010). Thus, it is an empirical question whether arc and homer 1a will also 
change their patterns of expression following prolonged drug self-administration.  
There are some studies that can inform a plausible hypothesis regarding the question. 
Fumagalli et al. have shown that a single 2h cocaine self-administration session has been 
found to elevate arc but not zif268 mRNA levels in the mPFC of rats. In addition, the 
effect is not found in yoked controls receiving the same amount of drug. In the dorsal 
striatum, arc expression is significantly increased in both yoked and self-administering 
animals, while a non-significant increase is found only for the self-administering rats in 
the Nacc. For zif268, the increase in expression is found in both Nacc and dorsal striatum, 
regardless of whether cocaine is self-administered or received passively (Fumagalli et al., 
2009). Following long-term cocaine self-administration (10 or 60 days), arc expression is 
slightly but significantly elevated in both the dorsal and ventral striatum. Increase in 
expression in these areas is also found for c-fos, with an even greater magnitude of the 
increase. However, homer 1a is not expressed above control levels in the striatum under 
the same conditions. In the mPFC, c-fos expression is also increased after long-term self-
administration, while homer 1a and arc are only elevated following 60 but not 10 day 
self-administration (Gao, Limpens, Spijker, Vanderschuren, & Voorn, 2017). Thus, IEG 
expression following cocaine self-administration depends on many factors including 
length of self-administration training, type of IEG, and brain area of interest. It also 
noteworthy that passively received cocaine and self-administered cocaine can have 
different effects on IEG expression. 
To date, there are no known studies that have examined the effects of heroin self-
administration on homer 1a expression in the brain. Only one study has investigated the 
effect of heroin self-administration on arc protein expression, where rats were trained 
to self-administer heroin in a runway self-administration model (Li et al., 2013). After 1, 
7, and 15 runway trials (1 trial per day), arc protein levels were significantly elevated in 
the mPFC, Nacc and DMS. Arc protein expression and run time were reduced to control 
levels after administration of NMDA and D1 receptor antagonists, suggesting that 
glutamatergic and dopaminergic neurotransmission are necessary for the behaviour and 
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protein expression. Passively received heroin also increased arc protein levels in all three 
brain areas. 
In summary, there are only a few studies that have studied the effects of heroin and 
cocaine self-administration on arc and homer 1a expression, but they all point to 
increased expression of both genes in the mPFC.  It also seems that, at least under 
certain conditions, homer 1a expression in the striatum is not increased above baseline 
after several days of cocaine self-administration. While arc is, there are regional 
differences between ventral and dorsal striatum, and the length of self-administration 
also matters, with longer training having a more pronounced affect. 
The self-administration paradigm constitutes a model of motivated drug-taking 
behaviour where drugs act as reinforcers (Panlilio & Goldberg, 2007). Considering that 
drug self-administration can also induce IEG expression in some brain areas and under 
certain conditions, the model provides a good opportunity to study active neuronal 
populations using catFISH. It was already shown that non-contingent administration of 
heroin and cocaine activate largely different neuronal populations across the striatum. 
Applying the catFISH technique to a self-administration paradigm would provide an 
opportunity to associate the activity of these neuronal populations with the reinforcing 
properties of the two drugs. Provided that dissociation is found again, it would be direct 
evidence for distinct circuitry underlying heroin- and cocaine-taking.  
The self-administration procedure also provides an opportunity to record and 
characterise other drug-induced behaviour such as locomotion and stereotypy. These 
behaviours are thought to be mediated in large part by dopaminergic neurotransmission 
and activity within the ventral and dorsal striatum. For example, microinjections of 
cocaine in the Nacc elicit locomotor behaviour in rats, and the effect is blocked by the 
DA receptor antagonist cis-flupenthixol (Delfs, Schreiber, & Kelley, 1990). Amphetamine 
(an indirect DA agonist) injected into the ventral lateral striatum elicits robust oral 
stereotypies such as gnawing, biting and licking (Kelley, Lang, & Gauthier, 1988). Thus, 
it can be expected that increases in IEG expression in the striatum will be correlated to 
locomotor behaviour and stereotypy, because IEG expression also reflects neuronal 
activity and DA neurotransmission to a great extent. In addition, drug-induced 
locomotor behaviour does not predict how well rats learn cocaine self-administration, 
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so it is likely that the two types of behaviour are mediated by separate neuronal systems 
within the striatum (Mandt, Johnston, Zahniser, & Allen, 2012; Mandt, Schenk, Zahniser, 
& Allen, 2008; Mantsch, Ho, Schlussman, & Kreek, 2001). Finally, operational definitions 
of locomotor behaviour can influence outcome measures of the behaviour, and 
stereotyped behaviour can be misrepresented as lack of drug effects on behaviour. For 
this reason several approaches to measuring drug-induced behaviour are preferred. 
The study presented here describes a pilot experiment where the catFISH technique was 
applied to a self-administration paradigm. Rats were trained to self-administer heroin 
and cocaine at doses of 100 µg/kg and 800 µg/kg, respectively. These doses were chosen 
to correspond to the doses used in the experiment reported in chapter 4. The higher 
dose of heroin (200 µg/kg) was not used, because preliminary observations revealed 
that some rats became sedated and did not respond on the second lever during test 
sessions (test session described in procedure).  After training, each rat was allowed to 
self-administer a combination of two drug injections 25 min apart, or was simply 
exposed to the self-administration environment. The aim of the study was to explore 
the possibility of measuring overlap between neuronal populations active during 
operant responding for drugs as opposed to passively received heroin and cocaine. Since 
arc and homer 1a differ in their expression patterns following drug self-administration, 
and their expression is not always elevated in the striatum, the PFC was also examined 
for changes in IEG expression. Finally, several measures of behaviour were taken 
immediately after self-administered heroin and cocaine infusions in order to find 
potential correlations between IEG expression and different aspects of behaviour. 
Methods 
Animals, housing and testing cages 
The rats in this experiment (n = 20) weighed 300-340g at the time of testing. Two of 
them were supplied by Charles-River, UK. Otherwise, supplier, weight upon arrival, and 
housing conditions were as described in general methods. 
The animals were kept in the housing cages described in general methods except during 
self-administration training and testing sessions, when they were moved to the operant 
chambers. These had two operating retractable levers positioned on opposite walls of 
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the chamber, with white LED lights positioned on the protruding part of each lever. 
Cameras were placed on top of each operant chamber to allow for recording of 
behaviour during testing sessions (details in procedure section). 
Drugs 
Heroin HCL was dissolved in sterile saline at a concentration of 0.6-0.68 mg/ml 
(depending on the weight of individual rats). Cocaine HCL was dissolved at a 
concentration of 4.8-5.5 mg/ml. All drug infusions had a volume of 50 µl, which 
corresponded to doses of 100 µg/kg for heroin, and a dose of 800 µg/kg for cocaine. The 
infusions were delivered over 5 sec using the same pumps as described in chapter 4, 
(infusion rate 10 µl/sec), but here these were activated contingently on the rats pressing 
a lever.  
Procedure 
Acclimatization and catheter surgery were done as described in general methods.  
Self-administration training. After a recovery period of 7 days, rats were habituated to 
the self-administration chambers during two 2h periods on two separate days. During 
habituation, the rats were connected to the infusion lines via their implanted cannulas 
and the springs suspended on the counterbalanced arms of the self-administration 
chambers. The animals were left to explore freely and no drugs were available for self-
administration.  
Following habituation, each rat underwent several stages of self-administration training 
where intravenous infusions of heroin or cocaine (on alternate days) were contingent 
upon the pressing of a lever (FR1 schedule). Each drug was paired with a different lever. 
There was one self-administration session a day, and each session lasted for a total of 
6h, and there were no more than 50 infusions available. In cases where rats reached the 
maximum number of infusions early, they were left in the chamber for the whole 
duration of the session. The sessions began with the insertion of the lever with the LED 
lights on. It remained extracted until the rat pressed it which led to the lever being 
retracted, lights going off, and the delivery of a 50 µl infusion over 5 sec. This was 
followed by a timeout period (TO). The duration of the TO between infusions progressed 
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from one session to another in the following way: 1 min, 5 min, 10 min, 15 min and 25 
min. This was done so that the rats got accustomed to the conditions of the final test 
session, described further on. The progression from one TO to the next for each rat was 
dependent on it reaching one of two criteria: self-administering 30% of the infusions 
available for the previous session or pressing the lever within 2 min after its first 
presentation for 4 consecutive sessions. Note that the total number of available 
infusions differed depending on the TO for the session (e.g. for 10 min TO, there were 
36 infusions available, for a 15 min TO, there were a total of 24 infusions available). 
Self-administration test session. After each rat had undergone at least two self-
administration sessions with each of the 5 TOs, it was subjected to a test session on a 
separate day which lasted ~30 min. The session began with the insertion of one of the 
levers which remained extracted for a maximum of 2.5 min or until the rat pressed it, 
whichever came first. If the rat failed to press, the session ended, and testing was 
restarted. If the rat did press within the designated time, it received an infusion of the 
drug associated with the lever. Then, a 25 min TO period followed after which a lever 
was presented for a second time, again for a maximum of 2.5 min or until the rat pressed 
it. If the rat did not press, the session ended and the rat was tested again on the 
following day. If it did press, a second infusion was delivered, followed by a period of ~5 
min. At the end of this period, the rat was euthanised with an intravenous injection of 
pentobarbital delivered manually through its catheter via a syringe. Then, the rat was 
decapitated, brain tissue was extracted, snap-frozen in isopentane and stored for 
catFISH analysis. There were 4 different drug combinations that the rats were allowed 
to self-administer: heroin-heroin, cocaine-cocaine, heroin-cocaine and cocaine-heroin. 
A final group of rats was exposed to the self-administration environment for the 
duration of the tests session, but no levers were presented and no drug infusions were 
available (exposure only, control group).  
The reason for choosing this type of control was that some animals in the control group 
had blocked catheters at the time of the test session, so having animals press for saline 
infusions was not possible. Additional animals could not be tested due to time 
constraints. It was possible to expose animals in the control group to the drug-associated 
levers without any infusions available. However, preliminary observations revealed that 
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rats would rarely press a second time if pressing the first lever had no consequences. So, 
exposing control animals to the drug-associated levers would have resulted in 
differences between experimental and control conditions in terms of lever-pressing 
behaviour. Thus, choosing only exposure to the drug-associated environment as a 
control condition was the best compromise in light of practical issues (catheter patency 
issues and time constraints) rather than a choice made on theoretical grounds. It is 
noted that, as a result, some of the behavioural changes in the experimental groups can 
be attributed to the conditioned effects of a discrete cue - presentation of the drug-
associated lever.   
Precise administration of two separate doses of the same or different drugs was 
achieved through back-filling of the infusion line similarly to the experiment described 
in the previous chapter. Behaviour was recorded for the whole duration of the test 
session, but different behavioural measures were taken at different time points 
(detailed description available in continuation).  
CatFISH. Whole brains were sectioned at 16 µm thickness, and coronal slices were taken 
at the level of the mPFC and the anterior striatum, (+3.70 mm, and +1.70 mm from 
bregma, respectively (Paxinos & Watson, 1986)). As in the procedures described in 
chapters 3 and 4, sections were removed starting from the tip of the olfactory bulbs until 
the ventral part of the brain sections (most caudal part of the olfactory bulbs) became 
attached to the dorsal part of the sections. At this point, the anterior forceps of the 
corpus callosum (fmi) was visible, and the lateral fissure reached halfway to the midline 
(+3.70 mm from bregma, fig. 5.1, next page). At this point, images of the PFC were taken 
from three locations. First, an imaginary line was followed from the tip of the lateral 
fissure to the midline. Where the two met was the point where the bottom left margin 
of the microscope field of view (MFV) was positioned. This was defined as the infralimbic 
cortex (IL). The MFV was then moved in a dorsal direction, until it was positioned 
between the midline and the medial side of the fmi. This was defined as the prelimbic 
cortex (PL). Finally, the MFV was moved further in the dorsal direction, along the midline, 
until the top margin of the MFV reached the angle between the midline and the most 
dorsal end of the section. This was defined as the anterior cingulate dorsal cortex (ACd). 
The sections of the striatum were delineated as described in chapter 4 (fig 5.2, next 
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page). The RNAscope probes and reagents, the in situ hybridisation, and the image 
acquisition and analysis protocols were as described in general methods. 
 
Fig. 5.1. Schematic representation of the rostrocaudal level defined as +3.70 mm from 
bregma during sectioning. Reference structures were as described in ch. 3. Green 
circles represent ROIs where images of the IL (1), PL (2), and ACd (3) were taken.  
 
Fig. 5.2. Schematic representation of regions of interest (ROI) where microscopic 
images were taken across the striatum: Nacc shell (1), Nacc core (2), DMS (3) and DLS 
(4). Reference structures were the same as described in ch.4. 
Design and behavioural measures 
This study had a mixed design. The between-subject independent variable was the 
combination of drugs that each rat was allowed to self-administer during the final 
testing session (heroin-heroin, cocaine-cocaine, heroin-cocaine, cocaine-heroin or no 
drug, n = 4 in each group). For some of the statistical analyses rats were grouped based 
1 
2 
3 
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on the first or second drug they self-administered. Within-subject independent variables 
were the different time periods during which behaviour was recorded within the testing 
session. Each rat was observed at several time points after the administration of the first 
drug and immediately after the administration of the second drug. The dependent 
variables were several behavioural measures. For the sake of analysis, the testing 
session was divided in 2 main periods – first 25 minutes reflecting the behavioural 
effects of the first drug, and last 5 min reflecting the effect of the second drug together 
with any potential carry-over effects of the first infusion. The first 25 min period was 
further divided in 5 min bins (labelled a-e, fig. 5.3, below). 
 
 
 
 
 
Fig. 5.3. Schematic representation of the final tests session timeline. Sections “a – e” 
represent 5 min bins of period 1. 
First, locomotion was measured by dividing the bottom of the self-administration 
chamber in four quadrants of equal size and counting the number of crosses each rat 
made over the borders of these quadrants. A crossover was defined as when the 
shoulder blades of the animal cross from one quadrant to another. Crossovers were 
counted during the whole periods 1a, 1c, 1e and the whole duration of period 2, and 
scores were converted in crosses/min. 
Second, the activity scale proposed by Ellinwood and Balster (1974) was used to provide 
an additional measure of drug-induced motor activity and stereotypy. Originally, the 
scale consists of 9 points corresponding to progressing levels of normal to drug-induced 
motor activity starting from none (0) and ending in stereotypical movements and 
dyskinesia (8, 9). A slight modification was made to the original order of the 5th and 6th 
points of the scale (the two were switched), because it was concluded that such order 
better reflects the progression from normal to drug-induced activity (table 5.1, next 
a b c d e 
Infusion 1 Infusion 2 
Period 1 Period 2 
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page). Scoring using this scale was done by observing animals for the last 20 sec of 
periods 1a-e and the last 20 sec of the 5th min of period 2 and assigning the appropriate 
score.  
Table 5.1. Scores, corresponding activity levels and operational definitions as 
adapted from the scale proposed by Ellinwood and Balster. 
Score Activity level Definition 
1 asleep lying down, eyes closed 
2 inactive lying down, eyes open 
3 in place activity 
(grooming) 
normal grooming (scratching, licking self, rubbing face with 
paws) 
4 normal/alert/active moving about cage, sniffing, rearing 
5 slow-patterned repetitive exploration of the cage at normal level of activity 
6 hyperactive running movement, rapid changes in position (jerky) 
7 fast patterned repetitive exploration of the cage with hyperactivity 
8 restricted remaining in the same place in cage with fast repetitive 
head/foreleg movement (licking, chewing, gnawing 
stereotypies) 
9 dyskinetic-reactive backing-up, jumping, seizures, abnormally maintained 
postures, dyskinetic movements 
 
Third, the latency to press the lever after each of the two lever presentations during the 
test session was recorded in seconds. This was defined as the amount of time between 
the moment the lever was extracted and the moment the rat pressed it. 
Finally, the occurrence of pre-defined categories of behaviour were counted according 
to methodology adopted from Fray, Sahakian, Robbins, Koob, and Iversen (1980). There 
were 10 behavioural categories in total (table 5.2, next page). Animals were observed 
during the last 10 sec of periods 1a-e as well as during the last 10 sec of the first 5 min 
of period 2 and the presence of any of the aforementioned behaviours was noted down. 
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Table 5.2. Categories and operational definitions for counting the occurrence of 
particular behaviours (adopted from Fray et al.). 
Category Definition 
still Asleep or not moving, with an occasional sniff 
locomotion All four legs moving 
rearing Both front feet off the cage floor 
sniffing Sniffing for more than 3 s 
licking Licking for more than 3 s 
gnawing Gnawing for more than 3 s 
head down Animal standing, walking or running with its nose below horizontal for 
more than 5 s 
swaying Rhythmic swaying movements of the animal's head or body for more 
than 3 s 
grooming Grooming for more than 3 s 
miscellaneous Any category of behaviour not already listed that occurs for more than 3 
s 
 
Results 
Self-administration training 
A number of caveats must be taken into account when interpreting the self-
administration data presented. These caveats arise from the differences in the speed of 
learning of individual rats. Every rat had to reach a criterion to progress from one stage 
of training to another, and different stages had different number of available infusions 
(due to different TO periods). In addition, the dose of cocaine was varied for some rats 
during the initial stages of training (to facilitate drug-taking in case the final testing dose 
is too high for acquisition). Finally, some rats required less training sessions than others 
overall. For all these reasons, the self-administration data are presented in several 
different ways, as seen in continuation. 
Figure 5.4 (p. 117) shows the average number of infusions self-administered as a 
function of session and drug. Since individual rats were trained for varying number of 
sessions depending on how quickly they acquired the behaviour (min 5, max 10 sessions), 
the data in fig. 5.4 represents self-administration for the last 7 sessions of training only. 
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Where rats learned quicker than that (4 out of 20 cases in total), their score was not 
included in the calculation of the mean for sessions they did not participate in. 
Rats pressed more (and more consistently) for heroin than for cocaine across all of the 
last 7 sessions of training. There was an increase in number of lever presses for heroin 
from the first to the last session (M = 11.75, SE = 1.38, and M = 15.63, SE = 0.93, 
respectively), while this was not the case for cocaine (first session: M = 8.4, SE = 3.19; 
last session: M = 4.25, SE = 1.3).  
Shapiro-Wilk tests revealed non-normal distributions of the scores for several of the 
sessions. Friedman’s ANOVAs revealed a significant difference between levels of heroin 
self-administration across sessions (χ2(6) = 32.49, p < .001), but there was no such 
difference in the case of cocaine (χ2(6) = 4.02, p = .674). Follow-up Wilcoxon’s tests were 
run with a Bonferroni correction (α = .025) to compare the amount of lever presses 
between the first and last sessions for both heroin and cocaine. Both tests were non-
significant: z = -2.15, p = .031 (heroin) and z = -0.41, p = .682 (cocaine). 
It must be noted here that the apparent decrease in self-administration over the last 
three sessions for both heroin and cocaine arises from the transition to sessions with 
longer TO periods and fewer available infusions.  
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To account for the change in TO and number of available infusions, the same data was 
also presented as percent of total available infusions self-administered for each session 
(fig. 5.5, next page). On average, rats increased heroin intake from the first session (M = 
23.5%, SE = 2.76), approaching the maximum amount of available heroin infusions by 
the last session (M = 87.45%, SE = 4.51). In contrast, they were much less inclined to self-
administer cocaine, seen as a lower amount of infusions self-administered on session 1 
(M = 16.6%, SE = 6.4) and as reaching less than a third of the available infusions by the 
last session (M = 27.86%, SE = 8.71). Note that the variability in cocaine self-
administration is also higher. 
Shapiro-Wilk tests revealed a non-normal distribution of scores across sessions for both 
heroin and cocaine. Friedman’s ANOVA tests were run and revealed significant changes 
between sessions for both heroin (χ2(6) = 68.46, p < .001) and cocaine (χ2(6) = 15.54, p 
= .016). Post-hoc Wilcoxon tests were run to compare self-administration scores 
between the first and last sessions for each drug. A Bonferroni correction was applied 
to correct for multiple comparisons, so α = .025. Rats self-administered significantly 
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higher percentage of available infusions on the last session relative to the first session 
for both heroin (z = -3.52, p < .001) and cocaine (z = -2.27, p = .023).  
 
Figure 5.6 (next page) shows the cumulative amount of heroin and cocaine self-
administered for each of the last 7 sessions in µg/kg. These data were presented to 
account for changes in the dose of cocaine across early training sessions for some rats 
that did not acquire the self-administration behaviour at the testing dose (800 µg/kg). 
For heroin, the amount of drug self-administered follows the lever-press data exactly, 
as the dose of 100 µg/kg did not change across sessions. On average, the highest amount 
of heroin and cocaine self-administered was found in session 5 (M = 1975, SE = 161.55 
and M = 8400, SE = 2439.33, respectively). 
Shapiro-Wilk tests revealed non-normal distributions of scores across several sessions. 
Friedman’s ANOVAs revealed a significant change across sessions in the case of heroin 
(χ2(6) = 32.49, p < .001), but not cocaine (χ2(6) = 9.99, p = .125). A post-hoc Wilcoxon test 
revealed a significant difference between amounts of heroin taken in the first and last 
sessions (z = -2.15, p = .031). 
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Finally, figure 5.7 (next page) shows the amount of heroin and cocaine taken during 
training by rats in each of the 4 experimental groups and the control group (testing day 
grouping). There was negligible difference in the amount of heroin taken by rats in all 5 
groups (coc-coc: M = 12650, SE = 1657.56; coc-her: M = 10350, SE = 870.34; her-coc: M 
= 11650, SE = 629.15; her-her: M = 10900, SE = 1368.70; and control: M = 10125, SE = 
2392.48). However, there was a more noticeable difference in the amount of cocaine 
taken by rats in each of the test day groups (coc-coc: M = 84050, SE = 43192.00; coc-her: 
M = 69200, SE = 24227.39; her-coc: M = 51750, SE = 13866.84; her-her: M = 6350, SE = 
1206.58; and control: M = 3500, SE = 1173.31).  
Shapiro-Wilk tests revealed normal distributions of the scores for amount of heroin 
taken across groups. The scores for amount of cocaine taken in the cocaine-cocaine 
group were not normally distributed. A one-way ANOVAs revealed that there was no 
significant difference between groups for amount of heroin taken (F(4,15) = 0.46, p 
= .762), while a Friedman’s ANOVA revealed a significant difference in the case of 
amount of cocaine taken (χ2(4) = 12.71, p = .013).  
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Post-hoc Mann-Whitney tests were run to follow up on the Friedman’s ANOVA, with a 
Bonferroni correction (α = .01). None of the comparisons were significant: heroin-heroin 
vs. control (U = 4, p = .343), heroin-heroin vs heroin-cocaine (U = 0, p = .029), heroin-
heroin vs cocaine-heroin (U = 2, p = .114), heroin-heroin vs. cocaine-cocaine (U = 0, p 
= .029), and cocaine-cocaine vs. heroin-cocaine (U = 8, p = 1). 
 
Measures of drug-induced behaviour 
Measures of locomotion, activity as defined be the Ellinwood et al. (1984) scale, and 
categorical classification of behaviour are presented for the two periods following drug 
infusions on test day. The first period (period 1) spans 25 min following the first infusion, 
while the second period (period 2) consists of the 5 min following the second infusion.  
Locomotion 
Figure 5.8 (next page) shows the level of locomotor behaviour during the tests session 
as a function of first drug received and time. The control group was only exposed to the 
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self-administration environment. In the first 5 min following the drug infusion, rats that 
received heroin and cocaine moved the most (M = 8.3, SE = 3.5 and M = 8.85, SE = 1.1, 
respectively), relative to rats that did not receive a drug (M = 3.65, SE = 1.55). Ten 
minutes later, activity remained high in the heroin group (M = 7.44, SE = 1.61), while for 
cocaine and the control group locomotion diminished (M = 3.81, SE = 0.52 and M = 1.43, 
SE = 0.69, respectively). In the 20-25 min period post injection, locomotion in the heroin 
group was still relatively high (M = 6.36, SE = 1.69), while in the cocaine group it was 
closer to controls (M = 2.84, SE = 0.57 and M = 1.25, SE = 0.85, respectively). 
 
Shapiro-Wilk tests revealed non-normal distributions of scores across some conditions. 
Therefore, drug groups in each 5 min bin were analysed separately using Kruskal-Wallis 
tests.  
The differences between groups in the first 5 min post-injection only approached 
significance, H(2) = 4.96, p = .084.  
In the 10-15 min period post-injection, there was a significant difference between drug 
treatments, H(2) = 9.28, p = .01. Mann-Whitney post-hoc tests (at α = .017) revealed that 
there was significantly more locomotion elicited by heroin relative to control, U = 1, p 
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= .008, but not relative to cocaine, U = 14.5, p = .065. Cocaine and control conditions 
were also not significantly different from each other, U = 13.5, p = .028. 
Finally, in the 20-25 min period post-injection, there was a significant difference 
between levels of locomotion across drug conditions, H(2) = 8.1, p = .018. Again, this 
difference stemmed from significantly higher locomotion levels in the heroin condition 
relative to control, U = 2, p = .016 (at α = .017).  
Figures 5.9 (next page) and 5.10 (p. 124) show the levels of locomotion in the first 5 min 
following the second drug infusion of the tests session. Figure 5.7 shows locomotion as 
a function of the second drug infusion only, while figure 5.8 shows locomotion as a 
function of the combination of drugs infused during the tests session (first and second). 
Considering the second infusion only (fig. 5.9), on average, the highest level of 
locomotion was elicited by cocaine (M = 9.31, SE = 1.83), followed by heroin (M = 3.03, 
SE = 0.85) and then the control condition (M = 0.66, SE = 0.49). Shapiro-Wilk tests 
revealed lack of normality in the cocaine and control conditions. 
A Kruskal-Wallis tests revealed a significant difference between conditions, H(2) = 12.6, 
p = .002. Post-hoc Mann-Whitney tests (at α = .017) revealed that there was significantly 
more locomotion in the cocaine relative to both the heroin and the control conditions 
(U = 6, p = .005 and U = 0, p = .004, respectively). Heroin and control conditions were 
not significantly different from each other, U = 4, p = .048. 
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When considering the combination of drugs received during the test session (fig. 5.10), 
the highest levels of locomotion were found in the heroin-cocaine group (M = 9.31, SE = 
1.83), followed by the cocaine-cocaine (M = 9.31, SE = 1.83), heroin-heroin (M = 9.31, SE 
= 1.83), cocaine-heroin (M = 9.31, SE = 1.83) and control/exposure-only groups (M = 9.31, 
SE = 1.83). Shapiro-Wilk tests revealed that there was a non-normal distribution of 
scores in the control group. 
A Kruskal-Wallis test revealed a significant difference between groups, H(4) = 13.3, p 
= .01, and post-hoc Mann-Whitney tests revealed that differences between the cocaine-
cocaine group and control, and heroin-cocaine and control only approached significance 
after a Bonferroni correction (U = 0, p = .029 and U = 0, p = .029, respectively, if α = .025). 
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Latency to press 
Figure 5.11 (next page) shows the latency to press a lever depending on the drug 
associated with it. On average, rats took longer to press a lever associated with cocaine 
(M = 52.46, SE = 11.39) than to press a lever associated with heroin (M = 31.10, SE = 
7.13). Where rats had to press twice for the same drug (cocaine-cocaine and heroin-
heroin groups), data were averaged from the two presses. Rats in the control condition 
were excluded from this analysis, as they were not given the opportunity to press. 
Shapiro-Wilk tests revealed normal distributions of the latency scores for both the 
heroin and cocaine levers. A paired-samples t-test revealed a significant difference 
between conditions, t(11) = 2.21, p = .049. 
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Fig. 5.10. Locomotion during the 5 min following the second drug 
infusion (period 2) as a function of combination of drugs received 
during the tests session. Error bars represent ± 1 SE. N = 4 for each 
group.
125 
 
 
Activity scale (Ellinwood et al. 1984) 
Figure 5.12 (next page) shows the average level of activity as measured by the 9-point 
scale as a function of first drug infusion and time. For both heroin and cocaine, and the 
control group, the highest average level of activity was found in the first 5 min of period 
1 (M = 7.69, SE = 0.25; M = 5.44, SE = 0.44 and M = 4.5, SE = 0.61, respectively). Then, 
activity gradually diminished over time for both drugs and the control group, but in all 
cases remained higher in the heroin group relative to the others: at 10 min, heroin M = 
7.44, SE = 0.26, cocaine M = 4.5, SE = 0.6 and control M = 3.5, SE = 0.54; at 15 min, heroin 
M = 5.81, SE = 0.62, cocaine M = 4.44, SE = 0.84, and control M = 2.5, SE = 0.2; at 20 min, 
heroin M = 6.25, SE = 0.71, cocaine M = 3.88, SE = 0.97, and control M = 2.75, SE = 0.6; 
and, finally, at 25 min, heroin M = 6.38, SE = 0.73, cocaine M = 4.31, SE = 0.88, and control 
M = 3, SE = 0.84. 
Shapiro-Wilk tests revealed lack of normality in several groups. Kruskal-Wallis tests were 
run to compare activity levels between drug groups and the control for each time bin, 
applying a Bonferroni correction (α = .01). 
0
10
20
30
40
50
60
70
Cocaine lever Heroin lever
L
at
en
cy
 t
o
 p
re
ss
 (
s)
Drug-associated lever
Fig. 5.11. Latency to press a lever as a function of the 
drug associated with it. Error bars represent ± 1 SE. 
*significantly different at the .05 level. N = 8 for each 
group.
*
126 
 
There was a significant difference between drug groups and control after the first 5 min 
of period 1, H(2) = 11.71, p = .003. This was also the case at the end of the 10 min bin, 
H(2) = 11.65, p = .003. There were no significant difference between drug groups and 
control for the rest of the time bins: 15 min, H(2) = 6.81, p = .033; 20 min, H(2) = 4.92, p 
= .085; and 25 min, H(2) = 5.92, p = .052. 
 
Post-hoc Mann-Whitney tests were run at α = .017. The difference in the 5 and 10 min 
bins arose from the heroin group having significantly higher activity levels relative to 
both cocaine and control: for the 5 min bin, U = 6, p = .005, and U = 0.5, p = .004, 
respectively; for the 10 min bin, U = 6, p = .005 and U = 0, p = .004, respectively. The 
cocaine group was not significantly different from control in either case: 5 min bin, U = 
9, p = .283; 10 min bin U = 9.5, p = .283. 
Figures 5.13 (next page) and 5.14 (p. 128) show the activity levels in period 2 as a 
function of either second drug self-administered during the session or the combination 
of drugs received during the session, respectively.  
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Considering the second drug infusion only (fig. 5.13), the highest level of activity on 
average was found in the heroin group, M = 6.63, SE = 0.75, followed by cocaine, M = 
5.06, SE = 0.45, and control, M = 2.75, SE = 0.25. Shapiro-Wilk tests revealed non-normal 
distributions across conditions.  
A Kruskal-Wallis test indicated a significant difference between groups, H(2) = 9.03, p 
= .011, and Mann-Whitney tests (at α = .017) revealed that there was a significant 
difference between cocaine and control, U = 1.5, p = .008. The other two comparisons 
were not significant after the correction: U = 3.5, p = .028 for heroin vs control, and U = 
0, p = .05 for heroin vs. cocaine. 
 
Considering the combination of drugs self-administered (fig. 5.14), the highest level of 
activity was found in the cocaine-heroin group (M = 7, SE = 0.71), followed by the heroin-
heroin group (M = 6.25, SE = 1.44), cocaine-cocaine (M = 5.13, SE = 0.66), heroin-cocaine 
(M = 5, SE = 0.71), and control (M = 2.75, SE = 0.25). Shapiro-Wilk tests revealed lack of 
normality in the heroin-heroin and control groups. A Kruskal-Wallis test indicated that 
there were no significant differences between groups, H(2) = 9.29, p = .054. 
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Table 5.3. Summary of locomotion and stereotypy data as measured by crossovers 
and the Ellinwood et al. scale, respectively. Data is presented as the effect of first or 
second drug injection (h – heroin, c – cocaine): (↑) significant increase relative to 
controls following Bonferroni correction, (−) no sig. difference from control, (↑) a 
significant increase from control which did not survive Bonferroni correction. 
  Period 1 (1st inj.) Period 2 (2nd inj.) 
  5’ 10’ 15’ 20’ 25’ overall after h after c 
Lo
co
m
o
ti
o
n
 
(c
ro
ss
o
ve
rs
) 
h −  ↑  ↑ ↑ − − 
c −  ↑  − ↑ ↑ ↑ 
El
lin
w
o
o
d
 
h ↑ ↑ − − − ↑ − − 
c − − − − − ↑ − − 
 
Categorical measures of behaviour 
As in the previous section, categorisation of behaviour was done separately for the two 
periods after each drug infusion of the test session. 
All comparisons between drug groups and controls were done using Fischer’s Exact Test 
(FET), since group sizes were too small to run chi-square tests. For comparisons between 
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Fig. 5.14. Activity 5 min after the second drug infusion of the 
tests session (period 2) as a function of combination of drugs 
received. Error bars represent ± 1 SE. N = 4 for each group.
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drug groups within each 5 min bin of period 1 it was necessary to apply a Bonferroni 
correction for multiple testing (α = .01). Only one of the comparisons in period 1 survived 
this correction. Regardless, comparisons where p-values were significant at the .05 level 
are reported. 
Figure 5.15 (below) shows the proportion of that exhibited locomotor behaviour as a 
function of time and first drug self-administered. Note the difference from the 
locomotor activity analysis as measured by number of crossovers. Differences between 
drug groups and control were significant at the .05 but not the .01 level only for the 5 
min bin, p = .035. That is, 75% of the rats in the cocaine and control conditions exhibited 
locomotor behaviour at the 5th min of period 1, while only 12.5% of rats in the heroin 
condition did so. 
 
Figure 5.16 (next page) shows the proportion of rats that exhibited gnawing behaviour 
as a function of first drug and time. At the end of the 5-10 min of period 1, 62.5% of rats 
in the heroin group exhibited gnawing behaviour, compared to 25% in the control group 
and none in the cocaine group, p = .028. 
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Fig. 5.15. Proportion of rats in each drug group showing locomotor 
behaviour in period 1 as a function of time. N = 4 for control, 8 for 
drug groups, at each time bin.
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Figure 5.17 (next page) shows the proportion of rats exhibiting sniffing behaviour as a 
function of time and first drug. In the first 5 min, 75% of rats in the cocaine and control 
conditions exhibited sniffing behaviour, while none of the rats in the heroin group did, 
p = .003. In the 5-10 min of period 1, 62.5% of rats in the cocaine group and 50% of rats 
in the control group exhibited the behaviour, while none in the heroin group did, p = .032.  
Figure 5.18 (next page) shows the proportion of rats exhibiting rearing behaviour. At the 
end of 10-15 min of period 1, 75% of rats showed rearing behaviour, while only 25% in 
the cocaine group and none in the control group did so, p = .035. At the end of 15-20 
min of period 1, 50% of rats in the heroin group were rearing, while none in the cocaine 
and control groups were doing so, p = .042. 
Figure 5.19 (p. 132) shows the proportion of rats exhibiting licking behaviour. At the end 
of 5-10 min of period 1, 50% of rats in the heroin group were exhibiting the behaviour, 
while none of the rats in the control and cocaine groups were doing so (p = .042). 
Figures 5.20-5.24 (pp. 132-134) show the proportion of rats in each drug group and the 
control that were exhibiting head down, sway, groom, still and miscellaneous 
behaviours, respectively. For these behaviours, none of the comparisons between 
groups at any time bin were significant either before or after a Bonferroni correction. 
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Fig. 5.16. Proportion of rats in each drug group showing gnawing 
behaviour in period 1 as a function of time. N = 4 for control, 8 for 
drug groups, at each time bin.
Cocaine Heroin Control
131 
 
 
0
25
50
75
100
0-5min 5-10min 10-15min 15-20min 20-25min
P
er
ce
n
t 
o
f 
ra
ts
 s
h
o
w
in
g
 b
eh
av
io
u
r
Time since first infusion of the test session
Fig. 5.17. Proportion of rats in each drug group showing sniffing 
behaviour in period 1 as a function of time. N = 4 for control, 8 for drug 
groups, at each time bin.
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Fig. 5.18. Proportion of rats in each drug group showing rearing 
behaviour in period 1 as a function of time. N = 4 for control, 8 for 
drug groups, at each time bin.
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Fig. 5.19. Proportion of rats in each drug group showing licking 
behaviour in period 1 as a function of time. N = 4 for control, 8 for 
drug groups, at each time bin.
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Fig. 5.20. Proportion of rats in each drug group showing head down 
behaviour in period 1 as a function of time. N = 4 for control, 8 for 
drug groups, at each time bin.
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Fig. 5.21. Proportion of rats in each drug group showing sway 
behaviour in period 1 as a function of time. N = 4 for control, 8 for drug 
groups, at each time bin.
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Fig. 5.22. Proportion of rats in each drug group showing grooming 
behaviour in period 1 as a function of time. N = 4 for control, 8 for drug 
groups, at each time bin.
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Fig. 5.23. Proportion of rats in each drug group staying still in period 1
as a function of time. N = 4 for control, 8 for drug groups, at each time 
bin.
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Fig. 5.24. Proportion of rats in each drug group showing miscellaneous 
behaviour in period 1 as a function of time. N = 4 for control, 8 for 
drug groups, at each time bin.
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Figure 5.25 (above) shows the proportion of rats showing each of the categorised 
behaviours 5 min after the second drug infusion (period 2) as a function of drug. A 
Bonferroni correction for multiple comparisons was applied, α = .005. Only the group 
comparisons for sniffing behaviour survived this correction, as 100% of rats in the 
cocaine group exhibited this behaviour, while none in the heroin and control groups did, 
p < .001. For locomotion, 75% of rats in the cocaine group exhibited the behaviour, 
compared to 12.5% and 0% in the heroin and control groups, respectively, p = .016. 
Finally, for the gnawing behaviour, 62.5% of rats in the heroin group exhibited the 
behaviour, compared to none in the cocaine and control groups, p = .008. None of the 
comparisons for the other behaviours were significant at either the .05 or .005 levels. 
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Fig. 5.25. Proportion of rats showing each of the listed behaviours 
following the second drug infusion during the test session (period 2). N = 
4 for control, 8 for drug groups, at each time bin.
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Table 5.4. Summary of categorical measures of behaviour. Data is presented as the 
effect of first or second drug injection (h – heroin, c – cocaine): (↑/↓) significant 
increase/decrease from control following Bonferroni correction, (−) no sig. 
difference, (↑/↓) a significant increase/decrease from control which did not survive 
Bonferroni correction. Behaviours for which no significant differences were found 
are not included. 
  Period 1  
(1st inj.) 
Period 2 
(2nd inj.) 
  5’ 10’ 15’ 20’ 25’ overall 
locomotion 
h ↓ − − − −  −  
c − − − − − ↑ 
gnawing 
h − ↑ − − − ↑ 
c − − − − − − 
sniffing 
h ↓ ↓ − − − − 
c − − − − − ↑ 
rearing 
h − − ↑ ↑ − − 
c − − − − − − 
licking 
h − ↑ − − − − 
c − − − − − − 
 
CatFISH 
Please note that due to exceptionally low levels of IEG expression across the striatum 
following self-administration (see Appendix 3), quantitative analysis of the IEG data was 
carried out only for the PFC. 
Infralimbic cortex (IL) 
Figure 5.26 (next page) shows the number of h1a- and arc-positive nuclei in the 
infralimbic cortex as a function of drugs self-administered during the test session. On 
average, the highest number of h1a-positive nuclei was found in the heroin-heroin 
group (M = 48.13, SE = 11.47), followed by the control group (M = 48, SE = 5.01), then 
the cocaine-cocaine group (M = 45.81, SE = 5.32), the heroin-cocaine (M = 38.69, SE = 
6.8) and the cocaine-heroin (M = 30.94, SE = 2.24) groups. On average, the highest level 
of arc expression was found in the control group (M = 32.44, SE = 12.54), followed by 
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heroin-cocaine (M = 24.06, SE = 3.87), then heroin-heroin (M = 23.81, SE = 6.9), cocaine-
cocaine (M = 22.69, SE = 4.42) and, finally, the cocaine-heroin (M = 13.06, SE = 1.85) 
group.  
Shapiro-Wilk tests revealed normal distributions of scores across groups for both h1a- 
and arc-positive nuclei. Levene’s tests revealed homogenous variance across groups for 
h1a, F(4,15) = 2.03, p = .141, but not arc, F(4,15) = 8.28, p = .001. One-way ANOVAs 
revealed no significant difference between groups for either h1a, F(4,15) = 1.17, p = .364, 
or arc, F(4,15) = 0.98, p = .450. Welch and Brown-Forsythe tests were also non-significant. 
 
Figure 5.27 (next page) shows the amount of nuclei in the infralimbic cortex co-
expressing h1a and arc calculated as a percentage of all mRNA-positive nuclei in that 
region of interest (ROI). The amount of co-expressing nuclei across conditions, in 
descending order, was as follows: heroin-heroin (M = 22.22, SE = 2.41), cocaine-cocaine 
(M = 21.77, SE = 2.33), control (M = 21.45, SE = 3.88), heroin-cocaine (M = 20.55, SE = 
2.25) and cocaine-heroin (M = 17.84, SE = 1.49). 
Shapiro-Wilk tests revealed a non-normal distribution only in the heroin-heroin 
condition, p = .022. Levene’s statistic was non-significant, F(4,15) = 0.96, p = .459. A one-
way ANOVA revealed no significant differences between groups, F(4,15) = 0.45, p = .769.  
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Fig. 5.26. Amount of h1a- and arc-positive nuclei in the 
infralimbic cortex (IL) as a function of drug group. Error bars 
represent ± 1 SE. N = 4 for each group.
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Prelimbic cortex (PL) 
Figure 5.28 (p. 140) shows the number of h1a- and arc-positive nuclei in the prelimbic 
cortex as a function of drug treatment. On average, the highest number of h1a-positive 
nuclei was found in the cocaine-cocaine group (M = 65.63, SE = 12.42), followed by the 
heroin-heroin group (M = 52.75, SE = 8.64), then the heroin-cocaine group (M = 48.94, 
SE = 7.01), the control (M = 45, SE = 4.4) and the cocaine-heroin (M = 36.69, SE = 5.04) 
groups. On average, the highest level of arc expression was found in the cocaine-cocaine 
group (M = 37.69, SE = 11.82), followed by control (M = 35.75, SE = 15.07), then heroin-
cocaine (M = 34, SE = 5.64), heroin-heroin (M = 29.94, SE = 7.15) and, finally, the cocaine-
heroin (M = 15.50, SE = 5.31) groups.  
Shapiro-Wilk tests revealed predominantly normal distributions except in the control 
condition for arc-positive nuclei, p = .033. Levene’s statistics revealed homogenous 
variance across groups for arc but not h1a, F(4,15) = 1.69, p = .204 and F(4,15) = 4.15, p 
= .018, respectively. One-way ANOVAs revealed no significant differences between 
groups for either h1a, F(4,15) = 1.17, p = .364, or arc, F(4,15) = 1.76, p = .189. Welch and 
Brown-Forsythe tests were also non-significant. 
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Fig. 5.27. Co-expressing nuclei as a percentage of all mRNA-
positive nuclei in the infralimbic cortex (IL). Error bars 
represent ± 1 SE. N = 4 for each group.
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Figure 5.29 (next page) shows the amount of nuclei in the prelimbic cortex co-expressing 
h1a and arc calculated as a percentage of all mRNA-positive nuclei (per ROI). The 
amount of co-expressing nuclei across conditions, in descending order, was as follows: 
cocaine-cocaine (M = 26.99, SE = 2.8), control (M = 22.87, SE = 2.58), heroin-heroin (M 
= 22.10, SE = 3.44), heroin-cocaine (M = 20.38, SE = 2.49) and cocaine-heroin (M = 17.31, 
SE = 2.91). 
Shapiro-Wilk tests revealed normal distribution of scores within conditions. Levene’s 
statistic was non-significant, F(4,15) = 0.07, p = .991. A one-way ANOVA revealed no 
significant differences between groups, F(4,15) = 1.54, p = .242.  
Anterior cingulate dorsal cortex (ACd) 
Figure 5.30 (p. 141) shows h1a- and arc-positive nuclei in the ACd as a function of drug 
treatment. On average, the highest number of h1a-positive nuclei was in the cocaine-
cocaine group (M = 67.81, SE = 8), followed by the heroin-cocaine group (M = 62.19, SE 
= 15.53), then the heroin-heroin group (M = 55.69, SE = 5.47), the control (M = 39.94, SE 
= 4.02) and the cocaine-heroin (M = 37.25, SE = 4.3) groups. On average, the highest 
level of arc expression was found in the cocaine-cocaine group (M = 34.94, SE = 8.02), 
followed by heroin-cocaine (M = 33.88, SE = 6.57), then heroin-heroin (M = 28.06, SE = 
8.08), control (M = 26.63, SE = 10.77) and, finally, the cocaine-heroin (M = 17, SE = 4.49) 
groups.  
Shapiro-Wilk tests revealed normal distributions within all drug groups. Levene’s 
statistics revealed homogenous variance across groups for both arc and h1a, F(4,15) = 
0.72, p = .592 and F(4,15) = 2.41, p = .095, respectively. One-way ANOVAs revealed no 
significant differences between groups for either h1a, F(4,15) = 2.46, p = .090, or arc, 
F(4,15) = 0.83, p = .526.  
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Figure 5.31 (p.142) shows the amount of nuclei in the ACd co-expressing h1a and arc 
calculated as a percentage of all mRNA-positive nuclei (per ROI). The amount of co-
expressing nuclei across conditions, in descending order, was as follows: cocaine-
cocaine (M = 24.88, SE = 4.04), heroin-cocaine (M = 22.36, SE = 3.54), heroin-heroin (M 
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Fig. 5.28. Amount of h1a- and arc-positive nuclei in the 
prelimbic cortex (PL) as a function of drug group. Error bars 
represent ± 1 SE. N = 4 for each group.
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Fig. 5.29. Co-expressing nuclei as a percentage of all mRNA-
positive nuclei in the prelimbic cortex (PL). Error bars represent 
± 1 SE. N = 4 for each group.
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= 21.81, SE = 4.92), cocaine-heroin (M = 18.66, SE = 2.49) and control (M = 18.38, SE = 
3.71). 
Shapiro-Wilk tests revealed normal distribution of scores within conditions. Levene’s 
statistic was non-significant, F(4,15) = 0.57, p = .688. A one-way ANOVA revealed no 
significant differences between groups, F(4,15) = 0.51, p = .731.  
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Fig. 5.30. Amount of h1a- and arc-positive nuclei in the anterior 
cingulate dorsal cortex (ACd) as a function of drug group. Error 
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Discussion 
The study reported here was a pilot study with a relatively small sample size and low 
statistical power. For this reason, parts of the following discussion revolve around the 
qualitative analysis of data, rather than statistically significant differences between 
treatment groups. This is particularly true for the categorical measures of behaviour (figs. 
5.13-5.23) where statistical differences between drug groups were not found after 
corrections for multiple testing.  
Self-administration and latency to approach drug-associated levers 
All rats learned to self-administer heroin quickly, and escalated intake over time. 
Conversely, although all rats included in the analysis also lever-pressed for cocaine, lever 
press frequencies were much lower and with high variability between individual animals. 
Rats were also quicker to approach the heroin-associated lever during the final test 
session. When heroin and cocaine self-administration levels were presented as a 
percentage of available infusions that were self-administered, on average, rats self-
administered a high proportion of the available heroin infusions, and a much lower 
proportion of available cocaine infusions. In fact, some rats had such low levels of 
cocaine self-administration that they could not be included in the final test session 
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Fig. 5.31. Co-expressing nuclei as a percentage of all mRNA-
positive nuclei in the anterior cingulate dorsal cortex (ACd). 
Error bars represent ± 1 SE. N = 4 for each group.
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groups where they had to press for cocaine. This resulted in the obvious methodological 
issue of having uneven levels of cocaine self-administration between groups in the final 
tests session. Taken together the data suggest that, under the conditions of this 
experiment, heroin was more effective reinforcer than cocaine, and rats were more 
motivated to obtain it. 
The preference for heroin over cocaine found in this sample of rats was unexpected. 
One possible explanation for the poor reinforcing properties of cocaine could be a high 
dose leading to anxiogenic effects. Chronic or acute treatment with 20 mg/kg i.p. 
cocaine increases plasma corticosterone, and decreases time spent in an open field and 
locomotion relative to saline treatment (Yang, Gorman, Dunn, & Goeders, 1992). 
However, other studies have successfully trained rats to self-administer cocaine at a 
dose of 800 µg/kg and even higher. Rats self-administer cocaine doses of the range 0.5-
2 mg/kg under both long and short access conditions (Mandt et al., 2012; Mantsch et al., 
2001; Pettit & Justice, 1991; Roberts, Loh, & Vickers, 1989; Wee, Specio, & Koob, 2007). 
An alternative explanation could be a particularly stress-prone strain or batch of animals 
used in this study. Rats from the same supplier and strain can differ in behavioural traits 
(e.g. sign-tracking vs. goal-tracking Fitzpatrick et al. (2013)) depending on the barrier 
they are raised in. Thus, although Sprague-Dawley rats are widely used in cocaine self-
administration studies, the rats in this study may represent a particularly stress-sensitive 
sample for which the 800 µg/kg dose of cocaine was anxiogenic and aversive. Issues with 
the training schedule itself or the drug-administration apparatus are unlikely, because 
these should have affected heroin similarly, but all animals learned to self-administer 
heroin easily. There is also the possibility that certain parameters of the training 
schedule and experimental setup might have been specifically necessary to facilitate 
cocaine but not heroin self-administration.  
Locomotion and stereotypy 
Following the first drug infusion of the test session, rats displayed a markedly different 
locomotor response depending on whether they received heroin or cocaine. Within the 
first 5 min following the first drug infusion, cocaine and heroin did not produce 
statistically significant increases in locomotion relative to saline, suggesting that activity 
during this time period cannot be distinguished from a conditioned effect of the self-
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administration environment. However, over the following 20 min post-infusion, 
locomotor activity in rats receiving heroin remained high, while activity in the cocaine 
and control groups diminished substantially. Immediately after the infusion locomotor 
activity in the heroin group was also quite variable, although high on average. This 
change in locomotor activity following heroin was accompanied by an increase in the 
average score on the scale adapted from Ellinwood and Balster, suggesting an increase 
in stereotyped behaviour relative to cocaine and controls which occurred in many rats 
instead of locomotion. With time, this kind of behaviour decreased and was replaced by 
locomotor behaviour. Note that the high score on the stereotypy scale following the 1st 
injection of the tests session was mostly the result of heroin-induced gnawing behaviour, 
which is assigned a score of 8 on the Ellinwood scale (see table 5.1, p.113; definitions in 
this table are copied from the original paper). Categorical measures of behaviour 
confirmed this observation (discussed further on). 
Cocaine- and heroin-induced locomotor behaviour are well-established phenomena, 
but are usually studied under conditions of intermittent non-contingent drug 
administration via the i.p. route. Under such conditions, both drugs elicit robust increase 
in locomotor activity, and this effect sensitizes with repeated drug administration, 
depending on environmental context and individual differences (Crombag, Jedynak, 
Redmond, Robinson, & Hope, 2002; Flagel, Watson, Akil, & Robinson, 2008; Paolone et 
al., 2007). The development of sensitisation (in the broader sense) following history of 
self-administration also depends heavily on circumstances such as the pattern of self-
administration as well as the presence or absence of an abstinence period. In a study 
using very similar self-administration parameters to the ones presented here (6h 
sessions, 40 available infusions, 1.5 mg/kg/inf), cocaine self-administration led to 
reduced locomotor and stereotypy response to a cocaine challenge, reduced DA release 
in the accumbens core, reduced ability of cocaine to block the DA transporter, and 
reduced DA release and uptake after artificial stimulation, relative to saline self-
administering animals, 24 hours after the final self-administration session (Calipari, 
Ferris, & Jones, 2014). Other studies have shown tolerance or lack of sensitisation effects 
within this time frame following self-administration (24h), which is in contrast to 
evidence for sensitisation following intermittent access self-administration paradigms 
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or after a period of abstinence (Hooks, Duffy, Striplin, & Kalivas, 1994; Kawa, Bentzley, 
& Robinson, 2016). It would have been of interest to examine the effects of the training 
schedule on tolerance and sensitisation in the present study given the lack of detectable 
IEG expression in the striatum, since the two phenomena are related (Chandra & Lobo, 
2017). However, the design of the present study did not allow for the assessment of 
tolerance or sensitisation, because all rats had undergone drug self-administration – a 
limitation that could be addressed in the future. 
Following the second drug injection, locomotor behaviour was highest in rats receiving 
cocaine, comparable to the levels following the first injection. Control levels of 
locomotion had subsided towards the end of the session, suggesting that the 
conditioned effect of the environment was transient. Locomotor activity after a second 
injection of heroin was not very different from that of controls. A breakdown of the 
effect into drug-combination groups revealed a trend towards increased locomotion 
following a second injection of cocaine, where the effect was more pronounced if the 
preceding injection was heroin.  The diminished locomotion in the case of a second 
injection of heroin could reflect a sedative effect or an increase in stereotypy. Thus, 
there was a trend suggesting an interaction between the effects of the first and second 
injections on locomotor behaviour. Indeed, animals pre-treated with heroin show an 
increase in locomotion after a cocaine challenge, and the effect is dose-dependent and 
additive (Leri, Flores, Rajabi, & Stewart, 2003). 
Stereotypy did not vary much between heroin- and cocaine-treated animals after the 
second injection of the test session, regardless of the first drug administered. Control 
animals scored low on the stereotypy scale, and heroin-treated animals tended to score 
higher than both cocaine-treated and controls. However, most differences did not reach 
statistical significance so definitive conclusions cannot be made.  
Categorical measures of behaviour 
Soon after the first drug injection of the test session (5-10 min), locomotor behaviour 
was present in the majority of animals receiving cocaine and those in the control group. 
By 15 min, a small proportion of these animals were showing this behaviour. For heroin, 
the pattern was the opposite – a small proportion of animals were exhibiting locomotor 
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behaviour early compared to later on following a heroin injection. Thus, categorical 
classification of behaviour confirmed the continuous measure of locomotion: cocaine-
induced and conditioned locomotion were present in the beginning of the test session, 
while heroin-induced locomotion was mostly seen later on. Heroin-treated animals also 
exhibited a lot of rearing behaviour towards the end of the first period in the test session. 
A notable difference was also seen in the proportion of animals exhibiting gnawing and 
sniffing behaviours. The majority of animals exhibiting the former behaviour were those 
who self-administered heroin, while the latter behaviour was more characteristic of 
animals receiving cocaine. This is not surprising, since oral stereotypy is a known 
consequence of repeated opiate treatment at high doses (Pollock & Kornetsky, 1996). 
There were no notable differences between drug groups and controls for other types of 
behaviour, except miscellaneous behaviours exhibited only by a few animals, but all of 
them receiving heroin. These behaviours included jumping, holding on to the wall of the 
cage or displaying catatonia. 
Following the second drug injection (or the last 5 min of the test session for control 
animals) the most prevalent types of behaviours were locomotion and sniffing 
(exploring) in cocaine-treated rats and gnawing stereotypy in the heroin-treated rats. 
The control group were mostly still, grooming or showing some other form of low 
activity. Thus, by the end of the test session, conditioned effects on behaviour had 
mostly disappeared, while heroin was still inducing stereotypy, and cocaine – increased 
locomotor activity and exploration. 
Summary of behaviour 
Heroin at a dose of 100 µg/kg was an effective reinforcer, maintaining escalating drug 
intake. Rats receiving heroin during the test session were the most active, expressing a 
mixture of locomotor and stereotyped behaviour in response to the drug. Stereotyped 
behaviour often took the form of gnawing, and occurred immediately (up to 5 min) after 
the heroin injection. After about 10 min had passed since the injection, these rats 
switched to locomotor and rearing behaviour. 
Rats were less motivated for cocaine than heroin – they self-administered relatively few 
of the available infusions every session, and took longer to approach the lever than they 
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did with heroin. Cocaine-receiving animals were active only immediately after the 
cocaine injection, and this effect was not easily discernible from potential conditioned 
effects of the drug-associated context. In contrast to the case of heroin, animals did not 
exhibit stereotyped behaviour following cocaine, but instead showed increased 
exploratory behaviour (locomotion and sniffing).  
There was evidence for interaction between the first and second injections of the test 
session in terms of drug-induced locomotor behaviour, but not other measures of 
behaviour. That is, locomotion was reduced with repeated cocaine or heroin 
administration. When a combination of the two drugs was self-administered, cocaine-
induced locomotion was not reduced by preceding heroin (was even slightly enhanced), 
while heroin-induced locomotion was reduced by cocaine. 
CatFISH 
There was very low expression of homer 1a in the striatum (see Appendix 3), so catFISH 
was used only to analyse IEG expression in the PFC. Arc expression in the striatum was 
more prevalent, but no quantitative analysis was done to determine whether drug 
treatments elevated expression over baseline. In the PFC, both h1a and arc expression 
was easily detectable, but was not affected by drug treatment during the test session. 
As already mentioned in the introduction, Fumagalli et al. have shown that a single 
cocaine self-administration session can result in increased arc expression in the PFC. 
However, their control groups consisted of yoked animals receiving cocaine and saline, 
and these two groups had comparable, lower levels of arc expression. Thus, it is possible 
that the increase in arc expression reflected a learning process rather than a drug effect. 
Indeed, Gao et al. (2017) did not find increased levels of arc expression following 10 days 
of cocaine self-administration (although there was an increase after 60 days). The saline 
controls in their study were exposed to the same self-administration environment, but 
did not receive any cocaine. Finally, Li et al. (2013) found elevated levels of arc protein 
product following runway training for heroin, but both the task and the schedule of 
reward delivery was very different from the self-administration procedure used here. 
They had only a single trial (drug treatment) per day. Thus, the reasons why no reliable 
increase of IEG expression was found in any experimental groups could be either that (i) 
such increase accompanies early learning but is absent following extended training; (ii) 
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that the training schedule and the task were not adequate to elicit IEG expression; or (iii) 
the duration of self-administration training was not long enough to cause changes 
relative to drug-naïve animals. This experiment was not designed to address the final 
possibility directly, but future studies must take it into account.  
Overlap was also not found to vary significantly between treatment groups, eliminating 
the possibility that some drug-specific activity pattern might be masked over by the high 
baseline activity.  
Conclusions and future suggestions 
Rats responded very differently to heroin and cocaine under the conditions of the 
present study, both in terms of self-administration behaviour and drug-induced 
behaviour such as locomotion and stereotypy. Low levels of homer 1a expression in the 
striatum and no change from baseline expression in the PFC prevented the use of 
catFISH to examine patterns of neuronal activity associated with any behaviour. The 
data presented here is not sufficient to exclude a possibility of using catFISH in this 
context. However, if findings reported in preceding chapters are to be related to drug 
self-administration behaviour, the parameters of the training schedule must be changed. 
One necessary change would be to test for an effect of duration of the training schedule. 
IEG expression seems to be evident only during very short or very long periods of drug 
self-administration (Fumagalli et al., 2009; Gao et al., 2017; Li et al., 2013). Alternatively, 
other IEGs can be used for catFISH. One possible alternative would be using c-fos instead 
of homer 1a to identify active neurons in the striatum, since c-fos and homer 1a mRNA 
have similar temporal profiles of expression (peak ~30 min following activity). Previous 
studies have shown that c-fos expression in striatum and PFC is still elevated by drugs 
even after many days of self-administration training. Finally, catFISH can be used to mark 
the neuronal populations activated by two drug stimuli administered 1h apart rather 
than 25 min apart, in order to avoid interactions between them. This can be achieved 
by using nuclear arc signal to tag one neuronal population and cytoplasmic h1a signal to 
mark the other, since h1a diffuses to the cytoplasm ~1h following cellular activity. 
The preference for heroin over cocaine shown by rats in this study is also intriguing. 
Future studies could address the question of whether this preference is the result of 
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availability of both drugs. That is, would the rats self-administer cocaine at higher rates 
if heroin was not available at all?  
The interaction between heroin and cocaine in terms of their effect primarily on 
locomotion but not stereotypy is to be noted as well. Stereotypy was much more 
prevalent in animals receiving heroin. It is possible that activity produced by heroin in 
the dorsal striatum is increased following prolonged exposure to heroin, producing a 
different pattern of activity than that seen after non-contingent drug administration in 
naïve animals. The interaction effects of heroin and cocaine self-administration on 
locomotor behaviour may in turn reflect the interaction seen in terms of overlap in the 
Nacc following non-contingent drug administration. Future studies could answer these 
questions if the right training schedule and IEGs are used to apply the catFISH technique 
to the self-administration paradigm. 
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Chapter 6 – Discussion 
 
1. Summary of findings and methodological considerations 
Summary of findings 
Non-contingent administration of heroin and cocaine at doses self-administered by rats 
elevated expression of the immediate-early genes homer 1a and arc in several parts of 
the striatum – a brain area involved in processing of reward and goal-directed behaviour. 
The temporal pattern of expression of the two genes was similar to the one found in the 
hippocampus following exploration of a novel environment. Levels of homer 1a 
expression were elevated within ~30 min following drug administration, while 
expression of arc was elevated as soon as 5 min after drug treatment. Thus, it was 
possible to take advantage of this difference and use the catFISH technique to search 
for neuronal populations activated by heroin and cocaine in the striatum, and to 
determine to what extent these populations are overlapping or distinct. This analysis 
revealed that cocaine activates the same population of neurons repeatedly in the Nacc 
core and the dorsal striatum (but not in the shell), which suggested the existence of a 
neuronal ensemble in those brain areas encoding for some of the effects of the drug. 
Conversely, the same was found for heroin only in the Nacc shell.  
Although evidence for neuronal ensembles responding to heroin and cocaine was found 
only in certain striatal areas, IEG expression was affected by both drugs across the whole 
striatum. That is, cocaine treatment did have an effect on homer 1a and arc expression 
in the Nacc shell. However, it was not possible to determine whether there were 
neurons responding reliably to the drug in this brain area. Heroin did increase homer 1a 
and arc expression in other parts of the striatum than the Nacc shell. Yet, the effect 
varied depending on what drug was administered beforehand, whether expression was 
measured in the dorsal striatum or the Nacc, and there was no evidence for a neuronal 
ensemble responding to heroin in other striatal areas than the shell. Regardless of 
whether they represented neuronal ensembles or not, the neuronal populations 
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responding to heroin and cocaine overlapped significantly only in the Nacc shell. In all 
other areas of the striatum, the overlap did not exceed chance levels. 
Finally, a self-administration experiment revealed that the dose of cocaine used for the 
non-contingent drug administration study did not maintain self-administration in a 
substantial proportion of animals. It was also evident that drug-induced behaviour such 
as locomotion and stereotypy persisted for at least 25 min following a self-administered 
drug injection; i.e. these behaviours were still evident by the time a second injection was 
administered for catFISH. This persistence of behaviour was more pronounced following 
100 µg/kg heroin than 800 µg/kg cocaine. Following 14 days of heroin and cocaine self-
administration IEG expression did not change in response to an injection of either drug 
in the PFC, and homer 1a expression was almost undetectable in the striatum.  
Thus, catFISH revealed that heroin and cocaine engage different neuronal populations 
in most parts of the striatum except the Nacc shell, at least as far as homer 1a and arc 
expression are concerned. However, this observation must be considered taking into 
account factors such as drug dose, possible interactions between heroin and cocaine 
administered in succession, and previous experience with each of the two drugs. 
Methodological considerations 
It is important to keep in mind that the relationship between neuronal activity from an 
electrophysiological point of view (i.e. firing of action potentials) and IEG expression is 
not straightforward. Although there are a lot of commonalities between different IEGs 
in terms of the molecular mechanisms which trigger IEG expression, there are cell-type 
and regional differences in levels of IEG expression, as well as differences in the 
preferred transcription factors involved in IEG transcription. Generally, IEGs are 
transcribed after a strong depolarisation of a neuron leads to calcium influx through 
NMDA receptors and calcium voltage-gated channels. Calcium then interacts with 
protein kinases (e.g. CaMK and MAPK) which in turn activate transcription factors (e.g. 
CREB, SRF) to promote IEG transcription (Kawashima et al., 2014). Thus, the first point 
to consider is what constitutes strong activation sufficient to trigger calcium influx. It 
seems the rate of action potential firing is the most defining factor in this case. For 
example, Sgambato et al. have shown that cortical stimulation elicits the highest rate of 
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c-fos protein expression when a high number of shocks are applied over a given 
stimulation period, regardless of the temporal pattern of stimulation (i.e. single shock 
vs. trains, or high vs. low frequency) (Sgambato, Abo, Rogard, Besson, & Deniau, 1997). 
In addition, elevated levels of phosphorylated (i.e. activated) CREB is seen following both 
high- and low-frequency stimulation, but only prolonged stimulation at low frequencies 
can lead to transcription of c-fos (Bito, Deisseroth, & Tsien, 1996). CREB activity is tied 
to both LTP and LTD-inducing kinds of stimulation (Deisseroth, Bito, & Tsien, 1996). 
Second, if voltage-gated calcium channels are involved in IEG transcription, then IEG 
transcription induced by acute heroin administration may be both positively and 
negatively affected. Interestingly, activation of the µ-opioid receptor can both activate 
the MAPK pathway (Macey, Lowe, & Chavkin, 2006), and suppress activity of voltage-
gated calcium channels. This presents a case of two competing mechanisms, one 
promoting and one supressing IEG expression in response to heroin. This could be one 
explanation for the substantially diminished expression of arc following repeated 
administration of heroin. Finally, expression of different IEGs may be more or less driven 
by one transcription factor or another, despite the fact that multiple converging 
intracellular cascades can promote transcription of the same IEG. This could explain, for 
example, why very low homer 1a transcription was found in the Nacc shell in response 
to cocaine, while arc transcription was high. The fact that heroin increased homer 1a in 
the shell further supports this point. Finally, several response elements may need to act 
in concert to allow c-fos expression (Robertson et al., 1995), and it is not unlikely that 
this is the case for other IEGs such as arc and homer 1a. 
In summary, although IEGs are widely recognised as markers of neuronal activity, drug-
induced IEG expression should be interpreted with caution. More precisely, this type of 
IEG expression is likely to reflect long-lasting neurobiological changes that occur as a 
result of early drug effects, and these changes occur under very specific circumstances 
that do not reflect all types of neuronal activity. The fact that changes in IEG expression 
were not found following a period of drug self-administration training further supports 
this claim. 
Another consideration to be taken into account is what was considered a neuronal 
ensemble throughout the studies presented in this thesis. Some discussion of the 
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different definitions of a neuronal ensemble was provided in ch.1. Additionally, some 
authors distinguish between neuronal assemblies, neuronal ensembles, and the 
memory engram. This is particularly the case in the context of memory research, 
amygdalar and hippocampal function. A neuronal assembly is defined as a group of 
neurons which are activated in concert due to established connections between them. 
Neuronal ensembles, on the other hand, refers to groups of neurons involved in a 
particular computation. In electrophysiological research, the term also refers to 
populations of neurons which present correlated activity during a specific task, 
regardless of their causal role in behaviour or perception (Deadwyler & Hampson, 1997). 
Importantly, individual neurons within neuronal ensembles tend to be noisy, but 
together they produce a coherent output. Finally, the engram is a term particularly 
relevant to memory research, and refers to the physical representation of memory in 
the brain – the sum of the biochemical and biophysical changes induced upon learning 
(Holtmaat & Caroni, 2016; Tonegawa, Pignatelli, Roy, & Ryan, 2015). Regardless of the 
particular terms used, it is generally accepted that the coordinated function of 
distributed neuronal populations is what constitutes the coding language of the brain.  
Calcium imaging has also proved a very useful tool for characterisation of neuronal 
ensembles, since it allows for the simultaneous recording of the activity of spatially 
distributed neurons of the cortex. Work in this field has corroborated findings using IEG-
driven neuronal tagging. For example, calcium imaging has revealed that the visual 
cortex is comprised of groups of coactive neurons (assemblies) which exhibit 
synchronised spontaneous activity. During perception, these assemblies become active 
in a similar fashion, but time-locked to the stimulus in question (ensembles). In addition, 
the firing of neurons in these ensembles is a probabilistic phenomenon, and only a 
proportion of neurons exhibit the highest probability of firing (“core ensembles”) (J. E. 
Miller, Ayzenshtat, Carrillo-Reid, & Yuste, 2014).  
Corroborating evidence for the function of the visual cortex has also been demonstrated 
in the field of IEG-tagged neuronal ensembles. In the primary visual cortex, upon initial 
experience with a light stimulus of a particular orientation, a large number of neurons 
express arc. Only a small subset of these neurons are recruited one day after. Thus, 
previously activated neurons are likely to be recruited again when the same stimulus is 
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presented a second time, thus forming a neuronal ensemble. Importantly, with repeated 
presentation of the stimulus, the ensemble becomes smaller and more reliably activated 
by the stimulus. Expression of arc is not necessary for this phenomenon, although it does 
improve the specificity of the resulting ensemble (Wang et al., 2006). 
Obviously, whether the organisation of neuronal networks and encoding of stimuli and 
memories is the same between cortical and subcortical structures is a separate question. 
However, there is convincing evidence that this might be the case, at least in terms of 
contextual fear conditioning and motivated behaviour. More importantly, manipulating 
neuronal ensembles in subcortical structures through IEG tagging and optogenetics has 
revealed the causal role of neuronal ensembles in these forms of behaviour. For example, 
activity of neurons in the lateral amygdala during cocaine CPP is determined by the 
activity of CREB, such that neurons with higher levels of CREB are more likely to be 
recruited during learning. In addition, ablation of these neurons abolishes the 
expression of the CPP memory (Hsiang et al., 2014). Similarly, the expression of 
contextual fear memories can be elicited by the optogenetic stimulation of neuronal 
ensembles in the hippocampus (Liu et al., 2012). 
One remaining question is whether there is evidence that memories of a drug effect are 
encoded similarly and independently of context. When cocaine is administered non-
contingently (following a sensitising protocol), a large proportion of the Nacc neurons 
recruited following the drug administration are those that have been activated during 
previous injections (Mattson et al., 2008). Thus, the drug itself seems to influence 
neuronal activity the same way as a visual stimulus does in the cortex – by activating 
neurons that are intrinsically more excitable. However, this effect is not completely 
independent of context, since there is a much larger number of neurons active in a 
context previously paired with drug delivery (in the same study). To some extent, the 
circumstances of drug administration define which and how many neurons will be 
activated. 
In summary, the concept of neuronal ensembles has a somewhat loose definition that 
varies depending on the specific field of research where it is used, and on the techniques 
used to define it. Nevertheless, there is general consensus that a population of neurons 
has to exhibit simultaneous activity time-locked to a given stimulus or behaviour in order 
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to be defined as an ensemble. In some cases, it is also required that the ensemble of 
neurons are causally involved in the expression of a behaviour, or are at least reliably 
activated by the repeated presentation of the same stimulus. In studies presented in 
this thesis, there were no available tools to infer causal role of the neuronal populations 
in behaviour. For this reason, a neuronal ensemble was defined as a population of 
neurons which is reliably active during the repeated presentation of the same drug 
stimulus. 
Finally, on several occasions it was implied that the distinct neuronal populations 
activated by heroin and cocaine across the striatum are indicative of dissociated circuitry 
processing the acute effects of the two drugs. This claim warrants a clarification of what 
is meant by a “circuitry”, and why distinct neuronal populations within the same brain 
area may be indicative of dissociated circuitries. The definition of circuitry used 
presently can be related (but not equated) to the Hebbian concept of “phase sequence”: 
the serial activation of cell assemblies bridging the gap between sensory input and 
motor output (Hebb, 1949). More specifically, a circuitry here is defined as all neurons 
activated in response to heroin or cocaine administration, the activity of which encodes 
for any of their subjective or overt behavioural effects. Dissociation of circuitries in this 
case implies that such neurons are characterised by one or more of the following: they 
comprise distinct neuronal populations within the same brain areas, they are embedded 
in different brain areas, they receive excitatory input from different up-stream sources 
(or combinations of sources), and/or send afferent projections to different down-stream 
targets (or combinations of targets), and/or exhibit distinct genetic/neurochemical 
profiles (e.g. express different receptors, release different neurotransmitters, etc.). The 
data presented in this thesis provides direct evidence for the first prerequisite for 
dissociated circuitries processing heroin and cocaine, but there is already existing 
evidence that the striatum is functionally and structurally organised to accommodate 
for the rest of the prerequisites as well, as described in continuation. 
First of all, MSNs and cortical pyramidal neurons are characterised by up- and down-
states meaning they alternate between highly polarised (-80 mV) vs. depolarised (-55 
mV) sub-threshold resting membrane potentials (J. A. Wolf, Schroeder, & Finkel, 2001). 
Action potential firing is rare during down-states and transition to up-states and spiking 
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activity is only possible with synchronised excitatory input coming from multiple sources 
converging onto single MSNs. Dopamine signalling through D1 receptors may further 
facilitate the transition to and the maintenance of up-states (O'Donnell, 2003). Thus, in 
order for MSNs to be excited (and to express IEGs), they must receive input from several 
sources which may include different combinations of amygdala, hippocampus, thalamus, 
PFC and VTA/SNc afferent inputs (Pennartz et al., 1994). Each of the brain areas sending 
these afferent projections i) may be affected differently by heroin, cocaine, and natural 
rewards (Chang et al., 1998; Mukherjee et al., 2018); ii) may contain neuronal ensembles 
involved in distinct functions (Warren et al., 2016; Zelikowsky et al., 2014), and iii) may 
be comprised of genetically distinct projection neurons. Thus, taking into account the 
integrative function of the striatum (i.e. the combined glutamatergic input it receives 
from multiple brain regions), the diverse connectivity and specialised functions of its 
input regions, and the necessity for synchronised excitatory input to elicit action 
potentials from MSNs, it is quite possible that distinct neuronal populations activated in 
the striatum represent activity within dissociated circuitries. Here it must be noted that, 
although the afferent inputs of the striatum from limbic and cortical areas are 
topographically organised in a ventromedial-dorsolateral fashion (see fig 1.1, p. 10), they 
are not constrained to perfectly defined striatal subregions, but are overlapping, with 
higher concentrations of certain afferents in e.g. shell vs core (Voorn et al., 2004). 
Further support for the possibility that distinct neuronal populations in the striatum 
pertain to distinct circuitries comes from the diverse output targets of the striatum, 
some discussion of which was presented in ch.1. More specifically, the cortico-striatal-
thalamocortical loops characteristic of the striatum are a good example of how parallel 
but distinct circuitries can pass through this brain area (Alexander, Crutcher, & DeLong, 
1990; Pennartz et al., 1994). 
It should also be taken into account that MSNs send collateral GABAergic projections to 
neighbouring MSNs. This mutual inhibition between MSNs is another functional-
anatomical feature predisposing the accumbens and rest of striatum to accommodate 
neuronal ensembles embedded in distinct circuitries – whilst one particular ensemble is 
active, it can decrease the activity in other ensembles so that only a particular 
computation is taking place over others. Lateral inhibition can also help in the formation 
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of well-defined activity patterns within ensembles; i.e. reduce the number of neurons 
active within a given ensemble, leaving more available neurons for encoding of other 
functions (Pennartz et al., 1994). 
Of course, all these characteristics of the striatum are only suggestive of the possibility 
that distinct circuitries process heroin and cocaine, in view of the data shown in this 
thesis. Further research is necessary to empirically ascertain the presence of such 
dissociated circuitries by incorporating i) viral tracing techniques to identify afferent and 
efferent input of heroin- and cocaine-activated neurons; ii) histochemistry – to assess 
for genetic differences between these neurons; and iii) opto- or chemogenetic 
techniques to look for functional differences of said neurons. 
2. Implications of main findings for addiction theory and treatment practice 
Theoretical implications  
Current theories of addiction have shifted their focus away from the acute effects of 
drugs in order to explain addictive behaviour through aberrant learning processes and 
long-term plastic changes in the brain. For example, incentive-sensitisation theory 
proposes that the crucial factor in drug addiction is the interplay between sensitised 
brain systems controlling motivation, and drug-associated stimuli to which these 
systems become hyper-reactive. Sensitisation can take many forms, and includes, but is 
not limited to, changes in dopamine transmission from the VTA, and glutamatergic 
transmission from the prefrontal cortex to the Nacc (Berridge & Robinson, 2016; M. E. 
Wolf, 2010). Frontal-striatal dysfunction theory further expands this view by proposing 
that dopamine signalling in the amygdala might be involved in the strengthening of 
associations between drug effects and stimuli from the environment. In addition, it 
suggests that hypofunction of the prefrontal cortex may result in diminished ability to 
control impulses arising from a hyper-reactive motivational system (Jentsch & Taylor, 
1999). Habit formation theory takes a somewhat different approach by suggesting that 
outcomes of behaviour in drug addiction become less and less able to control the 
behaviour, which becomes primarily dependent on stimulus-response associations 
(Everitt & Robbins, 2005). Regardless of the specific approach taken, there is an implied 
consensus between theories that the neurobiological and behavioural changes involving 
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the striatum and learning become relevant only following prolonged exposure to drugs. 
This framework has undoubtedly led to important insights into the psychobiological 
processes that underlie the maintenance of compulsive drug-seeking once it’s 
established. However, it still remains unclear which psychobiological processes give rise 
to addiction in the first place (Wise & Koob, 2014). Arguably, the early acute effects of 
drugs are important in this regard, because drug-induced behavioural and 
neurobiological changes have to begin somewhere. Knowing where in the brain drugs 
exert their effects initially and how (or if) these effects lead to pathological drug-taking 
is an equally important theoretical question to that of how addiction is maintained once 
it’s established. The studies presented here are a step towards answering these 
questions, especially considering the functional importance of IEG-expressing neurons. 
As discussed previously, neurons which express IEGs undergo changes in excitability, and 
are more likely to be incorporated in neuronal ensembles with a causal role in behaviour 
and perception. In addition, these neurons are more likely to undergo morphological 
changes. For example, silent synapses form preferentially in c-fos-positive neurons of 
the Nacc shell following repeated treatment with cocaine (Koya et al., 2012). Morphine 
treatment also results in the formation of silent synapses, albeit through different 
mechanisms (formation of new synapses vs. endocytosis of AMPA receptors at existing 
synapses, respectively (Graziane et al., 2016)). The findings presented here suggest that, 
at least initially, such changes may occur in an ensemble shared by heroin and cocaine 
in the Nacc shell. Conversely, different ensembles may undergo changes induced by 
each drug in the rest of the striatum.  
The functional significance of these convergent and divergent neurobiological changes 
following heroin and cocaine remain an open empirical question. That is, it remains to 
be determined if separation of neuronal ensembles within the same brain area leads to 
distinct behavioural effects of heroin and cocaine. Recently, it was shown that distinct, 
intermingled neuronal ensembles within the vmPFC can drive both reward and 
extinction memories for food (Warren et al., 2016). Thus, a separation of neuronal 
ensembles may indeed signify functional differences. 
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Possible implications for treatment and prevention of drug abuse disorders 
Treatments for addiction can be broadly classified in two main categories – behavioural 
psychotherapy and pharmacotherapy. Some types of behavioural therapies involve 
taking advantage of basic learning principles such as operant conditioning. For example, 
community-based approaches aim to encourage sobriety through positive social 
reinforcement (W. R. Miller, Meyers, & Hiller-Sturmhofel, 1999). Contingency 
management therapies reinforce abstinence through monetary or voucher prizes in 
exchange for drug-free samples (Petry, Martin, & Simcic, 2005). Cognitive-behavioural 
therapies usually involve training drug abusers to recognise and control triggers of drug 
craving, and craving itself (Carroll & Onken, 2005). Such approaches to addiction therapy 
do not have a direct connection to the neurobiology of the disorder. Yet, findings 
indicating dissociated neural substrates for different addictions may serve as proof of 
concept that heroin and cocaine addictions need to be conceptualised differently. For 
example, it has been shown that the environment can modulate the reinforcing (Caprioli 
et al., 2008; Caprioli, Paolone, et al., 2007) and subjective effects (Avvisati et al., 2016; 
Caprioli, Celentano, et al., 2007) of heroin and cocaine in opposite ways, as well as the 
propensity to relapse (Montanari et al., 2015). If behavioural therapies take into account 
high-risk factors for relapse and their management, there is good chance that these 
factors will be defined by drug-specific action in the brain at least to some extent. 
Pharmacotherapy for addiction involves the controlled administration of substances 
that either mimic the pharmacological effects of the abused drug, or reduce its 
reinforcing properties through blockade of its target receptors. The best known example 
is methadone substitution therapy for opiate addiction (Joseph, Stancliff, & Langrod, 
2000), but there are similar approaches for alcohol abuse (e.g. benzodiazepine 
treatment (Gatch & Lal, 1998)), as well as for nicotine addiction. More recently, research 
has focused on drugs that induce aversion to alcohol (e.g. ALDH inhibitors (Yao et al., 
2010)) or suppress the reinforcing properties of drugs through blockade of NMDA 
receptors (Bisaga & Popik, 2000). NMDA antagonists are also used for disruption of 
memories which underlie the conditioned effects of reward-associated cues in 
laboratory animals (Exton-McGuinness & Lee, 2015). With this new interest in NMDA- 
targeting drugs, a good understanding of the precise way the brain is encoding the 
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specific effects of drugs has a lot of relevance to pharmacotherapy. Given that drug-
induced brain changes and drug-related memories are a main driving force of drug 
addiction, and are dependent on the NMDA receptor, the ability to identify and target 
them with high specificity would be useful. In this context the separation of the neuronal 
populations encoding for heroin and cocaine effects is particularly relevant, as it implies 
that novel approaches may be more successful if they target drug-specific neural 
substrates instead of looking for a common substrate as a target. 
3. Future suggestions 
As already implied, the functional significance of the separation between neuronal 
populations responding to cocaine and heroin in the striatum remains to be determined. 
The Daun02 method and optogenetic manipulation of neurons activated during a 
specific event are useful tools in this regard. One suggestion for future research would 
be to test whether inactivation of neurons responding to cocaine can disrupt self-
administration and reinstatement of drug-seeking behaviour for heroin (or vice versa).  
In addition, it remains to be determined if there are any differences in terms of the 
genetic profile of neurons responding to the two drugs. A study using the fluorescence-
activated cell-sorting technique (FACS) has shown that striatal neurons expressing c-fos 
in response to a single injection of cocaine also express arc, and include mostly 
dopamine D1 receptor containing neurons. These strongly activated neurons also have 
increased levels of the phosphatase Mkp1, and reduced levels of the kinase Map2k6, 
meaning that p38 MAPK signalling might be attenuated in cocaine-activated striatal 
neurons (Guez-Barber et al., 2011). The selective expression of IEGs such as c-fos and 
arc in D1-expressing MSNs is not surprising considering that IEGs are expressed as a 
result of neuronal activity which involves depolarisation of the cell membrane and 
calcium influx. Calcium-initiated IEG transcription is moderated by D1 and D2 
dopaminergic receptors which stimulate and inhibit PKA, respectively (Tritsch & Sabatini, 
2012), and PKA is necessary for the phosphorylation of CREB which controls arc, homer 
1a and c-fos expression (Impey et al., 1998). In addition, activity at D1 receptors 
facilitates excitatory glutamatergic transmission in the striatum by increasing AMPA and 
NMDA receptor surface expression, enhancing currents through these receptors and 
inducing up-states in MSNs (Surmeier, Ding, Day, Wang, & Shen, 2007). Thus, it is likely 
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that activity at D1 receptors would have a facilitating effect on IEG transcription, and 
cells expressing D1 receptors would be more likely to express IEG compared to D2-
expressing MSNs. Cocaine has a direct effect on DA transmission through inhibition of 
DA re-uptake, while heroin’s effect is indirect and less pronounced (already discussed in 
chapter 1). Considering the separation of neuronal ensembles responding to cocaine 
and heroin as well, it is possible that the genetic profile of heroin-activated neurons will 
be different, and may include D2-receptor-expressing neurons. Future studies should 
address this question, because that would be the first step towards being able to identify 
and selectively target neurons that encode drug-specific information. 
Another possible line of investigation would be to examine the afferent and efferent 
projections of neurons responding to heroin and cocaine administration. Retro- and 
anterograde labelling techniques can reveal whether the two drugs preferentially 
engage neurons receiving information from different brain areas. Finally, the 
electrophysiological profile of neurons responding to cocaine and heroin can be 
determined using transgenic animals that express GFP under the promoter of IEGs such 
as c-fos and arc. 
Finally, it must be noted that, in the studies described so far in this thesis, no attempt 
was made to control for social factors on drug-induced IEG expression or reinforcement. 
The importance of social factors has recently begun to gain popularity in animal research 
of drug addiction (Heilig, Epstein, Nader, & Shaham, 2016), and studies modelling the 
effect of social factors on the reinforcing and motivating properties of heroin and 
cocaine have been taking place for a while. For example, a low dose of cocaine is more 
reinforcing, while a higher dose is less reinforcing in rats reared in isolation early in life 
(from postnatal day 21) relative to group housed rats, and isolated rats show higher 
levels of zif268 protein product in the Nacc shell and core, DMS and DLS following i.p. 
cocaine (Howes, Dalley, Morrison, Robbins, & Everitt, 2000). Accordingly, adult (42 days 
old) female rats who are housed individually have a higher break point on a progressive-
ratio schedule of cocaine reinforcement relative to pair-housed females (Westenbroek, 
Perry, & Becker, 2013). Heroin self-administration rates are also higher in adult isolated 
rats relative to pair-housed ones (Bozarth, Murray, & Wise, 1989). Finally, social 
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isolation facilitates the reinstatement if heroin-induced CPP (Turner, Sunohara-Neilson, 
Ovari, Healy, & Leri, 2014).  
While social isolation can promote the reinforcing and motivating properties of drugs of 
abuse, social interaction can serve as an alternative reinforcer acting in opposition to 
drug reinforcement. For example, social interaction can serve as a reinforcer in the CPP 
procedure, where one compartment can be paired with the presentation of a 
conspecific, while the other compartment is paired with drug administration. In such 
cases social interaction serves as a more potent reinforcer than cocaine, so that rats will 
choose the social-interaction-paired compartment over the cocaine-paired one. This 
effect is accompanied by reversal of cocaine-CPP-induced expression of the zif268 
protein in the Nacc, amygdala and VTA (Fritz et al., 2011). Finally, cocaine self-
administration is potentiated by the presence of a conspecific with access to cocaine 
during self-administration sessions, while decreased by the presence of an abstaining 
conspecific (Peitz et al., 2013; Smith, 2012). Thus, social factors can influence both the 
reinforcing properties of drugs and their ability to induce IEG expression.  
In the studies presented in this thesis, all rats were tested following individual housing, 
which may have facilitated IEG expression in response to cocaine, but also reduced their 
propensity to self-administer a high dose of cocaine (Howes et al., 2000). One possible 
suggestion for future research would be to examine if such an effect is present for 
heroin-induced IEG expression, in particular arc and homer 1a, which have not been 
examined so far. Social effects on heroin self-administration as a function of dose has 
also not been studied, and it would be of particular interest since it may explain why rats 
in the self-administration study (chapter 5) showed better performance on acquisition 
of heroin vs. cocaine self-administration at the doses used. 
4. Conclusion 
The common goal of the series of experiments presented in this thesis was to compare 
the acute effects of heroin and cocaine – namely, the pattern of neuronal activity elicited 
by the two drugs in brain areas believed to be central to the neurological basis of drug 
addiction. The catFISH technique was the most appropriate method for this purpose. It 
is one of few currently available techniques which allows for direct comparisons of 
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neuronal activity elicited by two separate stimuli, within the same experimental animal, 
and in deep subcortical brain areas. Despite some caveats, such as the interaction 
between drug injections administered 25 min apart, and the different levels of IEG 
expression between brain areas, the results suggests a significant separation between 
the neuronal populations responding to heroin and cocaine in the striatum. Although 
the functional significance of this separation could not be determined, it is safe to 
suggest that it exists and it should be taken into account by future studies. Overall, this 
thesis provides a proof of concept that heroin and cocaine are processed differently by 
the brain, even within a brain area considered to be the common substrate for the 
addictive properties of the two drugs. Future research should focus on characterising 
the neuronal populations engaged by heroin and cocaine in terms of their genetic profile, 
connectivity, electrophysiological properties, and the kind of behaviours for which they 
encode. 
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Image 1 (↑)
A representative image of the DMS of an 
animal that received two consecutive 
injections of cocaine after heroin and cocaine 
self-administration training. Note the lack of 
homer-1a-positive nuclei, and the low level of 
arc expression.
Image 2 (↓)
A representative image of the DLS of the same animal.
Image 3 (↑)
A representative image of the Nacc core of the same animal.
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